Danielson ML, Bitsko RH, Ghandour RM, et al. Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. children and adolescents, 2016. Journal of Clinical Child and Adolescent Psychology. 2018 Mar–Apr;47(2):199–212. doi: 10.1080/15374416.2017.1417860. PMID: 29363986. [PMC free article: PMC5834391] [PubMed: 29363986] [CrossRef]

Center for Disease Control and Prevention. Data and Statistics About ADHD. www​.https://www.cdc.gov​/ncbddd/adhd/data.html. Accessed August 23, 2021.

Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007 Jun;164(6):942–8. doi: 10.1176/ajp.2007.164.6.942. PMID: 17541055. [PubMed: 17541055] [CrossRef]

Hong SB, Dwyer D, Kim JW, et al. Subthreshold attention-deficit/hyperactivity disorder is associated with functional impairments across domains: a comprehensive analysis in a large-scale community study. Eur Child Adolesc Psychiatry. 2014 Aug;23(8):627–36. doi: 10.1007/s00787-013-0501-z. PMID: 24318039. [PubMed: 24318039] [CrossRef]

Asherson P, Trzaskowski M. Attention-deficit/hyperactivity disorder is the extreme and impairing tail of a continuum. J Am Acad Child Adolesc Psychiatry. 2015 Apr;54(4):249–50. doi: 10.1016/j.jaac.2015.01.014. PMID: 25791141. [PubMed: 25791141] [CrossRef]

Greven CU, Merwood A, van der Meer JMJ, et al. The opposite end of the attention deficit hyperactivity disorder continuum: genetic and environmental aetiologies of extremely low ADHD traits. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2016;57:523 - 31. [PMC free article: PMC4789118] [PubMed: 26474816]

McLennan JD. Understanding attention deficit hyperactivity disorder as a continuum. Canadian family physician Medecin de famille canadien. 2016;62(12):979–82. PMID: 27965331. [PMC free article: PMC5154646] [PubMed: 27965331]

MedicalNewsToday. What to know about ADHD misdiagnosis. 2019. https://www​.medicalnewstoday​.com/articles/325595. Accessed on May 5, 2023.

Hinshaw SP, Nguyen PT, O’Grady SM, et al. Annual Research Review: Attention-deficit/hyperactivity disorder in girls and women: underrepresentation, longitudinal processes, and key directions. J Child Psychol Psychiatry. 2022 Apr;63(4):484–96. doi: 10.1111/jcpp.13480. PMID: 34231220. [PubMed: 34231220] [CrossRef]

Greven C, Richards JS, Buitelaar JK. Chapter 16: Sex differences in ADHD. Oxford Textbook of Attention Deficit Hyperactivity Disorder In: Banaschewski T, Coghill D, Zuddas A, eds. Oxford Textbook of Attention Deficit Hyperactivity Disorder. Oxford University Press; 2018:154–60.

Charach A, Dashti B, Carson P, et al. Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers; Long-Term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment. Compartative Effectiveness Review No. 44 (Prepared by the McMaster University Evidence-based Practice Center under Contract No. MME2202 290-02-0020.) AHRQ Publication No. 12-EHC003-EF Agency for Healthcare Research and Quality Rockville, MD: Oct Preschoolers; Long-Term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment October 2011. http://www​.ncbi.nlm.nih​.gov/entrez/query​.fcgi?cmd=Retrieve&db​=PubMed&dopt​=Citation&list_uids​=22191110

Shi Y, Hunter Guevara LR, Dykhoff HJ, et al. Racial Disparities in Diagnosis of Attention-Deficit/Hyperactivity Disorder in a US National Birth Cohort. JAMA Netw Open. 2021 Mar 1;4(3):e210321. doi: 10.1001/jamanetworkopen.2021.0321. PMID: 33646315. [PMC free article: PMC7921900] [PubMed: 33646315] [CrossRef]

Morgan PL, Hillemeier MM, Farkas G, et al. Racial/ethnic disparities in ADHD diagnosis by kindergarten entry. J Child Psychol Psychiatry. 2014 Aug;55(8):905–13. doi: 10.1111/jcpp.12204. PMID: 24456307. [PMC free article: PMC4154600] [PubMed: 24456307] [CrossRef]

Fadus MC, Ginsburg KR, Sobowale K, et al. Unconscious Bias and the Diagnosis of Disruptive Behavior Disorders and ADHD in African American and Hispanic Youth. Academic Psychiatry. 2020 2020/02/01;44(1):95–102. doi: 10.1007/s40596-019-01127-6. [PMC free article: PMC7018590] [PubMed: 31713075] [CrossRef]

Chan E, Hopkins MR, Perrin JM, et al. Diagnostic practices for attention deficit hyperactivity disorder: a national survey of primary care physicians. Ambul Pediatr. 2005 Jul–Aug;5(4):201–8. doi: 10.1367/A04-054R1.1. PMID: 16026184. [PubMed: 16026184] [CrossRef]

Jensen-Doss A, Youngstrom EA, Youngstrom JK, et al. Predictors and moderators of agreement between clinical and research diagnoses for children and adolescents. Journal of Consulting and Clinical Psychology. 2014;82(6):1151–62. doi: 10.1037/a0036657. [PMC free article: PMC4278746] [PubMed: 24773574] [CrossRef]

Nobel E, Brunnekreef JA, Schachar RJ, et al. Parent–clinician agreement in rating the presence and severity of attention-deficit/hyperactivity disorder symptoms. ADHD Attention Deficit and Hyperactivity Disorders. 2019 2019/03/01;11(1):21–9. doi: 10.1007/s12402-018-0267-8. PMID: 30927229. [PubMed: 30927229] [CrossRef]

Parker A, Corkum P. ADHD Diagnosis: As Simple As Administering a Questionnaire or a Complex Diagnostic Process? Journal of Attention Disorders. 2016 Jun;20(6):478–86. doi: 10.1177/1087054713495736. PMID: 23887860. [PubMed: 23887860] [CrossRef]

Chang L-Y, Wang M-Y, Tsai P-S. Diagnostic Accuracy of Rating Scales for Attention-Deficit/Hyperactivity Disorder: A Meta-analysis. Pediatrics. 2016 Mar;137(3):e20152749. doi: 10.1542/peds.2015-2749. PMID: 26928969. [PubMed: 26928969] [CrossRef]

De Crescenzo F, Licchelli S, Ciabattini M, et al. The use of actigraphy in the monitoring of sleep and activity in ADHD: A meta-analysis. Sleep Med Rev. 2016 Apr;26:9–20. doi: 10.1016/j.smrv.2015.04.002. PMID: 26163053. [PubMed: 26163053] [CrossRef]

Williams LM, Hermens DF, Thein T, et al. Using Brain-Based Cognitive Measures to Support Clinical Decisions in ADHD. Pediatric Neurology. 2010 2010/02/01/;42(2):118–26. doi: 10.1016/j.pediatrneurol.2009.08.010. PMID: 20117748. [PubMed: 20117748] [CrossRef]

Wasserman T, Wasserman LD. The Sensitivity and Specificity of Neuropsychological Tests in the Diagnosis of Attention Deficit Hyperactivity Disorder. Applied Neuropsychology: Child. 2012 2012/07/01;1(2):90–9. doi: 10.1080/21622965.2012.702025. PMID: 23428295. [PubMed: 23428295] [CrossRef]

Barkley RA. Neuropsychological Testing is Not Useful in the Diagnosis of ADHD: Stop It (or Prove It)! The ADHD Report. 2019;27(2):1–8. doi: 10.1521/adhd.2019.27.2.1. [CrossRef]

Hult N, Kadesjö J, Kadesjö B, et al. ADHD and the QbTest: Diagnostic Validity of QbTest. Journal of Attention Disorders. 2018 Sep;22(11):1074–80. doi: 10.1177/1087054715595697. PMID: 26224575. [PubMed: 26224575] [CrossRef]

Anita Thapar, F.R.C.Psych., Ph.D. Discoveries on the Genetics of ADHD in the 21st Century: New Findings and Their Implications. American Journal of Psychiatry. 2018 Oct 1;175(10):943–50. doi: 10.1176/appi.ajp.2018.18040383. PMID: 30111187. [PubMed: 30111187] [CrossRef]

Snyder SM. Systems and methods to identify a subgroup of ADHD at higher risk for complicating conditions. US Patent and Trademark Office. (U.S. PPA Number 61/237,911; August 27, 2009) (U.S. PA Number 12/870,328; August 28, 2010). 2010.

Snyder SM, Rugino TA, Hornig M, et al. Integration of an EEG biomarker with a clinician’s ADHD evaluation. Brain and Behavior. 2015 Apr;5(4):e00330. doi: 10.1002/brb3.330. PMID: 25798338. [PMC free article: PMC4356845] [PubMed: 25798338] [CrossRef]

Bansal R, Staib LH, Laine AF, et al. Anatomical brain images alone can accurately diagnose chronic neuropsychiatric illnesses. PLoS One. 2012;7(12):e50698. doi: 10.1371/journal.pone.0050698. PMID: 23236384. [PMC free article: PMC3517530] [PubMed: 23236384] [CrossRef]

Haubold A, Peterson BS, Bansal R. Annual research review: progress in using brain morphometry as a clinical tool for diagnosing psychiatric disorders. J Child Psychol Psychiatry. 2012 May;53(5):519–35. doi: 10.1111/j.1469-7610.2012.02539.x. PMID: 22394424. [PMC free article: PMC4235515] [PubMed: 22394424] [CrossRef]

Ford-Jones PC. Misdiagnosis of attention deficit hyperactivity disorder: ‘Normal behaviour’ and relative maturity. Paediatrics & child health. 2015 May;20(4):200–2. doi: 10.1093/pch/20.4.200. PMID: 26038639. [PMC free article: PMC4443828] [PubMed: 26038639] [CrossRef]

Whitely M, Raven M, Timimi S, et al. Attention deficit hyperactivity disorder late birthdate effect common in both high and low prescribing international jurisdictions: a systematic review. J Child Psychol Psychiatry. 2019 Apr;60(4):380–91. doi: 10.1111/jcpp.12991. PMID: 30317644. [PMC free article: PMC7379308] [PubMed: 30317644] [CrossRef]

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: Psychiatric Publishing; 2013.

Sciutto MJ, Eisenberg M. Evaluating the Evidence For and Against the Overdiagnosis of ADHD. Journal of Attention Disorders. 2007 Sep;11(2):106–13. doi: 10.1177/1087054707300094. PMID: 17709814. [PubMed: 17709814] [CrossRef]

Tseregounis IE, Stewart SL, Crawford A, et al. Age- and Sex-Specific Increases in Stimulant Prescribing Rates—California, 2008-2017. Journal of Attention Disorders. 2020 Jan;24(2):205–14. doi: 10.1177/1087054719883008. PMID: 31680608. [PMC free article: PMC6937374] [PubMed: 31680608] [CrossRef]

Board AR, Guy G, Jones CM, et al. Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty — United States, 2014–2019. Drug and Alcohol Dependence. 2020 2020/12/01/;217:108297. doi: 10.1016/j.drugalcdep.2020.108297. PMID: 32961454. [PMC free article: PMC7851748] [PubMed: 32961454] [CrossRef]

Kazda L, Bell K, Thomas R, et al. Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Systematic Scoping Review. JAMA Network Open. 2021 Apr 1;4(4):e215335–e. doi: 10.1001/jamanetworkopen.2021.5335. PMID: 33843998. [PMC free article: PMC8042533] [PubMed: 33843998] [CrossRef]

Cook G. Big Pharma’s Manufactured Epidemic: The Misdiagnosis of ADHD. Scientific American. 2016;Oct 11, 2016.

Cha AE. CDC warns that Americans may be overmedicating youngest children with ADHD. The Washington Post. 2016.

Ramachandran S, Dertien D, Bentley SI. Prevalence of ADHD symptom malingering, nonmedical use, and drug diversion among college-enrolled adults with a prescription for stimulant medications. Journal of Addictive Diseases. 2020 2020/02/17;38(2):176–85. doi: 10.1080/10550887.2020.1732762. PMID: 32242510. [PubMed: 32242510] [CrossRef]

Pham T, Milanaik R, Kaplan A, et al. Household Diversion of Prescription Stimulants: Medication Misuse by Parents of Children with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2017 Oct;27(8):741–6. doi: 10.1089/cap.2016.0058. PMID: 28686059. [PubMed: 28686059] [CrossRef]

Visser SN, Danielson ML, Bitsko RH, et al. Trends in the Parent-Report of Health Care Provider-Diagnosed and Medicated Attention-Deficit/Hyperactivity Disorder: United States, 2003-2011. Journal of the American Academy of Child & Adolescent Psychiatry. 2014 Jan;53(1):34–46.e2. doi: 10.1016/j.jaac.2013.09.001. PMID: 24342384. [PMC free article: PMC4473855] [PubMed: 24342384] [CrossRef]

DosReis S, Barksdale CL, Sherman A, et al. Stigmatizing experiences of parents of children with a new diagnosis of ADHD. Psychiatr Serv. 2010 Aug;61(8):811–6. doi: 10.1176/ps.2010.61.8.811. PMID: 20675840. [PubMed: 20675840] [CrossRef]

Cook J, Knight E, Hume I, et al. The self-esteem of adults diagnosed with attention-deficit/hyperactivity disorder (ADHD): a systematic review of the literature. Atten Defic Hyperact Disord. 2014 Dec;6(4):249–68. doi: 10.1007/s12402-014-0133-2. PMID: 24668198. [PubMed: 24668198] [CrossRef]

Lebowitz MS. Stigmatization of ADHD: A Developmental Review. J Atten Disord. 2016 Mar;20(3):199–205. doi: 10.1177/1087054712475211. PMID: 23407279. [PubMed: 23407279] [CrossRef]

Wiener J, Malone M, Varma A, et al. Children’s Perceptions of Their ADHD Symptoms:Positive Illusions, Attributions, and Stigma. Canadian Journal of School Psychology. 2012;27(3):217–42. doi: 10.1177/0829573512451972. [CrossRef]

Weinstein D, Staffelbach D, Biaggio M. Attention-deficit hyperactivity disorder and posttraumatic stress disorder: Differential diagnosis in childhood sexual abuse. Clinical Psychology Review. 2000 2000/04/01/;20(3):359–78. doi: 10.1016/S0272-7358(98)00107-X. PMID: 10779899. [PubMed: 10779899] [CrossRef]

Szymanski K, Sapanski L, Conway F. Trauma and ADHD – Association or Diagnostic Confusion? A Clinical Perspective. Journal of Infant, Child, and Adolescent Psychotherapy. 2011 2011/01/01;10(1):51–9. doi: 10.1080/15289168.2011.575704. [CrossRef]

Langevin R, Marshall C, Wallace A, et al. Disentangling the Associations Between Attention Deficit Hyperactivity Disorder and Child Sexual Abuse: A Systematic Review. Trauma, Violence, & Abuse. 2021 Jul 9:15248380211030234. doi: 10.1177/15248380211030234. PMID: 34238078. [PMC free article: PMC10009485] [PubMed: 34238078] [CrossRef]

Dahmen B, Pütz V, Herpertz-Dahlmann B, et al. Early pathogenic care and the development of ADHD-like symptoms. Journal of Neural Transmission. 2012 2012/09/01;119(9):1023–36. doi: 10.1007/s00702-012-0809-8. PMID: 22661337. [PubMed: 22661337] [CrossRef]

Erskine HE, Norman RE, Ferrari AJ, et al. Long-Term Outcomes of Attention-Deficit/Hyperactivity Disorder and Conduct Disorder: A Systematic Review and Meta-Analysis. J Am Acad Child Adolesc Psychiatry. 2016 Oct;55(10):841–50. doi: 10.1016/j.jaac.2016.06.016. PMID: 27663939. [PubMed: 27663939] [CrossRef]

Mehta T, Mannem N, Yarasi NK, et al. Biomarkers for ADHD: the Present and Future Directions. Current Developmental Disorders Reports. 2020 2020/09/01;7(3):85–92. doi: 10.1007/s40474-020-00196-9. [CrossRef]

Faraone SV, Bonvicini C, Scassellati C. Biomarkers in the Diagnosis of ADHD – Promising Directions. Current Psychiatry Reports. 2014 2014/10/10;16(11):497. doi: 10.1007/s11920-014-0497-1. [PubMed: 25298126] [CrossRef]

Kemper AR, Maslow GR, Hill S, et al. Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents. Comparative Effectiveness Review No. 203. (Prepared by the Duke University Evidence-based Practice Center under Contract No. 290-2015-00004-I.) AHRQ Publication No. 18-EHC005-EF Agency for Healthcare Research and Quality (US). Rockville (MD): 2018. https://www​.ncbi.nlm​.nih.gov/pubmed/29558081

Biederman J, Fried R, DiSalvo M, et al. Evidence of Low Adherence to Stimulant Medication Among Children and Youths With ADHD: An Electronic Health Records Study. Psychiatr Serv. 2019 Oct 1;70(10):874–80. doi: 10.1176/appi.ps.201800515. PMID: 31242830. [PubMed: 31242830] [CrossRef]

Abrams Z. A new device for treating ADHD in children. Monitor on Psychology. http://www​.apa.org/monitor​/2019/07-08/adhd-children. 2019;50(7).

Bikic A, Leckman JF, Christensen TØ, et al. Attention and executive functions computer training for attention-deficit/hyperactivity disorder (ADHD): results from a randomized, controlled trial. European Child & Adolescent Psychiatry. 2018 2018/12/01;27(12):1563–74. doi: 10.1007/s00787-018-1151-y. PMID: 29644473. [PubMed: 29644473] [CrossRef]

McGough JJ, Sturm A, Cowen J, et al. Double-Blind, Sham-Controlled, Pilot Study of Trigeminal Nerve Stimulation for Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2019 Apr;58(4):403–11.e3. doi: 10.1016/j.jaac.2018.11.013. PMID: 30768393. [PMC free article: PMC6481187] [PubMed: 30768393] [CrossRef]

Moore AL, Carpenter DM, 2nd, Miller TM, et al. Clinician-delivered cognitive training for children with attention problems: effects on cognition and behavior from the ThinkRx randomized controlled trial. Neuropsychiatric disease and treatment. 2018;14:1671–83. doi: 10.2147/NDT.S165418. PMID: 29983567. [PMC free article: PMC6027847] [PubMed: 29983567] [CrossRef]

Rubia K. Precision medicine in neurotherapeutics for Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2021 Jul;60(7):813–5. doi: 10.1016/j.jaac.2020.11.013. PMID: 33264662. [PubMed: 33264662] [CrossRef]

Scionti N, Cavallero M, Zogmaister C, et al. Is cognitive training effective for improving executive functions in preschoolers? a systematic review and meta-analysis. Frontiers in Psychology. 2020 2020-January-10;10(2812):2812. doi: 10.3389/fpsyg.2019.02812. PMID: 31998168. [PMC free article: PMC6965160] [PubMed: 31998168] [CrossRef]

US Food and Drug Administration. FDA Permits Marketing of First Game-Based Digital Therapeutic to Improve Attention Function in Children with ADHD. FDA News Release. https://www​.fda.gov/news-events​/press-announcements​/fda-permits-marketing-first-game-based-digital-therapeutic-improve-attention-function-children-adhd. 2020;June 15.

Veloso A, Vicente SG, Filipe MG. Effectiveness of cognitive training for school-aged children and adolescents with Attention Deficit/Hyperactivity Disorder: a systematic review. Frontiers in Psychology. 2020 2020-January-14;10(2983):2983. doi: 10.3389/fpsyg.2019.02983. PMID: 32010026. [PMC free article: PMC6971402] [PubMed: 32010026] [CrossRef]

Voelker R. Trigeminal nerve stimulator for ADHD. JAMA. 2019 Jun 4;321(21):2066-. doi: 10.1001/jama.2019.6992. PMID: 31162556. [PubMed: 31162556] [CrossRef]

Westwood S, Radua J, Rubia K. Non-invasive brain stimulation as an alternative treatment for ADHD: a systematic review and meta-analysis. Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation. 2019;12(2):502. doi: 10.1016/j.brs.2018.12.644. [CrossRef]

Wong HC, Zaman R. Neurostimulation in treating ADHD. Psychiatr Danub. 2019 Sep;31(Suppl 3):265–75. PMID: 31488739. [PubMed: 31488739]

Zangen A. T033 Right prefrontal rTMS for the treatment of ADHD: Electrophysiological correlates and prognostic biomarkers. Clinical Neurophysiology. 2017 2017/03/01/;128(3):e11. doi: 10.1016/j.clinph.2016.10.131. [CrossRef]

Miller AR, Lalonde CE, McGrail KM. Children’s persistence with methylphenidate therapy: a population-based study. Can J Psychiatry. 2004 Nov;49(11):761–8. doi: 10.1177/070674370404901107. PMID: 15633854. [PubMed: 15633854] [CrossRef]

Coghill D, Seth S. Effective management of attention-deficit/hyperactivity disorder (ADHD) through structured re-assessment: the Dundee ADHD Clinical Care Pathway. Child Adolesc Psychiatry Ment Health. 2015;9:52. doi: 10.1186/s13034-015-0083-2. PMID: 26587055. [PMC free article: PMC4652349] [PubMed: 26587055] [CrossRef]

Steven R. Pliszka, M.D. Is There Long-Term Benefit From Stimulant Treatment for ADHD? American Journal of Psychiatry. 2019 Sep 1;176(9):685–6. doi: 10.1176/appi.ajp.2019.19070681. PMID: 31474129. [PubMed: 31474129] [CrossRef]

Craig SG, Davies G, Schibuk L, et al. Long-Term Effects of Stimulant Treatment for ADHD: What Can We Tell Our Patients? Current Developmental Disorders Reports. 2015 2015/03/01;2(1):1–9. doi: 10.1007/s40474-015-0039-5. [CrossRef]

Swanson JM. Debate: Are Stimulant Medications for Attention-Deficit/Hyperactivity Disorder Effective in the Long Term? (Against). J Am Acad Child Adolesc Psychiatry. 2019 Oct;58(10):936–8. doi: 10.1016/j.jaac.2019.07.001. PMID: 31515165. [PubMed: 31515165] [CrossRef]

Coghill D. Debate: Are Stimulant Medications for Attention-Deficit/Hyperactivity Disorder Effective in the Long Term? (For). J Am Acad Child Adolesc Psychiatry. 2019 Oct;58(10):938–9. doi: 10.1016/j.jaac.2019.07.002. PMID: 31515164. [PubMed: 31515164] [CrossRef]

Krinzinger H, Hall CL, Groom MJ, et al. Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence. Neuroscience & Biobehavioral Reviews. 2019 2019/12/01/;107:945–68. doi: 10.1016/j.neubiorev.2019.09.023. PMID: 31545988. [PubMed: 31545988] [CrossRef]

Shaw M, Hodgkins P, Caci H, et al. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med. 2012 Sep 4;10:99. doi: 10.1186/1741-7015-10-99. PMID: 22947230. [PMC free article: PMC3520745] [PubMed: 22947230] [CrossRef]

Arnold LE, Hodgkins P, Caci H, et al. Effect of treatment modality on long-term outcomes in attention-deficit/hyperactivity disorder: a systematic review. PLoS One. 2015;10(2):e0116407. doi: 10.1371/journal.pone.0116407. PMID: 25714373. [PMC free article: PMC4340791] [PubMed: 25714373] [CrossRef]

Swanson JM, Rommelse N, Cotton J, et al. 142. Attention Deficit Hyperactivity Disorder (updated chapter). In press (2022).

Wong HK, Tiffin PA, Chappell MJ, et al. Personalized Medication Response Prediction for Attention-Deficit Hyperactivity Disorder: Learning in the Model Space vs. Learning in the Data Space. Frontiers in physiology. 2017;8:199-. doi: 10.3389/fphys.2017.00199. PMID: 28443027. [PMC free article: PMC5387107] [PubMed: 28443027] [CrossRef]

Jadad AR, Boyle M, Cunningham C, et al. Treatment of attention-deficit/hyperactivity disorder. Evid Rep Technol Assess (Summ). 1999 Nov(11):i–viii, 1–341. PMID: 10790990. [PMC free article: PMC4782276] [PubMed: 10790990]

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980.

Catalá-López F, Hutton B, Núñez-Beltrán A, et al. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials. PLoS One. 2017;12(7):e0180355. doi: 10.1371/journal.pone.0180355. PMID: 28700715. [PMC free article: PMC5507500] [PubMed: 28700715] [CrossRef]

Joseph A, Ayyagari R, Xie M, et al. Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison. Eur Child Adolesc Psychiatry. 2017 Aug;26(8):875–97. doi: 10.1007/s00787-017-0962-6. PMID: 28258319. [PMC free article: PMC5532417] [PubMed: 28258319] [CrossRef]

Padilha S, Virtuoso S, Tonin FS, et al. Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis. Eur Child Adolesc Psychiatry. 2018 Oct;27(10):1335–45. doi: 10.1007/s00787-018-1125-0. PMID: 29460165. [PubMed: 29460165] [CrossRef]

Anand S, Tong H, Besag FMC, et al. Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment. Paediatr Drugs. 2017 Jun;19(3):235–50. doi: 10.1007/s40272-017-0224-6. PMID: 28391425. [PubMed: 28391425] [CrossRef]

Tsujii N, Usami M, Naya N, et al. Efficacy and Safety of Medication for Attention-Deficit Hyperactivity Disorder in Children and Adolescents with Common Comorbidities: A Systematic Review. Neurol Ther. 2021 Jun 4. doi: 10.1007/s40120-021-00249-0. PMID: 34089145. [PMC free article: PMC8571469] [PubMed: 34089145] [CrossRef]

Maglione M, Das L, Motala A, et al. Surveillance Assessment on CER 44: Attention Deficit Hyperactivity Disorder (ADHD): Effectiveness of Treatment in At-Risk Preschoolers; Long-term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment (CER 44) Agency for Healthcare Research and Quality. Rockville, MD: July 2012 2012.

Gidengil C, Goetz MB, Maglione M, et al. Safety of Vaccines Used for Routine Immunization in the United States: An Update. Comparative Effectiveness Review No. 244. (Prepared by the Southern California Evidence-based Practice Center under Contract No. 290-2015-00010-I.) AHRQ Publication No. 21-EHC024. . Rockville, MD: Agency for Healthcare Research and Quality (AHRQ); 2021.

Hempel S, Graham GD, Fu N, et al. A systematic review of modifiable risk factors in the progression of multiple sclerosis. Mult Scler. 2017 Apr;23(4):525–33. doi: 10.1177/1352458517690270. PMID: 28151053. [PubMed: 28151053] [CrossRef]

Hempel S, Newberry S, Ruelaz A, et al. Safety of probiotics used to reduce risk and prevent or treat disease. Evid Rep Technol Assess (Full Rep). 2011 Apr(200):1–645. PMID: 23126627. [PMC free article: PMC4780970] [PubMed: 23126627]

Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012 May 9;307(18):1959–69. doi: 10.1001/jama.2012.3507. PMID: 22570464. [PubMed: 22570464] [CrossRef]

Sterne JAC, Savovic J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898. PMID: 31462531. [PubMed: 31462531] [CrossRef]

University of Bristol. QUADAS-2. https://www​.bristol.ac​.uk/population-health-sciences​/projects/quadas/quadas-2/. Accessed on February 10, 2021.

Rover C, Knapp G, Friede T. Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies. BMC Med Res Methodol. 2015 Nov 14;15:99. doi: 10.1186/s12874-015-0091-1. PMID: 26573817. [PMC free article: PMC4647507] [PubMed: 26573817] [CrossRef]

Hempel S, Miles JN, Booth MJ, et al. Risk of bias: a simulation study of power to detect study-level moderator effects in meta-analysis. Syst Rev. 2013 Nov 28;2:107. doi: 10.1186/2046-4053-2-107. PMID: 24286208. [PMC free article: PMC4219184] [PubMed: 24286208] [CrossRef]

Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997 Sep 13;315(7109):629–34. doi: 10.1136/bmj.315.7109.629. PMID: 9310563. [PMC free article: PMC2127453] [PubMed: 9310563] [CrossRef]

Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994 Dec;50(4):1088–101. PMID: 7786990. [PubMed: 7786990]

Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000 Jun;56(2):455–63. doi: 10.1111/j.0006-341x.2000.00455.x. PMID: 10877304. [PubMed: 10877304] [CrossRef]

Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Content last reviewed March 2021. Effective Health Care Program Agency for Healthcare Research and Quality. Rockville, MD: 2021 https:​//effectivehealthcare​.ahrq.gov/products​/cer-methods-guide

Guy W. ECDEU Assessment Manual for Psychopharmacology US Department of Heath, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration. Rockville, MD: 1976.

DuPaul GJ, Power TJ, Anastopoulos AD, et al. ADHD Rating Scale—IV: Checklists, norms, and clinical interpretation: Guilford press; 1998.

DuPaul GJ, Power TJ, Anastopoulos AD, et al. ADHD Rating Scale—5: Checklists, norms, and clinical interpretation: Guilford press; 2016.

Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA). Canadian ADHD practice guidelines CADDRA. Toronto: 2011.

Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA). Canadian ADHD practice guidelines CADDRA. Toronto: 2020.

Berkman ND, Lohr KN, Ansari MT, et al. Grading the strength of a body of evidence when assessing health care interventions: an EPC update. Journal of clinical epidemiology. 2015;68(11):1312–24. [PubMed: 25721570]

Abbasi SH, Heidari S, Mohammadi MR, et al. Acetyl-L-carnitine as an adjunctive therapy in the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a placebo-controlled trial. Child Psychiatry Hum Dev. 2011 Jun;42(3):367–75. doi: 10.1007/s10578-011-0220-y. PMID: 21336630. [PubMed: 21336630] [CrossRef]

AbbVie, AbbVie. Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD). 2008.

Abikoff H, Gallagher R, Wells KC, et al. Remediating organizational functioning in children with ADHD: immediate and long-term effects from a randomized controlled trial. J Consult Clin Psychol. 2013 Feb;81(1):113–28. doi: 10.1037/a0029648. PMID: 22889336. [PMC free article: PMC3549033] [PubMed: 22889336] [CrossRef]

Abikoff H, Hechtman L, Klein RG, et al. Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry. 2004 Jul;43(7):802–11. doi: 10.1097/01.chi.0000128791.10014.ac. PMID: 15213581. [PubMed: 15213581] [CrossRef]

Abikoff H, Nissley-Tsiopinis J, Gallagher R, et al. Effects of MPH-OROS on the organizational, time management, and planning behaviors of children with ADHD. J Am Acad Child Adolesc Psychiatry. 2009 Feb;48(2):166–75. doi: 10.1097/CHI.0b013e3181930626. PMID: 19127171. [PubMed: 19127171] [CrossRef]

Abikoff H, Vitiello B, Riddle M, et al. Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007;17(5):581–92. PMID: 17979579. [PubMed: 17979579]

Abikoff HB, Thompson M, Laver-Bradbury C, et al. Parent training for preschool ADHD: a randomized controlled trial of specialized and generic programs. J Child Psychol Psychiatry. 2015 Jun;56(6):618–31. doi: 10.1111/jcpp.12346. PMID: 25318650. [PMC free article: PMC4400193] [PubMed: 25318650] [CrossRef]

Abramov DM, Lazarev VV, Gomes SC, et al. Estimating biological accuracy of DSM for attention deficit/hyperactivity disorder based on multivariate analysis for small samples. PeerJ. 2019;2019(6). doi: 10.7717/peerj.7074. [CrossRef]

Adams R, Finn P, Moes E, et al. Distractibility in Attention/Deficit/ Hyperactivity Disorder (ADHD): the virtual reality classroom. Child Neuropsychol. 2009 Mar;15(2):120–35. doi: 10.1080/09297040802169077. PMID: 18608217. [PubMed: 18608217] [CrossRef]

Aevi Genomic Medicine L, a Cerecor company, Inc C. Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD. 2016.

Aevi Genomic Medicine L, a Cerecor company, Inc C. PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations. 2018.

Ahmadi A, Kashefi M, Shahrokhi H, et al. Computer aided diagnosis system using deep convolutional neural networks for ADHD subtypes. Biomedical Signal Processing and Control. 2021;63. doi: 10.1016/j.bspc.2020.102227. [CrossRef]

Akhondzadeh S, Mohammadi MR, Khademi M. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371]. BMC Psychiatry. 2004 Apr 8;4:9. doi: 10.1186/1471-244x-4-9. PMID: 15070418. [PMC free article: PMC400741] [PubMed: 15070418] [CrossRef]

Algorta GP, Dodd AL, Stringaris A, et al. Diagnostic efficiency of the SDQ for parents to identify ADHD in the UK: a ROC analysis. Eur Child Adolesc Psychiatry. 2016 Sep;25(9):949–57. doi: 10.1007/s00787-015-0815-0. PMID: 26762184. [PMC free article: PMC4990620] [PubMed: 26762184] [CrossRef]

Allen AJ, Kurlan RM, Gilbert DL, et al. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology. 2005 Dec 27;65(12):1941–9. doi: 10.1212/01.wnl.0000188869.58300.a7. PMID: 16380617. [PubMed: 16380617] [CrossRef]

Alloway TP, Gathercole SE, Holmes J, et al. The diagnostic utility of behavioral checklists in identifying children with ADHD and children with working memory deficits. Child Psychiatry Hum Dev. 2009 Sep;40(3):353–66. doi: 10.1007/s10578-009-0131-3. PMID: 19280339. [PubMed: 19280339] [CrossRef]

Altınkaynak M, Dolu N, Güven A, et al. Diagnosis of Attention Deficit Hyperactivity Disorder with combined time and frequency features. Biocybernetics and Biomedical Engineering. 2020;40(3):927–37. doi: 10.1016/j.bbe.2020.04.006. [CrossRef]

Amado-Caballero P, Casaseca-de-la-Higuera P, Alberola-Lopez S, et al. Objective ADHD Diagnosis Using Convolutional Neural Networks Over Daily-Life Activity Records. IEEE J Biomed Health Inform. 2020 Sep;24(9):2690–700. doi: 10.1109/jbhi.2020.2964072. PMID: 31905156. [PubMed: 31905156] [CrossRef]

Amiri S, Mohammadi MR, Mohammadi M, et al. Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):145–9. doi: 10.1016/j.pnpbp.2007.07.025. PMID: 17765380. [PubMed: 17765380] [CrossRef]

Antshel KM, Remer R. Social skills training in children with attention deficit hyperactivity disorder: a randomized-controlled clinical trial. J Clin Child Adolesc Psychol. 2003 Mar;32(1):153–65. doi: 10.1207/S15374424JCCP3201_14. PMID: 12611031. [PubMed: 12611031] [CrossRef]

Arjona A, Angulo-Ruiz BY, Rodríguez-Martínez EI, et al. Time-frequency neural dynamics of ADHD children and adolescents during a Working Memory task. Neurosci Lett. 2023 Feb 28;798:137100. doi: 10.1016/j.neulet.2023.137100. PMID: 36720344. [PubMed: 36720344] [CrossRef]

Arnold LE, Amato A, Bozzolo H, et al. Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial. J Child Adolesc Psychopharmacol. 2007 Dec;17(6):791–802. doi: 10.1089/cap.2007.018. PMID: 18315451. [PubMed: 18315451] [CrossRef]

Arnold LE, Arns M, Barterian JA, et al. Neurofeedback for Attention-Deficit/Hyperactivity Disorder: 25-Month Follow-up of Double-Blind Randomized Controlled Trial. J Am Acad Child Adolesc Psychiatry. 2022 Dec 8;62(4):435–46. doi: 10.1016/j.jaac.2022.07.862. PMID: 36521694. [PMC free article: PMC10065891] [PubMed: 36521694] [CrossRef]

Ashkenasi A. Effect of transdermal methylphenidate wear times on sleep in children with attention deficit hyperactivity disorder. Pediatr Neurol. 2011 Dec;45(6):381–6. doi: 10.1016/j.pediatrneurol.2011.09.003. PMID: 22115000. [PubMed: 22115000] [CrossRef]

Aviv TM, Katz YJ, Berant E. The Contribution of Therapeutic Horseback Riding to the Improvement of Executive Functions and Self-Esteem Among Children With ADHD. J Atten Disord. 2021 Oct;25(12):1743–53. doi: 10.1177/1087054720925898. PMID: 32508191. [PubMed: 32508191] [CrossRef]

Azami S, Alimadadi Z, Ahmadi A, et al. The efficacy of cognitive-motor rehabilitation on cognitive functions and behavioral symptoms of attention deficit/hyperactivity disorder (ADHD) children: Specification of near-transfer and far-transfer effects in comparison to medication. J Educ Health Promot. 2023;12:64. doi: 10.4103/jehp.jehp_189_22. PMID: 37113411. [PMC free article: PMC10127477] [PubMed: 37113411] [CrossRef]

Bakhshayesh AR, Hänsch S, Wyschkon A, et al. Neurofeedback in ADHD: a single-blind randomized controlled trial. Eur Child Adolesc Psychiatry. 2011 Sep;20(9):481–91. doi: 10.1007/s00787-011-0208-y. PMID: 21842168. [PubMed: 21842168] [CrossRef]

Banaschewski T, Soutullo C, Lecendreux M, et al. Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder. CNS Drugs. 2013 Oct;27(10):829–40. doi: 10.1007/s40263-013-0095-5. PMID: 23893527. [PMC free article: PMC3784063] [PubMed: 23893527] [CrossRef]

Bangs ME, Emslie GJ, Spencer TJ, et al. Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression. J Child Adolesc Psychopharmacol. 2007 Aug;17(4):407–20. doi: 10.1089/cap.2007.0066. PMID: 17822337. [PubMed: 17822337] [CrossRef]

Bangs ME, Hazell P, Danckaerts M, et al. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder. Pediatrics. 2008 Feb;121(2):e314–20. doi: 10.1542/peds.2006-1880. PMID: 18245404. [PubMed: 18245404] [CrossRef]

Bard DE, Wolraich ML, Neas B, et al. The psychometric properties of the Vanderbilt attention-deficit hyperactivity disorder diagnostic parent rating scale in a community population. J Dev Behav Pediatr. 2013 Feb;34(2):72–82. doi: 10.1097/DBP.0b013e31827a3a22. PMID: 23363972. [PubMed: 23363972] [CrossRef]

Barkley RA, Grodzinsky GM. Are tests of frontal lobe functions useful in the diagnosis of attention deficit disorders? Clinical Neuropsychologist. 1994;8(2):121–39. doi: 10.1080/13854049408401552. [CrossRef]

Baziar S, Aqamolaei A, Khadem E, et al. Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study. J Child Adolesc Psychopharmacol. 2019 Apr;29(3):205–12. doi: 10.1089/cap.2018.0146. PMID: 30741567. [PubMed: 30741567] [CrossRef]

Bédard AC SM, Halperin JM, Krone B, Rajwan E, Newcorn JH. Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder. J Child Psychol Psychiatry. 2015 Jan;56(1):40–8. doi: 10.1111/jcpp.12272. PMID: 24942409. [PMC free article: PMC4272337] [PubMed: 24942409] [CrossRef]

Behdani F, Hebrani P, Naseraee A, et al. Does omega-3 supplement enhance the therapeutic results of methylphenidate in attention deficit hyperactivity disorder patients? J Res Med Sci. 2013 Aug;18(8):653–8. PMID: 24379840. [PMC free article: PMC3872603] [PubMed: 24379840]

Benzing V, Schmidt M. The effect of exergaming on executive functions in children with ADHD: A randomized clinical trial. Scand J Med Sci Sports. 2019 Aug;29(8):1243–53. doi: 10.1111/sms.13446. PMID: 31050851. [PubMed: 31050851] [CrossRef]

Berger I, Slobodin O, Cassuto H. Usefulness and Validity of Continuous Performance Tests in the Diagnosis of Attention-Deficit Hyperactivity Disorder Children. Arch Clin Neuropsychol. 2017 Feb;32(1):81–93. doi: 10.1093/arclin/acw101. PMID: 28122767. [PubMed: 28122767] [CrossRef]

Berger I GG. Objective measures of attention-deficit/hyperactivity disorder: a pilot study. Isr Med Assoc J. 2010 Sep;12(9):531–5. PMID: 21287795. [PubMed: 21287795]

Bergeron L, Smolla N, Berthiaume C, et al. Reliability, Validity, and Clinical Utility of the Dominic Interactive for Adolescents-Revised(A DSM-5-Based Self-Report Screen for Mental Disorders, Borderline Personality Traits, and Suicidality). Can J Psychiatry. 2017 Mar;62(3):211–22. doi: 10.1177/0706743716670129. PMID: 27638424. [PMC free article: PMC5317018] [PubMed: 27638424] [CrossRef]

Beriha SS. Computer aided diagnosis system to distinguish adhd from similar behavioral disorders. Biomedical and Pharmacology Journal. 2018;11(2):1135–41. doi: 10.13005/bpj/1474. [CrossRef]

Biederman J, Krishnan S, Zhang Y, et al. Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. Clin Ther. 2007 Mar;29(3):450–63. doi: 10.1016/s0149-2918(07)80083-x. PMID: 17577466. [PubMed: 17577466] [CrossRef]

Biederman J, Melmed RD, Patel A, et al. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics. 2008 Jan;121(1):e73–84. doi: 10.1542/peds.2006-3695. PMID: 18166547. [PubMed: 18166547] [CrossRef]

Biederman J, Swanson JM, Wigal SB, et al. A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study. J Clin Psychiatry. 2006 May;67(5):727–35. doi: 10.4088/jcp.v67n0506. PMID: 16841622. [PubMed: 16841622] [CrossRef]

Biederman J, Swanson JM, Wigal SB, et al. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Pediatrics. 2005 Dec;116(6):e777–84. doi: 10.1542/peds.2005-0617. PMID: 16322134. [PubMed: 16322134] [CrossRef]

Bigorra A, Garolera M, Guijarro S, et al. Long-term far-transfer effects of working memory training in children with ADHD: a randomized controlled trial. Eur Child Adolesc Psychiatry. 2016 Aug;25(8):853–67. doi: 10.1007/s00787-015-0804-3. PMID: 26669692. [PubMed: 26669692] [CrossRef]

Bilici M, Yildirim F, Kandil S, et al. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):181–90. doi: 10.1016/j.pnpbp.2003.09.034. PMID: 14687872. [PubMed: 14687872] [CrossRef]

Binesh M, Daghighi MR, Shirazi E, et al. Comparison of Auricular Therapy with Sham in Children with Attention Deficit/Hyperactivity Disorder: A Randomized Controlled Trial. J Altern Complement Med. 2020 Jun;26(6):515–20. doi: 10.1089/acm.2019.0477. PMID: 32434376. [PubMed: 32434376] [CrossRef]

Blader JC, Pliszka SR, Kafantaris V, et al. Stepped Treatment for Attention-Deficit/Hyperactivity Disorder and Aggressive Behavior: A Randomized, Controlled Trial of Adjunctive Risperidone, Divalproex Sodium, or Placebo After Stimulant Medication Optimization. J Am Acad Child Adolesc Psychiatry. 2021 Feb;60(2):236–51. doi: 10.1016/j.jaac.2019.12.009. PMID: 32007604. [PMC free article: PMC7390668] [PubMed: 32007604] [CrossRef]

Bledsoe JC, Xiao C, Chaovalitwongse A, et al. Diagnostic Classification of ADHD Versus Control: Support Vector Machine Classification Using Brief Neuropsychological Assessment. J Atten Disord. 2020 Sep;24(11):1547–56. doi: 10.1177/1087054716649666. PMID: 27231214. [PubMed: 27231214] [CrossRef]

Bloch Y FM, Maoz H, et al. Can computerized cognitive tests assist in the clinical diagnosis of attention-deficit hyperactivity disorder? J Neuropsychiatry Clin Neurosci. 2012 Winter;24(1):111–4. doi: 10.1176/appi.neuropsych.11010014. PMID: 22450621. [PubMed: 22450621] [CrossRef]

Block SL, Kelsey D, Coury D, et al. Once-daily atomoxetine for treating pediatric attention-deficit/hyperactivity disorder: comparison of morning and evening dosing. Clin Pediatr (Phila). 2009 Sep;48(7):723–33. doi: 10.1177/0009922809335321. PMID: 19420182. [PubMed: 19420182] [CrossRef]

Blumer JL, Findling RL, Shih WJ, et al. Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/hyperactivity disorder in children 6 to 17 years of age. Pediatrics. 2009 May;123(5):e770–6. doi: 10.1542/peds.2008-2945. PMID: 19403468. [PubMed: 19403468] [CrossRef]

Bluschke A, Eggert E, Friedrich J, et al. The Effects of Different Theta and Beta Neurofeedback Training Protocols on Cognitive Control in ADHD. J Cogn Enhanc. 2022;6(4):463–77. doi: 10.1007/s41465-022-00255-6. PMID: 36373033. [PMC free article: PMC9638270] [PubMed: 36373033] [CrossRef]

Boroujeni YK, Rastegari AA, Khodadadi H. Diagnosis of attention deficit hyperactivity disorder using non-linear analysis of the EEG signal. IET Syst Biol. 2019 Oct;13(5):260–6. doi: 10.1049/iet-syb.2018.5130. PMID: 31538960. [PMC free article: PMC8687398] [PubMed: 31538960] [CrossRef]

Bostic JQ, Biederman J, Spencer TJ, et al. Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial. J Child Adolesc Psychopharmacol. 2000 Fall;10(3):205–16. doi: 10.1089/10445460050167313. PMID: 11052410. [PubMed: 11052410] [CrossRef]

Boucugnani LL, Jones RW. Behaviors analogous to frontal lobe dysfunction in children with attention deficit hyperactivity disorder. Archives of Clinical Neuropsychology. 1989 1989/01/01/;4(2):161–73. doi: 10.1016/0887-6177(89)90154-6. [CrossRef]

Boyer BE, Geurts HM, Prins PJ, et al. One-year follow-up of two novel CBTs for adolescents with ADHD. Eur Child Adolesc Psychiatry. 2016 Mar;25(3):333–7. doi: 10.1007/s00787-015-0776-3. PMID: 26433369. [PubMed: 26433369] [CrossRef]

Brams M, Childress AC, Greenbaum M, et al. SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results of a Randomized, Double-Blind Placebo-Controlled Study. J Child Adolesc Psychopharmacol. 2018 Feb;28(1):19–28. doi: 10.1089/cap.2017.0053. PMID: 28816509. [PMC free article: PMC5771539] [PubMed: 28816509] [CrossRef]

Breaux RP, Griffith SF, Harvey EA. Preschool Neuropsychological Measures as Predictors of Later Attention Deficit Hyperactivity Disorder. J Abnorm Child Psychol. 2016 Nov;44(8):1455–71. doi: 10.1007/s10802-016-0140-1. PMID: 26936037. [PMC free article: PMC5010792] [PubMed: 26936037] [CrossRef]

Breaux RP, Langberg JM, McLeod BD, et al. The importance of therapeutic processes in school-based psychosocial treatment of homework problems in adolescents with ADHD. J Consult Clin Psychol. 2018 May;86(5):427–38. doi: 10.1037/ccp0000300. PMID: 29683700. [PubMed: 29683700] [CrossRef]

Buitelaar JK, Michelson D, Danckaerts M, et al. A randomized, double-blind study of continuation treatment for attention-deficit/hyperactivity disorder after 1 year. Biol Psychiatry. 2007 Mar 1;61(5):694–9. doi: 10.1016/j.biopsych.2006.03.066. PMID: 16893523. [PubMed: 16893523] [CrossRef]

Buitelaar JK, van der Gaag RJ, Swaab-Barneveld H, et al. Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side-effects. J Child Psychol Psychiatry. 1996 Jul;37(5):587–95. doi: 10.1111/j.1469-7610.1996.tb01445.x. PMID: 8807439. [PubMed: 8807439] [CrossRef]

Bul KC, Kato PM, Van der Oord S, et al. Behavioral Outcome Effects of Serious Gaming as an Adjunct to Treatment for Children With Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial. J Med Internet Res. 2016 Feb 16;18(2):e26. doi: 10.2196/jmir.5173. PMID: 26883052. [PMC free article: PMC4773597] [PubMed: 26883052] [CrossRef]

Bunte TL LS, Schoemaker K, et al. Clinical usefulness of observational assessment in the diagnosis of DBD and ADHD in preschoolers. J Clin Child Adolesc Psychol. 2013;42(6):749–61. doi: 10.1080/15374416.2013.773516. [PubMed: 23477379] [CrossRef]

Burton CL, Wright L, Shan J, et al. SWAN scale for ADHD trait-based genetic research: a validity and polygenic risk study. J Child Psychol Psychiatry. 2019 Sep;60(9):988–97. doi: 10.1111/jcpp.13032. PMID: 30908652. [PubMed: 30908652] [CrossRef]

Bussing R, Schuhmann E, Belin TR, et al. Diagnostic utility of two commonly used ADHD screening measures among special education students. J Am Acad Child Adolesc Psychiatry. 1998 Jan;37(1):74–82. doi: 10.1097/00004583-199801000-00020. PMID: 9444903. [PubMed: 9444903] [CrossRef]

Canivez GL, Gaboury AR. Construct Validity and Diagnostic Utility of the Cognitive Assessment System for ADHD. J Atten Disord. 2016 Jun;20(6):519–29. doi: 10.1177/1087054713489021. PMID: 23757332. [PubMed: 23757332] [CrossRef]

Carucci S, Romaniello R, Demuru G, et al. Omega-3/6 supplementation for mild to moderate inattentive ADHD: a randomised, double-blind, placebo-controlled efficacy study in Italian children. Eur Arch Psychiatry Clin Neurosci. 2022 Dec;272(8):1453–67. doi: 10.1007/s00406-022-01428-2. PMID: 35672606. [PubMed: 35672606] [CrossRef]

Catherine Joy R, Thomas George S, Albert Rajan A, et al. Detection of ADHD From EEG Signals Using Different Entropy Measures and ANN. Clin EEG Neurosci. 2021 Aug 23:15500594211036788. doi: 10.1177/15500594211036788. PMID: 34424101. [PubMed: 34424101] [CrossRef]

Cedergren K, Ostlund S, Asberg Johnels J, et al. Monitoring medication response in ADHD: what can continuous performance tests tell us? Eur Arch Psychiatry Clin Neurosci. 2022 Mar;272(2):291–9. doi: 10.1007/s00406-021-01319-y. PMID: 34420075. [PMC free article: PMC8866368] [PubMed: 34420075] [CrossRef]

Ceresoli-Borroni G, Nasser A, Adewole T, et al. A Double-Blind, Randomized Study of Extended-Release Molindone for Impulsive Aggression in ADHD. J Atten Disord. 2021 Sep;25(11):1564–77. doi: 10.1177/1087054720909084. PMID: 32338106. [PubMed: 32338106] [CrossRef]

Çetin FH, Taş Torun Y, Işik Taner Y. Atomoxetine versus OROS methylphenidate in attention deficit hyperactivity disorder: A six-month follow up study for efficacy and adverse effects. Dikkat eksikliği hiperaktivite bozukluğu tedavisinde atomoksetin ve osmotik salınımlı metilfenidat: Etkinlik ve yan etki profilinin değerlendirildiği Altı Aylık İzlem Çalışması. 2015;35(2):88–96. doi: 10.5336/medsci.2015-43336. [CrossRef]

Chacko A WB, Wymbs FA, et al. . Enhancing traditional behavioral parent training for single mothers of children with ADHD. J Clin Child Adolesc Psychol. 2009 Mar;38(2):206–18. doi: 10.1080/15374410802698388. [PubMed: 19283599] [CrossRef]

Chan AS, Ding Z, Lee TL, et al. Temporal processing deficit in children with attention-deficit/hyperactivity disorder: An online assessment. Digit Health. 2022 Jan–Dec;8:20552076221120325. doi: 10.1177/20552076221120325. PMID: 36060612. [PMC free article: PMC9434659] [PubMed: 36060612] [CrossRef]

Chang JP, Su KP, Mondelli V, et al. High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels. Transl Psychiatry. 2019 Nov 20;9(1):303. doi: 10.1038/s41398-019-0633-0. PMID: 31745072. [PMC free article: PMC6864068] [PubMed: 31745072] [CrossRef]

Chang MY, Ouyang CS, Chiang CT, et al. A New Method of Diagnosing Attention-Deficit Hyperactivity Disorder in Male Patients by Quantitative EEG Analysis. Clin EEG Neurosci. 2019 Sep;50(5):339–47. doi: 10.1177/1550059419859164. PMID: 31321994. [PubMed: 31321994] [CrossRef]

Chang SH, Shie JJ, Yu NY. Enhancing Executive Functions and Handwriting with a Concentrative Coordination Exercise in Children with ADHD: A Randomized Clinical Trial. Percept Mot Skills. 2022 Aug;129(4):1014–35. doi: 10.1177/00315125221098324. PMID: 35507726. [PubMed: 35507726] [CrossRef]

Chang TM, Wu RC, Yang RC, et al. Objective diagnosis of ADHD through movement analysis by using a smart chair with piezoelectric material. Pediatr Neonatol. 2023 Jan;64(1):46–52. doi: 10.1016/j.pedneo.2022.06.007. PMID: 36089537. [PubMed: 36089537] [CrossRef]

Chang Y, Stevenson C, Chen IC, et al. Neurological state changes indicative of ADHD in children learned via EEG-based LSTM networks. J Neural Eng. 2022 Feb 10;19(1). doi: 10.1088/1741-2552/ac4f07. PMID: 35081524. [PubMed: 35081524] [CrossRef]

Charach A, Chen S, Hogg-Johnson S, et al. Using the Conners’ Teacher Rating Scale-Revised in school children referred for assessment. Can J Psychiatry. 2009 Apr;54(4):232–41. doi: 10.1177/070674370905400404. PMID: 19321029. [PubMed: 19321029] [CrossRef]

Chelune GJ, Ferguson W, Koon R, et al. Frontal lobe disinhibition in attention deficit disorder. Child Psychiatry Hum Dev. 1986 Summer;16(4):221–34. doi: 10.1007/BF00706479. PMID: 3743175. [PubMed: 3743175] [CrossRef]

Chen C, Li Z, Liu X, et al. Cognitive Control Deficits in Children With Subthreshold Attention-Deficit/Hyperactivity Disorder. Front Hum Neurosci. 2022;16:835544. doi: 10.3389/fnhum.2022.835544. PMID: 35360286. [PMC free article: PMC8963720] [PubMed: 35360286] [CrossRef]

Chen CC, Wu EHK, Chen YQ, et al. Neuronal Correlates of Task Irrelevant Distractions Enhance the Detection of Attention Deficit/Hyperactivity Disorder. IEEE Transactions on Neural Systems and Rehabilitation Engineering. 2023;31:1302–10. doi: 10.1109/TNSRE.2023.3241649. [CrossRef]

Chen H, Chen W, Song Y, et al. EEG characteristics of children with attention-deficit/hyperactivity disorder. Neuroscience. 2019 May 15;406:444–56. doi: 10.1016/j.neuroscience.2019.03.048. PMID: 30926547. [PubMed: 30926547] [CrossRef]

Chen H, Song Y, Li X. A deep learning framework for identifying children with ADHD using an EEG-based brain network. Neurocomputing. 2019;356:83–96. doi: 10.1016/j.neucom.2019.04.058. [CrossRef]

Chen IC, Lee PW, Wang LJ, et al. Incremental Validity of Multi-Method and Multi-Informant Evaluations in the Clinical Diagnosis of Preschool ADHD. J Atten Disord. 2021 Dec 23:10870547211045739. doi: 10.1177/10870547211045739. PMID: 34949123. [PubMed: 34949123] [CrossRef]

Chen WJ, Faraone SV, Biederman J, et al. Diagnostic accuracy of the Child Behavior Checklist scales for attention-deficit hyperactivity disorder: a receiver-operating characteristic analysis. J Consult Clin Psychol. 1994 Oct;62(5):1017–25. doi: 10.1037/0022-006x.62.5.1017. PMID: 7806710. [PubMed: 7806710] [CrossRef]

Chen Y, Tang Y, Wang C, et al. ADHD classification by dual subspace learning using resting-state functional connectivity. Artif Intell Med. 2020 Mar;103:101786. doi: 10.1016/j.artmed.2019.101786. PMID: 32143793. [PubMed: 32143793] [CrossRef]

Chiarenza GA, Villa S, Galan L, et al. Junior temperament character inventory together with quantitative EEG discriminate children with attention deficit hyperactivity disorder combined subtype from children with attention deficit hyperactivity disorder combined subtype plus oppositional defiant disorder. Int J Psychophysiol. 2018 Aug;130:9–20. doi: 10.1016/j.ijpsycho.2018.05.007. PMID: 29787785. [PubMed: 29787785] [CrossRef]

Children’s Hospital Medical Center CSCsH. The Effects of ADHD Medication (TEAM) Study. 2015.

Childress AC, Lloyd E, Jacobsen L, et al. Efficacy and Safety of Lisdexamfetamine in Preschool Children With Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2022 May 13. doi: 10.1016/j.jaac.2022.03.034. PMID: 35577034. [PubMed: 35577034] [CrossRef]

Childress AC, Spencer T, Lopez F, et al. Efficacy and safety of dexmethylphenidate extended-release capsules administered once daily to children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009 Aug;19(4):351–61. doi: 10.1089/cap.2009.0007. PMID: 19702487. [PubMed: 19702487] [CrossRef]

Cho S, Lee SI, Yoo H, et al. A randomized, open-label assessment of response to various doses of atomoxetine in Korean pediatric outpatients with attention-deficit/hyperactivity disorder. Psychiatry Investigation. 2011;8(2):141–8. doi: 10.4306/pi.2011.8.2.141. [PMC free article: PMC3149109] [PubMed: 21852991] [CrossRef]

Chow JC, Ouyang CS, Chiang CT, et al. Novel method using Hjorth mobility analysis for diagnosing attention-deficit hyperactivity disorder in girls. Brain Dev. 2019 Apr;41(4):334–40. doi: 10.1016/j.braindev.2018.11.006. PMID: 30473392. [PubMed: 30473392] [CrossRef]

Chu KC, Huang YS, Tseng CF, et al. Reliability and validity of DS-ADHD: A decision support system on attention deficit hyperactivity disorders. Comput Methods Programs Biomed. 2017 Mar;140:241–8. doi: 10.1016/j.cmpb.2016.12.003. PMID: 28254080. [PubMed: 28254080] [CrossRef]

Chu L, Zhu P, Ma C, et al. Effects of Combing Group Executive Functioning and Online Parent Training on School-Aged Children With ADHD: A Randomized Controlled Trial. Front Pediatr. 2021;9:813305. doi: 10.3389/fped.2021.813305. PMID: 35223713. [PMC free article: PMC8874140] [PubMed: 35223713] [CrossRef]

Churchill SS, Leo MC, Brennan EM, et al. Longitudinal Impact of a Randomized Clinical Trial to Improve Family Function, Reduce Maternal Stress and Improve Child Outcomes in Families of Children with ADHD. Matern Child Health J. 2018 Aug;22(8):1172–82. doi: 10.1007/s10995-018-2502-5. PMID: 29476416. [PubMed: 29476416] [CrossRef]

Coelho LF, Barbosa DLF, Rizzutti S, et al. Group cognitive behavioral therapy for children and adolescents with ADHD. Psicol Reflex Crit. 2017 May 16;30(1):11. doi: 10.1186/s41155-017-0063-y. PMID: 32026094. [PMC free article: PMC6967068] [PubMed: 32026094] [CrossRef]

Coghill DR, Banaschewski T, Lecendreux M, et al. Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design. J Am Acad Child Adolesc Psychiatry. 2014 Jun;53(6):647–57.e1. doi: 10.1016/j.jaac.2014.01.017. PMID: 24839883. [PubMed: 24839883] [CrossRef]

Cohen ML, Kelly PC, Atkinson AW. Parent, teacher, child. A trilateral approach to attention deficit disorder. Am J Dis Child. 1989 Oct;143(10):1229–33. PMID: 2801667. [PubMed: 2801667]

Coles EK, Pelham WE, Fabiano GA, et al. Randomized Trial of First-Line Behavioral Intervention to Reduce Need for Medication in Children with ADHD. J Clin Child Adolesc Psychol. 2020 Sep–Oct;49(5):673–87. doi: 10.1080/15374416.2019.1630835. PMID: 31411903. [PMC free article: PMC7018583] [PubMed: 31411903] [CrossRef]

Concordia Pharmaceuticals Inc. B. Efficacy & Safety of KAPVAY™ Extended-Release in Children & Adolescents With Attention Deficit Hyperactivity Disorder. 2011.

Conners CK, Casat CD, Gualtieri CT, et al. Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry. 1996 Oct;35(10):1314–21. doi: 10.1097/00004583-199610000-00018. PMID: 8885585. [PubMed: 8885585] [CrossRef]

Connor DF FR, Kollins SH, Sallee F, López FA, Lyne A, Tremblay G. Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial. CNS Drugs. 2010 Sep;24(9):755–68. doi: 10.2165/11537790-000000000-00000. PMID: 20806988. [PubMed: 20806988] [CrossRef]

Corkum P, Elik N, Blotnicky-Gallant PAC, et al. Web-Based Intervention for Teachers of Elementary Students With ADHD: Randomized Controlled Trial. J Atten Disord. 2019 Feb;23(3):257–69. doi: 10.1177/1087054715603198. PMID: 26362259. [PubMed: 26362259] [CrossRef]

Cornu C, Mercier C, Ginhoux T, et al. A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms. Eur Child Adolesc Psychiatry. 2018 Mar;27(3):377–84. doi: 10.1007/s00787-017-1058-z. PMID: 28993963. [PubMed: 28993963] [CrossRef]

Cree RA, Bitsko RH, Danielson ML, et al. Surveillance of ADHD Among Children in the United States: Validity and Reliability of Parent Report of Provider Diagnosis. J Atten Disord. 2023 Jan;27(2):111–23. doi: 10.1177/10870547221131979. PMID: 36326292. [PMC free article: PMC9843610] [PubMed: 36326292] [CrossRef]

Crippa A, Salvatore C, Molteni E, et al. The Utility of a Computerized Algorithm Based on a Multi-Domain Profile of Measures for the Diagnosis of Attention Deficit/Hyperactivity Disorder. Front Psychiatry. 2017;8:189. doi: 10.3389/fpsyt.2017.00189. PMID: 29042856. [PMC free article: PMC5632354] [PubMed: 29042856] [CrossRef]

Crippa A, Tesei A, Sangiorgio F, et al. Behavioral and cognitive effects of docosahexaenoic acid in drug-naïve children with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled clinical trial. Eur Child Adolesc Psychiatry. 2019 Apr;28(4):571–83. doi: 10.1007/s00787-018-1223-z. PMID: 30246216. [PubMed: 30246216] [CrossRef]

Culbertson WC, Zillmer EA. The Tower of LondonDX: A Standardized Approach to Assessing Executive Functioning in Children. Archives of Clinical Neuropsychology. 1998 1998/04/01/;13(3):285–301. doi: 10.1016/S0887-6177(97)00033-4. [PubMed: 14590643] [CrossRef]

Das W, Khanna S. A Robust Machine Learning Based Framework for the Automated Detection of ADHD Using Pupillometric Biomarkers and Time Series Analysis. Sci Rep. 2021 Aug 12;11(1):16370. doi: 10.1038/s41598-021-95673-5. PMID: 34385511. [PMC free article: PMC8361128] [PubMed: 34385511] [CrossRef]

Dashbozorgi Z, Ghaffari A, Karamali Esmaili S, et al. Effect of Neurofeedback Training on Aggression and Impulsivity in Children With Attention-Deficit/Hyperactivity Disorder: A Double-Blinded Randomized Controlled Trial. Basic Clin Neurosci. 2021 Sep–Oct;12(5):693–702. doi: 10.32598/bcn.2021.2363.1. PMID: 35173923. [PMC free article: PMC8818111] [PubMed: 35173923] [CrossRef]

David D, Dobrean A, Păsărelu CR, et al. Psychotherapy, Atomoxetine or Both? Preliminary Evidence from a Comparative Study of Three Types of Treatment for Attention-Deficit/Hyperactivity Disorder in Children. Cognitive Therapy and Research. 2021;45(1):149–65. doi: 10.1007/s10608-020-10157-6. [CrossRef]

Daviss WB, Patel NC, Robb AS, et al. Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis. J Am Acad Child Adolesc Psychiatry. 2008 Feb;47(2):189–98. doi: 10.1097/chi.0b013e31815d9ae4. PMID: 18182964. [PubMed: 18182964] [CrossRef]

Deb S, Dhaliwal AJ, Roy M. The usefulness of Conners’ Rating Scales-Revised in screening for attention deficit hyperactivity disorder in children with intellectual disabilities and borderline intelligence. J Intellect Disabil Res. 2008 Nov;52(11):950–65. doi: 10.1111/j.1365-2788.2007.01035.x. PMID: 18179511. [PubMed: 18179511] [CrossRef]

Dehbozorghi S, Bagheri S, Moradi K, et al. Efficacy and safety of tipepidine as adjunctive therapy in children with attention‐deficit/hyperactivity disorder: Randomized, double‐blind, placebo‐controlled clinical trial. Psychiatry and Clinical Neurosciences. 2019 Nov 2019;73(11):690–6. [PubMed: 31294924]

Dell’Agnello G, Maschietto D, Bravaccio C, et al. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study. Eur Neuropsychopharmacol. 2009 Nov;19(11):822–34. doi: 10.1016/j.euroneuro.2009.07.008. PMID: 19716683. [PubMed: 19716683] [CrossRef]

Denton CA, Tamm L, Schatschneider C, et al. The Effects of ADHD Treatment and Reading Intervention on the Fluency and Comprehension of Children with ADHD and Word Reading Difficulties: A Randomized Clinical Trial. Sci Stud Read. 2020;24(1):72–89. doi: 10.1080/10888438.2019.1640704. PMID: 32982141. [PMC free article: PMC7518569] [PubMed: 32982141] [CrossRef]

Dentz A, Guay MC, Gauthier B, et al. Is the Cogmed program effective for youths with attention deficit/hyperactivity disorder under pharmacological treatment? Applied Cognitive Psychology. 2020;34(3):577–89. doi: 10.1002/acp.3631. [CrossRef]

Deserno MK, Bathelt J, Groenman AP, et al. Probing the overarching continuum theory: data-driven phenotypic clustering of children with ASD or ADHD. Eur Child Adolesc Psychiatry. 2022 Jun 10. doi: 10.1007/s00787-022-01986-9. PMID: 35687205. [PMC free article: PMC10533623] [PubMed: 35687205] [CrossRef]

Diamond IR, Tannock R, Schachar RJ. Response to methylphenidate in children with ADHD and comorbid anxiety. J Am Acad Child Adolesc Psychiatry. 1999 Apr;38(4):402–9. doi: 10.1097/00004583-199904000-00012. PMID: 10199111. [PubMed: 10199111] [CrossRef]

Dittmann RW, Cardo E, Nagy P, et al. Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study. CNS Drugs. 2013 Dec;27(12):1081–92. doi: 10.1007/s40263-013-0104-8. PMID: 23959815. [PMC free article: PMC3835923] [PubMed: 23959815] [CrossRef]

Dittmann RW, Schacht A, Helsberg K, et al. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany. J Child Adolesc Psychopharmacol. 2011 Apr;21(2):97–110. doi: 10.1089/cap.2009.0111. PMID: 21488751. [PubMed: 21488751] [CrossRef]

Dong Y, Chow BW, Mo J, et al. Dialogic reading with attention-deficit-hyperactivity disorder (ADHD) kindergarteners: Does reading with parents or siblings enhance their language development? Dev Psychol. 2022 Oct 6;59(5):862–73. doi: 10.1037/dev0001466. PMID: 36201815. [PubMed: 36201815] [CrossRef]

Dose C, Hautmann C, Buerger M, et al. Telephone-assisted self-help for parents of children with attention-deficit/hyperactivity disorder who have residual functional impairment despite methylphenidate treatment: a randomized controlled trial. J Child Psychol Psychiatry. 2017 Jun;58(6):682–90. doi: 10.1111/jcpp.12661. PMID: 27878809. [PubMed: 27878809] [CrossRef]

Dovis S, Van der Oord S, Wiers RW, et al. Improving executive functioning in children with ADHD: training multiple executive functions within the context of a computer game. a randomized double-blind placebo controlled trial. PLoS One. 2015;10(4):e0121651. doi: 10.1371/journal.pone.0121651. PMID: 25844638. [PMC free article: PMC4386826] [PubMed: 25844638] [CrossRef]

Doyle A, Ostrander R, Skare S, et al. Convergent and criterion-related validity of the Behavior Assessment System for Children-Parent Rating Scale. J Clin Child Psychol. 1997 Sep;26(3):276–84. doi: 10.1207/s15374424jccp2603_6. PMID: 9292385. [PubMed: 9292385] [CrossRef]

Doyle R, Mick E, Biederman J. Convergence between the Achenbach youth self-report and structured diagnostic interview diagnoses in ADHD and non-ADHD youth. J Nerv Ment Dis. 2007 Apr;195(4):350–2. doi: 10.1097/01.nmd.0000253732.79172.43. PMID: 17435486. [PubMed: 17435486] [CrossRef]

Dreakhshanpour PF, Deylamsalehi A, Moghaddas SSJ, et al. EFFICACY OF ARIPIPRAZOLE AND RISPERIDONE IN TREATMENT OF CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: A DOUBLE-BLIND CLINICAL TRIAL STUDY. Bulletin of Pharmaceutical Sciences. Assiut. 2022;45(1):281–8. doi: 10.21608/bfsa.2022.239464. [CrossRef]

Duda M, Haber N, Daniels J, et al. Crowdsourced validation of a machine-learning classification system for autism and ADHD. Transl Psychiatry. 2017 May 16;7(5):e1133. doi: 10.1038/tp.2017.86. PMID: 28509905. [PMC free article: PMC5534954] [PubMed: 28509905] [CrossRef]

Duda M, Ma R, Haber N, et al. Use of machine learning for behavioral distinction of autism and ADHD. Transl Psychiatry. 2016 Feb 9;6(2):e732. doi: 10.1038/tp.2015.221. PMID: 26859815. [PMC free article: PMC4872425] [PubMed: 26859815] [CrossRef]

Duke University, National Institute of Mental Health. Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study). 2009a.

Duke University, National Institute of Mental Health. Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study). 2009b.

DuPaul GJ, Anastopoulos AD, Shelton TL, et al. Multimethod assessment of attention-deficit hyperactivity disorder: The diagnostic utility of clinic-based tests. Journal of Clinical Child Psychology. 1992;21(4):394–402. doi: 10.1207/s15374424jccp2104_10. [CrossRef]

DuPaul GJ, Evans SW, Owens JS, et al. School-based intervention for adolescents with attention-deficit/hyperactivity disorder: Effects on academic functioning. J Sch Psychol. 2021 Aug;87:48–63. doi: 10.1016/j.jsp.2021.07.001. PMID: 34303447. [PubMed: 34303447] [CrossRef]

Durgut E, Orengul AC, Algun ZC. Comparison of the effects of treadmill and vibration training in children with attention deficit hyperactivity disorder: A randomized controlled trial. NeuroRehabilitation. 2020;47(2):121–31. doi: 10.3233/nre-203040. PMID: 32741784. [PubMed: 32741784] [CrossRef]

Duric NS, Assmus J, Gundersen D, et al. Multimodal treatment in children and adolescents with attention-deficit/hyperactivity disorder: a 6-month follow-up. Nord J Psychiatry. 2017 Jul;71(5):386–94. doi: 10.1080/08039488.2017.1305446. PMID: 28345387. [PubMed: 28345387] [CrossRef]

Ebesutani C, Bernstein A, Nakamura BJ, et al. Concurrent Validity of the Child Behavior Checklist DSM-Oriented Scales: Correspondence with DSM Diagnoses and Comparison to Syndrome Scales. J Psychopathol Behav Assess. 2010 Sep;32(3):373–84. doi: 10.1007/s10862-009-9174-9. PMID: 20700377. [PMC free article: PMC2914253] [PubMed: 20700377] [CrossRef]

Edwards MC, Sigel BA. Estimates of the utility of Child Behavior Checklist/Teacher Report Form Attention Problems scale in the diagnosis of ADHD in children referred to a specialty clinic. Journal of Psychopathology and Behavioral Assessment. 2015;37:50–9. doi: 10.1007/s10862-014-9431-4. [CrossRef]

Egeland J AA, Saunes BK. Few effects of far transfer of working memory training in ADHD: a randomized controlled trial. PLoS One. 2013;8(10):e75660. doi: 10.1371/journal.pone.0075660. [PMC free article: PMC3790857] [PubMed: 24124503] [CrossRef]

Eiraldi RB, Power TJ, Karustis JL, et al. Assessing ADHD and comorbid disorders in children: the Child Behavior Checklist and the Devereux Scales of Mental Disorders. J Clin Child Psychol. 2000 Mar;29(1):3–16. doi: 10.1207/S15374424jccp2901_2. PMID: 10693028. [PubMed: 10693028] [CrossRef]

Ekhlasi A, Nasrabadi AM, Mohammadi M. Analysis of EEG brain connectivity of children with ADHD using graph theory and directional information transfer. Biomed Tech (Berl). 2022 Oct 6;68(2):133–46. doi: 10.1515/bmt-2022-0100. PMID: 36197950. [PubMed: 36197950] [CrossRef]

El-Sayed E, van’t Hooft I, Fried I, et al. Measurements of attention deficits and impulsivity: a Swedish study of the Gordon Diagnostic System. Acta Paediatr. 1999 Nov;88(11):1262–8. doi: 10.1080/080352599750030400. PMID: 10591431. [PubMed: 10591431] [CrossRef]

Eli Lilly Company. An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD). 2004.

Eli Lilly Company. Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany. 2006.

Eli Lilly Company. Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD). 2007.

Eli Lilly Company. Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD). 2008.

Elkins RM, Carpenter AL, Pincus DB, et al. Inattention symptoms and the diagnosis of comorbid attention-deficit/hyperactivity disorder among youth with generalized anxiety disorder. J Anxiety Disord. 2014 Dec;28(8):754–60. doi: 10.1016/j.janxdis.2014.09.003. PMID: 25260213. [PMC free article: PMC4252769] [PubMed: 25260213] [CrossRef]

Elmaadawi AZ, Patel R, Almaaitah Y, et al. Effect of pharmacogenomic testing on pediatric mental health outcome: a 6-month follow-up. Pharmacogenomics. 2022 Dec 5. doi: 10.2217/pgs-2022-0131. PMID: 36468359. [PubMed: 36468359] [CrossRef]

Emser TS, Johnston BA, Steele JD, et al. Assessing ADHD symptoms in children and adults: evaluating the role of objective measures. Behav Brain Funct. 2018 May 18;14(1):11. doi: 10.1186/s12993-018-0143-x. PMID: 29776429. [PMC free article: PMC5960089] [PubMed: 29776429] [CrossRef]

Enns JE, Randall JR, Smith M, et al. A Multimodal Intervention for Children with ADHD Reduces Inequity in Health and Education Outcomes. Can J Psychiatry. 2017 Jun;62(6):403–12. doi: 10.1177/0706743717692301. PMID: 28146649. [PMC free article: PMC5455871] [PubMed: 28146649] [CrossRef]

Epstein JN, Kelleher KJ, Baum R, et al. Impact of a Web-Portal Intervention on Community ADHD Care and Outcomes. Pediatrics. 2016 Aug;138(2). doi: 10.1542/peds.2015-4240. PMID: 27462065. [PMC free article: PMC4960725] [PubMed: 27462065] [CrossRef]

Epstein JN, Rabiner D, Johnson DE, et al. Improving attention-deficit/hyperactivity disorder treatment outcomes through use of a collaborative consultation treatment service by community-based pediatricians: a cluster randomized trial. Arch Pediatr Adolesc Med. 2007 Sep;161(9):835–40. doi: 10.1001/archpedi.161.9.835. PMID: 17768282. [PubMed: 17768282] [CrossRef]

Ercan ES, Ardic UA, Kutlu A, et al. No beneficial effects of adding parent training to methylphenidate treatment for ADHD + ODD/CD children: a 1-year prospective follow-up study. J Atten Disord. 2014 Feb;18(2):145–57. doi: 10.1177/1087054711432884. PMID: 22522574. [PubMed: 22522574] [CrossRef]

Estrada-Plana V, Esquerda M, Mangues R, et al. A Pilot Study of the Efficacy of a Cognitive Training Based on Board Games in Children with Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial. Games Health J. 2019 Aug;8(4):265–74. doi: 10.1089/g4h.2018.0051. PMID: 30653355. [PubMed: 30653355] [CrossRef]

Evans SW, Langberg JM, Schultz BK, et al. Evaluation of a school-based treatment program for young adolescents with ADHD. J Consult Clin Psychol. 2016 Jan;84(1):15–30. doi: 10.1037/ccp0000057. PMID: 26501496. [PubMed: 26501496] [CrossRef]

F. C. New marker using bioimpedance technology in screening for attention deficit/hyperactivity disorder (ADHD) in children as an adjunct to conventional diagnostic methods. Psychol Res Behav Manag. 2011;4:113–7. doi: 10.2147/prbm.s22924. [PMC free article: PMC3218780] [PubMed: 22114541] [CrossRef]

Fabiano GA, Schatz NK, Morris KL, et al. Efficacy of a family-focused intervention for young drivers with attention-deficit hyperactivity disorder. J Consult Clin Psychol. 2016 Dec;84(12):1078–93. doi: 10.1037/ccp0000137. PMID: 27618640. [PMC free article: PMC5125890] [PubMed: 27618640] [CrossRef]

Fallah R, Eiliaei S, Ferdosian F. Clinical Trial of Efficacy Evaluation of Omega-3 with Risperidone on Seizures Frequency in Children with Refractory Epilepsy and Attention-Deficit/Hyperactivity Disorder. Iran J Child Neurol. 2018 Fall;12(4):28–36. PMID: 30279706. [PMC free article: PMC6160632] [PubMed: 30279706]

Faraone SV, Newcorn JH, Antshel KM, et al. The Groundskeeper Gaming Platform as a Diagnostic Tool for Attention-Deficit/Hyperactivity Disorder: Sensitivity, Specificity, and Relation to Other Measures. J Child Adolesc Psychopharmacol. 2016 Oct;26(8):672–85. doi: 10.1089/cap.2015.0174. PMID: 27105181. [PMC free article: PMC5069710] [PubMed: 27105181] [CrossRef]

Farmer CA, Epstein JN, Findling RL, et al. Risperidone Added to Psychostimulant in Children with Severe Aggression and Attention-Deficit/Hyperactivity Disorder: Lack of Effect on Attention and Short-Term Memory. J Child Adolesc Psychopharmacol. 2017 Mar;27(2):117–24. doi: 10.1089/cap.2016.0040. PMID: 27348211. [PMC free article: PMC5367910] [PubMed: 27348211] [CrossRef]

Ferrin M, Moreno-Granados JM, Salcedo-Marin MD, et al. Evaluation of a psychoeducation programme for parents of children and adolescents with ADHD: immediate and long-term effects using a blind randomized controlled trial. Eur Child Adolesc Psychiatry. 2014 Aug;23(8):637–47. doi: 10.1007/s00787-013-0494-7. PMID: 24292412. [PubMed: 24292412] [CrossRef]

Ferrin M, Perez-Ayala V, El-Abd S, et al. A Randomized Controlled Trial Evaluating the Efficacy of a Psychoeducation Program for Families of Children and Adolescents With ADHD in the United Kingdom: Results After a 6-Month Follow-Up. J Atten Disord. 2020 Mar;24(5):768–79. doi: 10.1177/1087054715626509. PMID: 26838557. [PubMed: 26838557] [CrossRef]

Ferrin M VA. Examination of neurological subtle signs in ADHD as a clinical tool for the diagnosis and their relationship to spatial working memory. J Child Psychol Psychiatry. 2012 Apr;53(4):390–400. doi: 10.1111/j.1469-7610.2011.02496.x. PMID: 22141455. [PubMed: 22141455] [CrossRef]

Fiks AG, Mayne SL, Michel JJ, et al. Distance-Learning, ADHD Quality Improvement in Primary Care: A Cluster-Randomized Trial. J Dev Behav Pediatr. 2017 Oct;38(8):573–83. doi: 10.1097/dbp.0000000000000490. PMID: 28816912. [PMC free article: PMC5657444] [PubMed: 28816912] [CrossRef]

Findling RL, Adler LA, Spencer TJ, et al. Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial. J Child Adolesc Psychopharmacol. 2019 Mar;29(2):80–9. doi: 10.1089/cap.2018.0083. PMID: 30694697. [PubMed: 30694697] [CrossRef]

Findling RL, Childress AC, Cutler AJ, et al. Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2011 Apr;50(4):395–405. doi: 10.1016/j.jaac.2011.01.007. PMID: 21421179. [PubMed: 21421179] [CrossRef]

Findling RL, Short EJ, Manos MJ. Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2001 Dec;40(12):1441–7. doi: 10.1097/00004583-200112000-00015. PMID: 11765290. [PubMed: 11765290] [CrossRef]

Findling RL, Turnbow J, Burnside J, et al. A randomized, double-blind, multicenter, parallel-group, placebo-controlled, dose-optimization study of the methylphenidate transdermal system for the treatment of ADHD in adolescents. CNS Spectr. 2010 Jul;15(7):419–30. doi: 10.1017/s1092852900000353. PMID: 20625364. [PubMed: 20625364] [CrossRef]

Findling RL BO, Melmed RD, López FA, Sallee FR, Arnold LE, Pratt RD. A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2008 Jan;69(1):149–59. doi: 10.4088/jcp.v69n0120. PMID: 18312050. [PubMed: 18312050] [CrossRef]

Florida International University. Novel Approach to Stimulant Induced Weight Suppression and Its Impact on Growth. 2010. https://clinicaltrials.gov/ct2/show/NCT01109849. Accessed on October 11 2022.

Florida International University. Intervention for Teens With ADHD and Substance Use. 2015.

Forbes GB. Clinical utility of the Test of Variables of Attention (TOVA) in the diagnosis of attention-deficit/hyperactivity disorder. J Clin Psychol. 1998 Jun;54(4):461–76. doi: 10.1002/(sici)1097-4679(199806)54:4<461::aid-jclp8>3.0.co;2-q. PMID: 9623751. [PubMed: 9623751] [CrossRef]

François-Sévigny J, Pilon M, Gauthier LA. Differences in Parents and Teachers’ Perceptions of Behavior Manifested by Gifted Children with ADHD Compared to Gifted Children without ADHD and Non-Gifted Children with ADHD Using the Conners 3 Scale. Brain Sci. 2022 Nov 18;12(11). doi: 10.3390/brainsci12111571. PMID: 36421895. [PMC free article: PMC9688281] [PubMed: 36421895] [CrossRef]

Frei H, Everts R, von Ammon K, et al. Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial. Eur J Pediatr. 2005 Dec;164(12):758–67. doi: 10.1007/s00431-005-1735-7. PMID: 16047154. [PubMed: 16047154] [CrossRef]

Frei H, Thurneysen A. Treatment for hyperactive children: homeopathy and methylphenidate compared in a family setting. Br Homeopath J. 2001 Oct;90(4):183–8. doi: 10.1054/homp.1999.0506. PMID: 11680802. [PubMed: 11680802] [CrossRef]

Fuchs T, Birbaumer N, Lutzenberger W, et al. Neurofeedback treatment for attention-deficit/hyperactivity disorder in children: a comparison with methylphenidate. Appl Psychophysiol Biofeedback. 2003 Mar;28(1):1–12. doi: 10.1023/a:1022353731579. PMID: 12737092. [PubMed: 12737092] [CrossRef]

Fuentes J, Danckaerts M, Cardo E, et al. Long-term quality-of-life and functioning comparison of atomoxetine versus other standard treatment in pediatric attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2013 Dec;33(6):766–74. doi: 10.1097/JCP.0b013e31829c762b. PMID: 23963057. [PubMed: 23963057] [CrossRef]

Gao MS, Tsai FS, Lee CC. Learning a Phenotypic-Attribute Attentional Brain Connectivity Embedding for ADHD Classification using rs-fMRI. Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:5472–5. doi: 10.1109/embc44109.2020.9175789. PMID: 33019218. [PubMed: 33019218] [CrossRef]

Garcia-Argibay M, Zhang-James Y, Cortese S, et al. Predicting childhood and adolescent attention-deficit/hyperactivity disorder onset: a nationwide deep learning approach. Mol Psychiatry. 2022 Dec 19. doi: 10.1038/s41380-022-01918-8. PMID: 36536075. [PMC free article: PMC10005952] [PubMed: 36536075] [CrossRef]

García-Sánchez C, Estévez-González A, Suárez-Romero E, et al. Right hemisphere dysfunction in subjects with attention-deficit disorder with and without hyperactivity. J Child Neurol. 1997 Feb;12(2):107–15. doi: 10.1177/088307389701200207. PMID: 9075020. [PubMed: 9075020] [CrossRef]

Gardner W, Lucas A, Kolko DJ, et al. Comparison of the PSC-17 and alternative mental health screens in an at-risk primary care sample. J Am Acad Child Adolesc Psychiatry. 2007 May;46(5):611–8. doi: 10.1097/chi.0b013e318032384b. PMID: 17450052. [PubMed: 17450052] [CrossRef]

Garg J, Arun P, Chavan BS. Comparative short term efficacy and tolerability of methylphenidate and atomoxetine in attention deficit hyperactivity disorder. Indian Pediatr. 2014 Jul;51(7):550–4. doi: 10.1007/s13312-014-0445-5. PMID: 25031133. [PubMed: 25031133] [CrossRef]

Gargaro BA, May T, Tonge BJ, et al. Using the DBC-P Hyperactivity Index to screen for ADHD in young people with autism and ADHD: A pilot study. Research in Autism Spectrum Disorders. 2014 2014/09/01/;8(9):1008–15. doi: 10.1016/j.rasd.2014.05.004. [CrossRef]

Gau SS, Huang YS, Soong WT, et al. A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine in Taiwanese children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2007 Aug;17(4):447–60. doi: 10.1089/cap.2006.0091. PMID: 17822340. [PubMed: 17822340] [CrossRef]

Gau SS, Shen HY, Soong WT, et al. An open-label, randomized, active-controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan. J Child Adolesc Psychopharmacol. 2006 Aug;16(4):441–55. doi: 10.1089/cap.2006.16.441. PMID: 16958569. [PubMed: 16958569] [CrossRef]

Geissler JM, Vloet TD, Strom N, et al. Does helping mothers in multigenerational ADHD also help children in the long run? 2-year follow-up from baseline of the AIMAC randomized controlled multicentre trial. Eur Child Adolesc Psychiatry. 2020 Oct;29(10):1425–39. doi: 10.1007/s00787-019-01451-0. PMID: 31807943. [PubMed: 31807943] [CrossRef]

Geladé K, Bink M, Janssen TW, et al. An RCT into the effects of neurofeedback on neurocognitive functioning compared to stimulant medication and physical activity in children with ADHD. Eur Child Adolesc Psychiatry. 2017 Apr;26(4):457–68. doi: 10.1007/s00787-016-0902-x. PMID: 27665293. [PMC free article: PMC5364239] [PubMed: 27665293] [CrossRef]

Geller D, Donnelly C, Lopez F, et al. Atomoxetine Treatment for Pediatric Patients with Attention-Deficit/Hyperactivity Disorder with Comorbid Anxiety Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 2007 09/01/;46(9):1119–S. doi: 10.1097/chi.0b013e3180ca8385. PMID: 17712235. [PubMed: 17712235] [CrossRef]

Geurts HM, Verté S, Oosterlaan J, et al. How specific are executive functioning deficits in attention deficit hyperactivity disorder and autism? J Child Psychol Psychiatry. 2004 May;45(4):836–54. doi: 10.1111/j.1469-7610.2004.00276.x. PMID: 15056314. [PubMed: 15056314] [CrossRef]

Gevensleben H HB, Albrecht B, et al. Neurofeedback training in children with ADHD: 6-month follow-up of a randomised controlled trial. Eur Child Adolesc Psychiatry. 2010 Sep;19(9):715–24. doi: 10.1007/s00787-010-0109-5. [PMC free article: PMC3128749] [PubMed: 20499120] [CrossRef]

Ghajar A, Aghajan-Nashtaei F, Afarideh M, et al. l-Carnosine as Adjunctive Therapy in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J Child Adolesc Psychopharmacol. 2018 Jun;28(5):331–8. doi: 10.1089/cap.2017.0157. PMID: 29469593. [PubMed: 29469593] [CrossRef]

Ghanizadeh A, Haddad B. The effect of dietary education on ADHD, a randomized controlled clinical trial. Ann Gen Psychiatry. 2015;14:12. doi: 10.1186/s12991-015-0050-6. PMID: 25767556. [PMC free article: PMC4357187] [PubMed: 25767556] [CrossRef]

Gibbons RD, Kupfer DJ, Frank E, et al. Computerized Adaptive Tests for Rapid and Accurate Assessment of Psychopathology Dimensions in Youth. J Am Acad Child Adolesc Psychiatry. 2020 Nov;59(11):1264–73. doi: 10.1016/j.jaac.2019.08.009. PMID: 31465832. [PMC free article: PMC7042076] [PubMed: 31465832] [CrossRef]

Gilbert H, Qin L, Li D, et al. Aiding the diagnosis of AD/HD in childhood: Using actigraphy and a continuous performance test to objectively quantify symptoms. Res Dev Disabil. 2016 Dec;59:35–42. doi: 10.1016/j.ridd.2016.07.013. PMID: 27497372. [PubMed: 27497372] [CrossRef]

Goh PK, Elkins AR, Bansal PS, et al. Data-Driven Methods for Predicting ADHD Diagnosis and Related Impairment: The Potential of a Machine Learning Approach. Res Child Adolesc Psychopathol. 2023 Jan 19. doi: 10.1007/s10802-023-01022-7. PMID: 36656406. [PubMed: 36656406] [CrossRef]

Gomez R, Vance A, Stavropoulos V. Test-Retest Measurement Invariance of Clinic Referred Children’s ADHD Symptoms. Journal of Psychopathology and Behavioral Assessment. 2018;40(2):194–205. doi: 10.1007/s10862-017-9636-4. [CrossRef]

Gomez R, Vance A, Watson S, et al. ROC Analyses of Relevant Conners 3-Short Forms, CBCL, and TRF Scales for Screening ADHD and ODD. Assessment. 2021 Jan;28(1):73–85. doi: 10.1177/1073191119876023. PMID: 31535569. [PubMed: 31535569] [CrossRef]

González-Castro P, Cueli M, Rodríguez C, et al. Efficacy of Neurofeedback Versus Pharmacological Support in Subjects with ADHD. Appl Psychophysiol Biofeedback. 2016 Mar;41(1):17–25. doi: 10.1007/s10484-015-9299-4. PMID: 26290167. [PubMed: 26290167] [CrossRef]

Grazioli S, Crippa A, Rosi E, et al. Exploring telediagnostic procedures in child neuropsychiatry: addressing ADHD diagnosis and autism symptoms through supervised machine learning. Eur Child Adolesc Psychiatry. 2023 Jan 25:1–11. doi: 10.1007/s00787-023-02145-4. PMID: 36695897. [PMC free article: PMC9875192] [PubMed: 36695897] [CrossRef]

Greenhill LL, Biederman J, Boellner SW, et al. A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006 May;45(5):503–11. doi: 10.1097/01.chi.0000205709.63571.c9. PMID: 16601402. [PubMed: 16601402] [CrossRef]

Greenhill LL, Muniz R, Ball RR, et al. Efficacy and safety of dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006 Jul;45(7):817–23. doi: 10.1097/01.chi.0000220847.41027.5d. PMID: 16832318. [PubMed: 16832318] [CrossRef]

Griffiths KR, Leikauf JE, Tsang TW, et al. Response inhibition and emotional cognition improved by atomoxetine in children and adolescents with ADHD: The ACTION randomized controlled trial. J Psychiatr Res. 2018 Jul;102:57–64. doi: 10.1016/j.jpsychires.2018.03.009. PMID: 29674270. [PMC free article: PMC9148271] [PubMed: 29674270] [CrossRef]

Grodzinsky GM, Diamond R. Frontal lobe functioning in boys with attention‐deficit hyperactivity disorder. Developmental Neuropsychology. 1992 1992/01/01;8(4):427–45. doi: 10.1080/87565649209540536. [CrossRef]

Guevara JP, Power TJ, Bevans K, et al. Improving Care Management in Attention-Deficit/Hyperactivity Disorder: An RCT. Pediatrics. 2021 Aug;148(2). doi: 10.1542/peds.2020-031518. PMID: 34281997. [PubMed: 34281997] [CrossRef]

Gungor M, Kurutas EB, Oner E, et al. Diagnostic performance of erythropoietin and erythropoietin receptors levels in children with attention deficit hyperactivity disorder. Clinical Psychopharmacology and Neuroscience. 2021;19(3):530–6. doi: 10.9758/cpn.2021.19.3.530. [PMC free article: PMC8316662] [PubMed: 34294622] [CrossRef]

Gustafsson PA B-TU, Duchen K, et al. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD. Acta Paediatr. 2010 Oct;99(10):1540–9. doi: 10.1111/j.1651-2227.2010.01871.x. PMID: 20491709. [PubMed: 20491709] [CrossRef]

Guttentag S, Bishop S, Doggett R, et al. The Utility of Parent-Report Screening Tools in Differentiating Autism versus Attention-Deficit/Hyperactivity Disorder in School-Age Children. Autism: The International Journal of Research and Practice. 2022 02/01/;26(2):473–87. PMID: EJ1327733. [PubMed: 34219504]

Häger LA, Åsberg Johnels J, Kropotov JD, et al. Biomarker support for ADHD diagnosis based on Event Related Potentials and scores from an attention test. Psychiatry Res. 2021 Jun;300:113879. doi: 10.1016/j.psychres.2021.113879. PMID: 33882399. [PubMed: 33882399] [CrossRef]

Hahn-Markowitz J, Berger I, Manor I, et al. Efficacy of Cognitive-Functional (Cog-Fun) Occupational Therapy Intervention Among Children With ADHD: An RCT. J Atten Disord. 2020 Mar;24(5):655–66. doi: 10.1177/1087054716666955. PMID: 27637735. [PubMed: 27637735] [CrossRef]

Hall CL, Guo B, Valentine AZ, et al. The Validity of the SNAP-IV in Children Displaying ADHD Symptoms. Assessment. 2020 Sep;27(6):1258–71. doi: 10.1177/1073191119842255. PMID: 30991820. [PubMed: 30991820] [CrossRef]

Hall CL, Selby K, Guo B, et al. Innovations in Practice: an objective measure of attention, impulsivity and activity reduces time to confirm attention deficit/hyperactivity disorder diagnosis in children – a completed audit cycle. Child and Adolescent Mental Health. 2016;21(3):175–8. doi: 10.1111/camh.12140. [PubMed: 32680350] [CrossRef]

Hamadache S, Hoberg K, Zaplana Labarga S, et al. Is the QbMini a Valid Instrument for ADHD Assessment? J Atten Disord. 2021 Aug;25(10):1384–94. doi: 10.1177/1087054720903361. PMID: 32075486. [PubMed: 32075486] [CrossRef]

Harfterkamp M, van de Loo-Neus G, Minderaa RB, et al. A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2012 Jul;51(7):733–41. doi: 10.1016/j.jaac.2012.04.011. PMID: 22721596. [PubMed: 22721596] [CrossRef]

Hariri M DA, Djalali M, et al. Effect of n-3 supplementation on hyperactivity, oxidative stress and inflammatory mediators in children with attention-deficit-hyperactivity disorder. Malays J Nutr. 2012 Dec;18(3):329–35. PMID: 24568073. [PubMed: 24568073]

Hasaneen BM, Sarhan M, Samir S, et al. T2∗ magnetic resonance imaging: A non-invasive biomarker of brain iron content in children with attention-deficit/hyperactivity disorder. Egyptian Journal of Radiology and Nuclear Medicine. 2017;48(1):161–7. doi: 10.1016/j.ejrnm.2016.08.001. [CrossRef]

Hasslinger J, Bölte S, Jonsson U. Slow Cortical Potential Versus Live Z-score Neurofeedback in Children and Adolescents with ADHD: A Multi-arm Pragmatic Randomized Controlled Trial with Active and Passive Comparators. Res Child Adolesc Psychopathol. 2021 Sep 3. doi: 10.1007/s10802-021-00858-1. PMID: 34478006. [PMC free article: PMC8940855] [PubMed: 34478006] [CrossRef]

Hazell PL, Stuart JE. A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. J Am Acad Child Adolesc Psychiatry. 2003 Aug;42(8):886–94. doi: 10.1097/01.Chi.0000046908.27264.00. PMID: 12874489. [PubMed: 12874489] [CrossRef]

Helgadóttir H, Gudmundsson Ó, Baldursson G, et al. Electroencephalography as a clinical tool for diagnosing and monitoring attention deficit hyperactivity disorder: a cross-sectional study. BMJ Open. 2015 Jan 16;5(1):e005500. doi: 10.1136/bmjopen-2014-005500. PMID: 25596195. [PMC free article: PMC4298102] [PubMed: 25596195] [CrossRef]

Heller MD, Roots K, Srivastava S, et al. A Machine Learning-Based Analysis of Game Data for Attention Deficit Hyperactivity Disorder Assessment. Games Health J. 2013 Oct;2(5):291–8. doi: 10.1089/g4h.2013.0058. PMID: 26196929. [PubMed: 26196929] [CrossRef]

Hemamy M, Pahlavani N, Amanollahi A, et al. The effect of vitamin D and magnesium supplementation on the mental health status of attention-deficit hyperactive children: a randomized controlled trial. BMC Pediatr. 2021 Apr 17;21(1):178. doi: 10.1186/s12887-021-02631-1. PMID: 33865361. [PMC free article: PMC8052751] [PubMed: 33865361] [CrossRef]

Herbert SD, Harvey EA, Roberts JL, et al. A randomized controlled trial of a parent training and emotion socialization program for families of hyperactive preschool-aged children. Behav Ther. 2013 Jun;44(2):302–16. doi: 10.1016/j.beth.2012.10.004. PMID: 23611079. [PubMed: 23611079] [CrossRef]

Hervas A, Huss M, Johnson M, et al. Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, controlled, phase III trial. Eur Neuropsychopharmacol. 2014 Dec;24(12):1861–72. doi: 10.1016/j.euroneuro.2014.09.014. PMID: 25453486. [PubMed: 25453486] [CrossRef]

Hinshaw SP, Carte ET, Sami N, et al. Preadolescent girls with attention-deficit/hyperactivity disorder: II. Neuropsychological performance in relation to subtypes and individual classification. J Consult Clin Psychol. 2002 Oct;70(5):1099–111. doi: 10.1037//0022-006x.70.5.1099. PMID: 12362960. [PubMed: 12362960] [CrossRef]

Hirayama S, Terasawa K, Rabeler R, et al. The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial. J Hum Nutr Diet. 2014 Apr;27 Suppl 2:284–91. doi: 10.1111/jhn.12090. PMID: 23495677. [PubMed: 23495677] [CrossRef]

Hiscock H, Mulraney M, Heussler H, et al. Impact of a behavioral intervention, delivered by pediatricians or psychologists, on sleep problems in children with ADHD: a cluster-randomized, translational trial. J Child Psychol Psychiatry. 2019 Nov;60(11):1230–41. doi: 10.1111/jcpp.13083. PMID: 31184382. [PubMed: 31184382] [CrossRef]

Hogue A, Horan Fisher J, Dauber S, et al. Randomized Trial of Academic Training and Medication Decision-Making for Adolescents with ADHD in Usual Care. J Clin Child Adolesc Psychol. 2020 Feb 20:1–14. doi: 10.1080/15374416.2020.1716362. PMID: 32078394. [PMC free article: PMC7438261] [PubMed: 32078394] [CrossRef]

Hong N, Comer JS. High-End Specificity of the Attention-Deficit/Hyperactivity Problems Scale of the Child Behavior Checklist for Ages 1.5-5 in a Sample of Young Children with Disruptive Behavior Disorders. Child Psychiatry Hum Dev. 2019 Apr;50(2):222–9. doi: 10.1007/s10578-018-0834-4. PMID: 30056520. [PubMed: 30056520] [CrossRef]

Hong SS, Cho SH. Treating attention deficit hyperactivity disorder with acupuncture: A randomized controlled trial. European Journal of Integrative Medicine. 2016;8(3):150–7. doi: 10.1016/j.eujim.2015.11.018. [CrossRef]

Hosainzadeh Maleki Z, Mashhadi A, Soltanifar A, et al. Barkley’s Parent Training Program, Working Memory Training and their Combination for Children with ADHD: Attention Deficit Hyperactivity Disorder. Iran J Psychiatry. 2014 Apr;9(2):47–54. PMID: 25632280. [PMC free article: PMC4300465] [PubMed: 25632280]

Huang XX, Ou P, Qian QF, et al. Long-term effectiveness of behavioural intervention in preschool children with attention deficit hyperactivity disorder in Southeast China – a randomized controlled trial. BMC Pediatrics. 2021;21(1). doi: 10.1186/s12887-021-03046-8. [CrossRef]

Huang YH CC, Ou HY, et al. Treatment effects of combining social skill training and parent training in Taiwanese children with attention deficit hyperactivity disorder. Journal of the Formosan Medical Association. 2015;114(3):260–7. [PubMed: 25777975]

Hudziak JJ, Copeland W, Stanger C, et al. Screening for DSM-IV externalizing disorders with the Child Behavior Checklist: a receiver-operating characteristic analysis. J Child Psychol Psychiatry. 2004 Oct;45(7):1299–307. doi: 10.1111/j.1469-7610.2004.00314.x. PMID: 15335349. [PubMed: 15335349] [CrossRef]

Ichikawa H, Miyajima T, Yamashita Y, et al. Phase II/III Study of Lisdexamfetamine Dimesylate in Japanese Pediatric Patients with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2020 Feb;30(1):21–31. doi: 10.1089/cap.2019.0076. PMID: 31718254. [PMC free article: PMC7041327] [PubMed: 31718254] [CrossRef]

Ickowicz A, Schachar RJ, Sugarman R, et al. The parent interview for child symptoms: a situation-specific clinical research interview for attention-deficit hyperactivity and related disorders. Can J Psychiatry. 2006 Apr;51(5):325–8. doi: 10.1177/070674370605100508. PMID: 16986822. [PubMed: 16986822] [CrossRef]

Jacobson LA, Pritchard AE, Koriakin TA, et al. Initial Examination of the BRIEF2 in Clinically Referred Children With and Without ADHD Symptoms. J Atten Disord. 2020 Oct;24(12):1775–84. doi: 10.1177/1087054716663632. PMID: 27519529. [PMC free article: PMC5303680] [PubMed: 27519529] [CrossRef]

Jahanshahloo HR, Shamsi M, Ghasemi E, et al. Automated and ERP-Based Diagnosis of Attention-Deficit Hyperactivity Disorder in Children. J Med Signals Sens. 2017 Jan–Mar;7(1):26–32. PMID: 28487830. [PMC free article: PMC5394803] [PubMed: 28487830]

Jain R, Segal S, Kollins SH, et al. Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2011 Feb;50(2):171–9. doi: 10.1016/j.jaac.2010.11.005. PMID: 21241954. [PubMed: 21241954] [CrossRef]

Jarrett MA, Meter AV, Youngstrom EA, et al. Evidence-Based Assessment of ADHD in Youth Using a Receiver Operating Characteristic Approach. J Clin Child Adolesc Psychol. 2018 Sep–Oct;47(5):808–20. doi: 10.1080/15374416.2016.1225502. PMID: 27775429. [PubMed: 27775429] [CrossRef]

Jensen PS, Arnold LE, Swanson JM, et al. 3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):989–1002. doi: 10.1097/CHI.0b013e3180686d48. PMID: 17667478. [PubMed: 17667478] [CrossRef]

Jensen-Doss A, Osterberg LD, Hickey JS, et al. Agreement between chart diagnoses and standardized instrument ratings of youth psychopathology. Adm Policy Ment Health. 2013 Sep;40(5):428–37. doi: 10.1007/s10488-012-0436-6. PMID: 22918708. [PubMed: 22918708] [CrossRef]

Ji H, Wu S, Won J, et al. The Effects of Exergaming on Attention in Children With Attention Deficit/Hyperactivity Disorder: Randomized Controlled Trial. JMIR Serious Games. 2023 May 9;11:e40438. doi: 10.2196/40438. PMID: 37159253. [PMC free article: PMC10206614] [PubMed: 37159253] [CrossRef]

Jiménez-Figueroa G, Ardila-Duarte C, Pineda DA, et al. Prepotent response inhibition and reaction times in children with attention deficit/hyperactivity disorder from a Caribbean community. Atten Defic Hyperact Disord. 2017 Dec;9(4):199–211. doi: 10.1007/s12402-017-0223-z. PMID: 28238028. [PubMed: 28238028] [CrossRef]

Johansson V, Noren Selinus E, Kuja-Halkola R, et al. The Quantified Behavioral Test Failed to Differentiate ADHD in Adolescents With Neurodevelopmental Problems. J Atten Disord. 2021 Feb;25(3):312–21. doi: 10.1177/1087054718787034. PMID: 30024318. [PubMed: 30024318] [CrossRef]

Johnson JK, Liranso T, Saylor K, et al. A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD. J Atten Disord. 2020 Jan;24(2):348–58. doi: 10.1177/1087054719836159. PMID: 30924702. [PMC free article: PMC6939319] [PubMed: 30924702] [CrossRef]

Johnson M OS, Fransson G, et al. Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents. J Atten Disord. 2009 Mar;12(5):394–401. doi: 10.1177/1087054708316261. PMID: 18448859. [PubMed: 18448859] [CrossRef]

Johnstone JM, Hatsu I, Tost G, et al. Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youths: A Placebo-Controlled Randomized Clinical Trial. J Am Acad Child Adolesc Psychiatry. 2022 May;61(5):647–61. doi: 10.1016/j.jaac.2021.07.005. PMID: 34303786. [PMC free article: PMC8782920] [PubMed: 34303786] [CrossRef]

Johnstone SJ, Parrish L, Jiang H, et al. Aiding diagnosis of childhood attention-deficit/hyperactivity disorder of the inattentive presentation: Discriminant function analysis of multi-domain measures including EEG. Biol Psychol. 2021 Apr;161:108080. doi: 10.1016/j.biopsycho.2021.108080. PMID: 33744372. [PubMed: 33744372] [CrossRef]

Juneja M, Mehar H, Sairam S, et al. Children’s Color Trail Test for Objective Assessment of Attention in Children with Attention Deficit Hyperactivity Disorder: A Diagnostic Accuracy Study. Indian Pediatr. 2019 Dec 15;56(12):1025–8. PMID: 31884432. [PubMed: 31884432]

Kadri A, Slimani M, Bragazzi NL, et al. Effect of Taekwondo Practice on Cognitive Function in Adolescents with Attention Deficit Hyperactivity Disorder. Int J Environ Res Public Health. 2019 Jan 12;16(2). doi: 10.3390/ijerph16020204. PMID: 30642062. [PMC free article: PMC6352161] [PubMed: 30642062] [CrossRef]

Kahbazi M, Ghoreishi A, Rahiminejad F, et al. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder. Psychiatry Res. 2009 Aug 15;168(3):234–7. doi: 10.1016/j.psychres.2008.06.024. PMID: 19439364. [PubMed: 19439364] [CrossRef]

Kam HJ, Shin YM, Cho SM, et al. Development of a Decision Support Model for Screening Attention-deficit Hyperactivity Disorder with Actigraph-based Measurements of Classroom Activity. Appl Clin Inform. 2010;1(4):377–93. doi: 10.4338/ACI-2010-05-RA-0033. PMID: 23616848. [PMC free article: PMC3633315] [PubMed: 23616848] [CrossRef]

Karabiber Cura O, Kocaaslan Atli S, Akan A. Attention deficit hyperactivity disorder recognition based on intrinsic time-scale decomposition of EEG signals. Biomedical Signal Processing and Control. 2023;81. doi: 10.1016/j.bspc.2022.104512. [CrossRef]

Karakaya D, Özgür G. Effect of a Solution-Focused Approach on Self-Efficacy and Self-Esteem in Turkish Adolescents With Attention-Deficit/Hyperactivity Disorder. J Psychosoc Nurs Ment Health Serv. 2019 Nov 1;57(11):45–55. doi: 10.3928/02793695-20190708-01. PMID: 31305949. [PubMed: 31305949] [CrossRef]

Kareem MEA, Latef SAA, Rafaatamin O. Impact of intervention program on attention of Attention Deficit Hyperactivity Children (ADHD). Pakistan Journal of Medical and Health Sciences. 2021;15(1):407–11.

Karr JE, Kibby MY, Jagger-Rickels AC, et al. Sensitivity and Specificity of an Executive Function Screener at Identifying Children With ADHD and Reading Disability. J Atten Disord. 2021 Jan;25(1):134–40. doi: 10.1177/1087054718763878. PMID: 29562850. [PMC free article: PMC6146073] [PubMed: 29562850] [CrossRef]

Katz M LA, Kol-Degani H, et al. A compound herbal preparation (CHP) in the treatment of children with ADHD: a randomized controlled trial. J Atten Disord. 2010 Nov;14(3):281–91. doi: 10.1177/1087054709356388. PMID: 20228219. [PubMed: 20228219] [CrossRef]

Kelsey DK, Sumner CR, Casat CD, et al. Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial. Pediatrics. 2004 Jul;114(1):e1–8. doi: 10.1542/peds.114.1.e1. PMID: 15231966. [PubMed: 15231966] [CrossRef]

Kennerley S, Jaquiery B, Hatch B, et al. Informant discrepancies in the assessment of attention-deficit/hyperactivity disorder. Journal of Psychoeducational Assessment. 2018 Mar 2018;36(2):136–47.

Khaksarian M, Ahangari N, Masjedi-Arani A, et al. A comparison of methylphenidate (MPH) and combined methylphenidate with crocus sativus (saffron) in the treatment of children and adolescents with ADHD: A randomized, double-blind, parallel-group, clinical trial. Iranian Journal of Psychiatry and Behavioral Sciences. 2021;15(3). doi: 10.5812/IJPBS.108390. [CrossRef]

Khoshbakht Y, Moghtaderi F, Bidaki R, et al. The effect of dietary approaches to stop hypertension (DASH) diet on attention-deficit hyperactivity disorder (ADHD) symptoms: a randomized controlled clinical trial. Eur J Nutr. 2021 Mar 14. doi: 10.1007/s00394-021-02527-x. PMID: 33715085. [PubMed: 33715085] [CrossRef]

Kim J LY, Han D, et al. The utility of quantitative electroencephalography and Integrated Visual and Auditory Continuous Performance Test as auxiliary tools for the Attention Deficit Hyperactivity Disorder diagnosis. Clin Neurophysiol. 2015;126(3):532–40. doi: 10.1016/j.clinph.2014.06.034. [PubMed: 25088931] [CrossRef]

Kim JW LJ, Kim BN, et al. Theta-phase gamma-amplitude coupling as a neurophysiological marker of attention deficit/hyperactivity disorder in children. Neurosci Lett. 2015 Aug 31;603:25–30. doi: 10.1016/j.neulet.2015.07.006. [PubMed: 26170246] [CrossRef]

Kim SC, Lee H, Lee HS, et al. Adjuvant Therapy for Attention in Children with ADHD Using Game-Type Digital Therapy. Int J Environ Res Public Health. 2022 Nov 14;19(22). doi: 10.3390/ijerph192214982. PMID: 36429699. [PMC free article: PMC9690113] [PubMed: 36429699] [CrossRef]

Kofler MJ, Wells EL, Singh LJ, et al. A randomized controlled trial of central executive training (CET) versus inhibitory control training (ICT) for ADHD. J Consult Clin Psychol. 2020 Aug;88(8):738–56. doi: 10.1037/ccp0000550. PMID: 32700955. [PMC free article: PMC7384295] [PubMed: 32700955] [CrossRef]

Koh JEW, Ooi CP, Lim-Ashworth NS, et al. Automated classification of attention deficit hyperactivity disorder and conduct disorder using entropy features with ECG signals. Comput Biol Med. 2021 Dec 4;140:105120. doi: 10.1016/j.compbiomed.2021.105120. PMID: 34896884. [PubMed: 34896884] [CrossRef]

Koh JEW, Ooi CP, Lim-Ashworth NS, et al. Automated classification of attention deficit hyperactivity disorder and conduct disorder using entropy features with ECG signals. Computers in Biology and Medicine. 2022;140. doi: 10.1016/j.compbiomed.2021.105120. [CrossRef]

Kolko DJ, Hart JA, Campo J, et al. Effects of Collaborative Care for Comorbid Attention Deficit Hyperactivity Disorder Among Children With Behavior Problems in Pediatric Primary Care. Clin Pediatr (Phila). 2020 Jul;59(8):787–800. doi: 10.1177/0009922820920013. PMID: 32503395. [PMC free article: PMC7444430] [PubMed: 32503395] [CrossRef]

Kollins SH, DeLoss DJ, Cañadas E, et al. A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial. Lancet Digit Health. 2020 Apr;2(4):e168–e78. doi: 10.1016/s2589-7500(20)30017-0. PMID: 33334505. [PubMed: 33334505] [CrossRef]

Kollins SH, Jain R, Brams M, et al. Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD. Pediatrics. 2011 Jun;127(6):e1406–13. doi: 10.1542/peds.2010-1260. PMID: 21555501. [PMC free article: PMC3387872] [PubMed: 21555501] [CrossRef]

Kollins SH, López FA, Vince BD, et al. Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011 Apr;21(2):111–20. doi: 10.1089/cap.2010.0064. PMID: 21476931. [PubMed: 21476931] [CrossRef]

Korfmacher AK, Hirsch O, Chavanon ML, et al. Self-management training vs. neurofeedback interventions for attention deficit hyperactivity disorder: Results of a randomized controlled treatment study. Front Psychiatry. 2022;13:969351. doi: 10.3389/fpsyt.2022.969351. PMID: 36061275. [PMC free article: PMC9433654] [PubMed: 36061275] [CrossRef]

Kratochvil CJ, Heiligenstein JH, Dittmann R, et al. Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. J Am Acad Child Adolesc Psychiatry. 2002 Jul;41(7):776–84. doi: 10.1097/00004583-200207000-00008. PMID: 12108801. [PubMed: 12108801] [CrossRef]

Kratochvil CJ, Newcorn JH, Arnold LE, et al. Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. J Am Acad Child Adolesc Psychiatry. 2005 Sep;44(9):915–24. doi: 10.1097/01.chi.0000169012.81536.38. PMID: 16113620. [PubMed: 16113620] [CrossRef]

Kratochvil CJ VB, Stoner JA, Daughton JM, Lubberstedt BD, Murray DW, Chrisman AK, Faircloth MA, Itchon-Ramos NB, Kollins SH, Maayan LA, Greenhill LL, Kotler LA, Fried J, March JS. A double-blind, placebo-controlled study of atomoxetine in young children with ADHD. Pediatrics. 2011 Apr;127(4):e862–8. doi: 10.1542/peds.2010-0825. PMID: 21422081. [PMC free article: PMC3387889] [PubMed: 21422081] [CrossRef]

Krieger V, Amador-Campos JA. Clinical presentations of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents: comparison of neurocognitive performance. Child Neuropsychol. 2021 Apr 30:1–30. doi: 10.1080/09297049.2021.1917530. PMID: 33928840. [PubMed: 33928840] [CrossRef]

Kurlan R, Goetz CG, McDermott MP, et al. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology. 2002a Feb 26;58(4):527–36. doi: 10.1212/wnl.58.4.527. PMID: 11865128. [PubMed: 11865128] [CrossRef]

Kurlan R, Goetz CG, McDermott MP, et al. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology. 2002b Feb 26;58(4):527–36. doi: 10.1212/wnl.58.4.527. PMID: 11865128. [PubMed: 11865128] [CrossRef]

Kurokami T, Kobayashi H, Nakajima M, et al. Establishment of an objective index for the diagnosis of attention deficit/hyperactivity disorder by the continuous performance test “MOGRAZ”. Brain Dev. 2022 Nov;44(10):664–71. doi: 10.1016/j.braindev.2022.07.002. PMID: 35879141. [PubMed: 35879141] [CrossRef]

Kurowski BG, Epstein JN, Pruitt DW, et al. Benefits of Methylphenidate for Long-Term Attention Problems After Traumatic Brain Injury in Childhood: A Randomized, Double-Masked, Placebo-Controlled, Dose-Titration, Crossover Trial. J Head Trauma Rehabil. 2019 Mar/Apr;34(2):E1–e12. doi: 10.1097/htr.0000000000000432. PMID: 30169436. [PMC free article: PMC6395577] [PubMed: 30169436] [CrossRef]

Lange AM, Daley D, Frydenberg M, et al. Parent Training for Preschool ADHD in Routine, Specialist Care: A Randomized Controlled Trial. J Am Acad Child Adolesc Psychiatry. 2018 Aug;57(8):593–602. doi: 10.1016/j.jaac.2018.04.014. PMID: 30071980. [PubMed: 30071980] [CrossRef]

Lau C, Stewart SL, Saklofske DH, et al. Psychometric Evaluation of the interRAI Child and Youth Mental Health Disruptive/Aggression Behaviour Scale (DABS) and Hyperactive/Distraction Scale (HDS). Child Psychiatry Hum Dev. 2018 Apr;49(2):279–89. doi: 10.1007/s10578-017-0751-y. PMID: 28791517. [PubMed: 28791517] [CrossRef]

Lavigne JV, Dulcan MK, LeBailly SA, et al. Computer-assisted management of attention-deficit/hyperactivity disorder. Pediatrics. 2011 Jul;128(1):e46–53. doi: 10.1542/peds.2010-2684. PMID: 21669891. [PMC free article: PMC3124100] [PubMed: 21669891] [CrossRef]

Law SF SR. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder? J Am Acad Child Adolesc Psychiatry. 1999;38(8):944–51. [PubMed: 10434485]

Lee W, Lee D, Lee S, et al. Deep-Learning-Based ADHD Classification Using Children’s Skeleton Data Acquired through the ADHD Screening Game. Sensors (Basel). 2022 Dec 26;23(1). doi: 10.3390/s23010246. PMID: 36616844. [PMC free article: PMC9824773] [PubMed: 36616844] [CrossRef]

Lefler EK, Hartung CM, Fedele DA. Psychometric properties of a primary care mental health screening tool for young children. Children’s Health Care. 2012;41(2):79–96. doi: 10.1080/02739615.2012.657058. [CrossRef]

Lesica S, Skeel R, Fust B. The parent-reported ADHD symptom infrequency scale (PRASIS): a parent report measure of ADHD symptom exaggeration. Child Neuropsychol. 2023 Feb;29(2):255–75. doi: 10.1080/09297049.2022.2081676. PMID: 35618325. [PubMed: 35618325] [CrossRef]

Levy JD, Kronenberger WG, Dunn DW. Development of a Very Brief Measure of ADHD: The CHAOS Scale. J Atten Disord. 2017 May;21(7):575–86. doi: 10.1177/1087054713497792. PMID: 23995051. [PubMed: 23995051] [CrossRef]

Li D, Guo J. Intervention Effect of Theme Building Block Games on the Mental Health and Behavior of Children with Attention Deficit Hyperactivity Disorder. Psychiatr Danub. 2022 Winter;34(4):660–7. doi: 10.24869/psyd.2022.660. PMID: 36548878. [PubMed: 36548878] [CrossRef]

Li F, Zheng Y, Smith SD, et al. A preliminary study of movement intensity during a Go/No-Go task and its association with ADHD outcomes and symptom severity. Child and Adolescent Psychiatry and Mental Health. 2016;10(1). doi: 10.1186/s13034-016-0135-2. [CrossRef]

Li W, Zhou T, Zou L, et al. Identification of attention deficit/hyperactivity disorder in children using multiple ERP features. Current Bioinformatics. 2018;13(5):501–7. doi: 10.2174/1574893612666171201142836. [CrossRef]

Li YL, Tang YQ, Liu B, et al. Electroencephalogram diagnosis and biofeedback treatment for the child with attention deficit hyperactivity disorder. Chinese Journal of Clinical Rehabilitation. 2005;9(8):236–7.

Liang X, Qiu H, Wang P, et al. The impacts of a combined exercise on executive function in children with ADHD: A randomized controlled trial. Scand J Med Sci Sports. 2022 Aug;32(8):1297–312. doi: 10.1111/sms.14192. PMID: 35611615. [PubMed: 35611615] [CrossRef]

Liechti MD VL, Muller UC, et al. Diagnostic value of resting electroencephalogram in attention-deficit/hyperactivity disorder across the lifespan. Brain Topogr. 2013 Jan;26(1):135–51. doi: 10.1007/s10548-012-0258-6. [PubMed: 23053601] [CrossRef]

Lim CG, Poh XWW, Fung SSD, et al. A randomized controlled trial of a brain-computer interface based attention training program for ADHD. PLoS One. 2019;14(5):e0216225. doi: 10.1371/journal.pone.0216225. PMID: 31112554. [PMC free article: PMC6528992] [PubMed: 31112554] [CrossRef]

Lin DY, Kratochvil CJ, Xu W, et al. A randomized trial of edivoxetine in pediatric patients with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2014 May;24(4):190–200. doi: 10.1089/cap.2013.0043. PMID: 24840045. [PMC free article: PMC4026219] [PubMed: 24840045] [CrossRef]

Lin H, Haider SP, Kaltenhauser S, et al. Population level multimodal neuroimaging correlates of attention-deficit hyperactivity disorder among children. Front Neurosci. 2023;17:1138670. doi: 10.3389/fnins.2023.1138670. PMID: 36908780. [PMC free article: PMC9992191] [PubMed: 36908780] [CrossRef]

Lin HY. The Effect of Spatial Uncertainty on Visual Search in Older School-Aged Children with and without ADHD. Arch Clin Neuropsychol. 2023 Jan 30. doi: 10.1093/arclin/acad003. PMID: 36715611. [PubMed: 36715611] [CrossRef]

Lin IC, Chang SC, Huang YJ, et al. Distinguishing different types of attention deficit hyperactivity disorder in children using artificial neural network with clinical intelligent test. Front Psychol. 2022;13:1067771. doi: 10.3389/fpsyg.2022.1067771. PMID: 36710799. [PMC free article: PMC9875079] [PubMed: 36710799] [CrossRef]

Lindhiem O, Goel M, Shaaban S, et al. Objective Measurement of Hyperactivity Using Mobile Sensing and Machine Learning: Pilot Study. JMIR Form Res. 2022 Apr 25;6(4):e35803. doi: 10.2196/35803. PMID: 35468089. [PMC free article: PMC9086887] [PubMed: 35468089] [CrossRef]

Liu X, Sun L, Zhang D, et al. Phase-Amplitude Coupling Brain Networks in Children with Attention-Deficit/Hyperactivity Disorder. Clin EEG Neurosci. 2022 Sep;53(5):399–405. doi: 10.1177/15500594221086195. PMID: 35257602. [PubMed: 35257602] [CrossRef]

Longridge R, Norman S, Henley W, et al. Investigating the agreement between the clinician and research diagnosis of attention deficit hyperactivity disorder and how it changes over time; a clinical cohort study. Child Adolesc Ment Health. 2019 May;24(2):133–41. doi: 10.1111/camh.12285. PMID: 32677186. [PubMed: 32677186] [CrossRef]

Ludyga S, Mücke M, Leuenberger R, et al. Behavioral and neurocognitive effects of judo training on working memory capacity in children with ADHD: A randomized controlled trial. Neuroimage Clin. 2022;36:103156. doi: 10.1016/j.nicl.2022.103156. PMID: 35988343. [PMC free article: PMC9402389] [PubMed: 35988343] [CrossRef]

Luo J, Huang H, Wang S, et al. A Wearable Diagnostic Assessment System vs. SNAP-IV for the auxiliary diagnosis of ADHD: a diagnostic test. BMC Psychiatry. 2022 Jun 21;22(1):415. doi: 10.1186/s12888-022-04038-3. PMID: 35729503. [PMC free article: PMC9214968] [PubMed: 35729503] [CrossRef]

Luo N, Luo X, Zheng S, et al. Aberrant brain dynamics and spectral power in children with ADHD and its subtypes. Eur Child Adolesc Psychiatry. 2022 Aug 22. doi: 10.1007/s00787-022-02068-6. PMID: 35996018. [PMC free article: PMC10576687] [PubMed: 35996018] [CrossRef]

Luo X, Guo X, Zhao Q, et al. A randomized controlled study of remote computerized cognitive, neurofeedback, and combined training in the treatment of children with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry. 2022 Feb 19:1–12. doi: 10.1007/s00787-022-01956-1. PMID: 35182242. [PMC free article: PMC8857637] [PubMed: 35182242] [CrossRef]

Lv YB, Cheng W, Wang MH, et al. Effect of non-pharmacological treatment on the full recovery of social functioning in patients with attention deficit hyperactivity disorder. World Journal of Clinical Cases. 2023;11(14):3238–47. doi: 10.12998/wjcc.v11.i14.3238. [PMC free article: PMC10237121] [PubMed: 37274030] [CrossRef]

Manor I, Magen A, Keidar D, et al. The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled trial, followed by an open-label extension. Eur Psychiatry. 2012 Jul;27(5):335–42. doi: 10.1016/j.eurpsy.2011.05.004. PMID: 21807480. [PubMed: 21807480] [CrossRef]

Marcano JL, Bell MA, Beex AAL. Classification of ADHD and non-ADHD subjects using a universal background model. Biomedical Signal Processing and Control. 2018;39:204–12. doi: 10.1016/j.bspc.2017.07.023. [PMC free article: PMC6557459] [PubMed: 31186670] [CrossRef]

Markovska-Simoska S, Pop-Jordanova N. Quantitative EEG in Children and Adults With Attention Deficit Hyperactivity Disorder: Comparison of Absolute and Relative Power Spectra and Theta/Beta Ratio. Clin EEG Neurosci. 2017 Jan;48(1):20–32. doi: 10.1177/1550059416643824. PMID: 27170672. [PubMed: 27170672] [CrossRef]

Martenyi F, Zavadenko NN, Jarkova NB, et al. Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia. Eur Child Adolesc Psychiatry. 2010 Jan;19(1):57–66. doi: 10.1007/s00787-009-0042-7. PMID: 19568826. [PubMed: 19568826] [CrossRef]

Martín-Brufau R, Nombela Gómez M. Bioelectrical Markers of ADHD: Enhancement of Direct EEG Analysis. Electronic Journal of Research in Educational Psychology. 2017 04/01/;15(1):185–200. PMID: EJ1136431.

Martin-Martinez D C-d-l-HP, Alberola-Lopez S, et al. Nonlinear analysis of actigraphic signals for the assessment of the attention-deficit/hyperactivity disorder (ADHD). Med Eng Phys. 2012 Nov;34(9):1317–29. doi: 10.1016/j.medengphy.2011.12.023. [PubMed: 22297088] [CrossRef]

Matier-Sharma K, Perachio N, Newcorn JH, et al. Differential diagnosis of ADHD: Are objective measures of attention, impulsivity, and activity level helpful? Child Neuropsychology. 1995;1(2):118–27. doi: 10.1080/09297049508402243. [CrossRef]

Matthijssen AM, Dietrich A, Bierens M, et al. Continued Benefits of Methylphenidate in ADHD After 2 Years in Clinical Practice: A Randomized Placebo-Controlled Discontinuation Study. Am J Psychiatry. 2019 Sep 1;176(9):754–62. doi: 10.1176/appi.ajp.2019.18111296. PMID: 31109200. [PubMed: 31109200] [CrossRef]

Mattingly G, Arnold V, Yan B, et al. A Phase 3, Randomized Double-Blind Study of the Efficacy and Safety of Low-Dose SHP465 Mixed Amphetamine Salts Extended-Release in Children with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2020 Nov;30(9):549–57. doi: 10.1089/cap.2020.0005. PMID: 33185468. [PMC free article: PMC7698843] [PubMed: 33185468] [CrossRef]

Maya-Piedrahita MC, Herrera-Gomez PM, Berrío-Mesa L, et al. Supported Diagnosis of Attention Deficit and Hyperactivity Disorder from EEG Based on Interpretable Kernels for Hidden Markov Models. Int J Neural Syst. 2022 Mar;32(3):2250008. doi: 10.1142/s0129065722500083. PMID: 34996341. [PubMed: 34996341] [CrossRef]

Mayes SD, Calhoun SL. The Gordon Diagnostic System and WISC-III Freedom from Distractibility Index: validity in identifying clinic-referred children with and without ADHD. Psychol Rep. 2002 Oct;91(2):575–87. doi: 10.2466/pr0.2002.91.2.575. PMID: 12416852. [PubMed: 12416852] [CrossRef]

Mayes SD, Calhoun SL. Similarities and differences in Wechsler Intelligence Scale for Children--Third Edition (WISC-III) profiles: support for subtest analysis in clinical referrals. Clin Neuropsychol. 2004 Dec;18(4):559–72. doi: 10.1080/13854040490888530. PMID: 15841957. [PubMed: 15841957] [CrossRef]

Mayfield AR, Parke EM, Barchard KA, et al. Equivalence of mother and father ratings of ADHD in children. Child Neuropsychology. 2018 Feb 2018;24(2):166–83. doi: 10.1080/09297049.2016.1236186. PMID: 27729001. [PubMed: 27729001] [CrossRef]

McCarthy A, Asghar S, Wilens T, et al. Using a Brief Parent-Report Measure to Track Outcomes for Children and Teens with ADHD. Child Psychiatry Hum Dev. 2016 Jun;47(3):407–16. doi: 10.1007/s10578-015-0575-6. PMID: 26271346. [PubMed: 26271346] [CrossRef]

McCracken JT, McGough JJ, Loo SK, et al. Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study. J Am Acad Child Adolesc Psychiatry. 2016 Aug;55(8):657–66.e1. doi: 10.1016/j.jaac.2016.05.015. PMID: 27453079. [PMC free article: PMC4976782] [PubMed: 27453079] [CrossRef]

McGrath PJ L-PP, Thurston C, MacLean C, Cunningham C, Waschbusch DA, Watters C, Stewart S, Bagnell A, Santor D, Chaplin W. Telephone-based mental health interventions for child disruptive behavior or anxiety disorders: randomized trials and overall analysis. J Am Acad Child Adolesc Psychiatry. 2011 Nov;50(11):1162–72. doi: 10.1016/j.jaac.2011.07.013. PMID: 22024004. [PubMed: 22024004] [CrossRef]

McIntosh DE, Mulkins RS, Dean RS. Utilization of maternal perinatal risk indicators in the differential diagnosis of ADHD and UADD children. Int J Neurosci. 1995 Mar;81(1–2):35–46. doi: 10.3109/00207459509015297. PMID: 7775071. [PubMed: 7775071] [CrossRef]

Mehri M, Chehrzad MM, Mardani A, et al. The effect of behavioral parent training on sleep problems of school-age children with ADHD: A parallel randomized controlled trial. Arch Psychiatr Nurs. 2020 Aug;34(4):261–7. doi: 10.1016/j.apnu.2020.04.001. PMID: 32828358. [PubMed: 32828358] [CrossRef]

Merzon L, Pettersson K, Aronen ET, et al. Eye movement behavior in a real-world virtual reality task reveals ADHD in children. Sci Rep. 2022 Nov 24;12(1):20308. doi: 10.1038/s41598-022-24552-4. PMID: 36434040. [PMC free article: PMC9700686] [PubMed: 36434040] [CrossRef]

Meyer J, Ramklint M, Hallerbäck MU, et al. Evaluation of a structured skills training group for adolescents with attention-deficit/hyperactivity disorder: a randomised controlled trial. Eur Child Adolesc Psychiatry. 2021 Mar 15. doi: 10.1007/s00787-021-01753-2. PMID: 33721085. [PMC free article: PMC9343260] [PubMed: 33721085] [CrossRef]

Michelson D, Allen AJ, Busner J, et al. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry. 2002 Nov;159(11):1896–901. doi: 10.1176/appi.ajp.159.11.1896. PMID: 12411225. [PubMed: 12411225] [CrossRef]

Michelson D, Faries D, Wernicke J, et al. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics. 2001 Nov;108(5):E83. doi: 10.1542/peds.108.5.e83. PMID: 11694667. [PubMed: 11694667] [CrossRef]

Mikami AY, Griggs MS, Lerner MD, et al. A randomized trial of a classroom intervention to increase peers’ social inclusion of children with attention-deficit/hyperactivity disorder. J Consult Clin Psychol. 2013 Feb;81(1):100–12. doi: 10.1037/a0029654. PMID: 22866680. [PMC free article: PMC3522754] [PubMed: 22866680] [CrossRef]

Mikolas P, Vahid A, Bernardoni F, et al. Training a machine learning classifier to identify ADHD based on real-world clinical data from medical records. Sci Rep. 2022 Jul 28;12(1):12934. doi: 10.1038/s41598-022-17126-x. PMID: 35902654. [PMC free article: PMC9334289] [PubMed: 35902654] [CrossRef]

Minder F, Zuberer A, Brandeis D, et al. Informant-related effects of neurofeedback and cognitive training in children with ADHD including a waiting control phase: a randomized-controlled trial. Eur Child Adolesc Psychiatry. 2018 Aug;27(8):1055–66. doi: 10.1007/s00787-018-1116-1. PMID: 29396712. [PubMed: 29396712] [CrossRef]

Mitchell WG, Chavez JM, Baker SA, et al. Reaction time, impulsivity, and attention in hyperactive children and controls: a video game technique. J Child Neurol. 1990 Jul;5(3):195–204. doi: 10.1177/088307389000500308. PMID: 2398235. [PubMed: 2398235] [CrossRef]

Miyahara M, Healey DM, Halperin JM. One-week temporal stability of hyperactivity in preschoolers with ADHD during psychometric assessment. Psychiatry Clin Neurosci. 2014 Feb;68(2):120–6. doi: 10.1111/pcn.12096. PMID: 24552632. [PMC free article: PMC3930929] [PubMed: 24552632] [CrossRef]

Moghaddari M, Lighvan MZ, Danishvar S. Diagnose ADHD disorder in children using convolutional neural network based on continuous mental task EEG. Comput Methods Programs Biomed. 2020 Dec;197:105738. doi: 10.1016/j.cmpb.2020.105738. PMID: 32927404. [PubMed: 32927404] [CrossRef]

Mohammadi MR, Kazemi MR, Zia E, et al. Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double-blind trial. Hum Psychopharmacol. 2010 Nov;25(7–8):560–5. doi: 10.1002/hup.1154. PMID: 21312290. [PubMed: 21312290] [CrossRef]

Mohammadi MR MS, Keshavarz SA, et al. Melatonin effects in methylphenidate treated children with attention deficit hyperactivity disorder: a randomized double blind clinical trial. Iran J Psychiatry. 2012 Spring;7(2):87–92. [PMC free article: PMC3428643] [PubMed: 22952551]

Mohammadzadeh S, Baghi N, Yousefi F, et al. Effect of omega-3 plus methylphenidate as an alternative therapy to reduce attention deficit-hyperactivity disorder in children. Korean J Pediatr. 2019 Sep;62(9):360–6. doi: 10.3345/kjp.2018.06982. PMID: 31122010. [PMC free article: PMC6753311] [PubMed: 31122010] [CrossRef]

Montoya A, Hervas A, Cardo E, et al. Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder. Curr Med Res Opin. 2009 Nov;25(11):2745–54. doi: 10.1185/03007990903316152. PMID: 19785510. [PubMed: 19785510] [CrossRef]

Mostajeran Z, Mosavat SH, Najafi M, et al. Whey Protein (Ma’aljobon) as a Complementary Therapy for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD): A Randomized Open-label Controlled Clinical Trial. Galen Med J. 2020;9:e1690. doi: 10.31661/gmj.v9i0.1690. PMID: 34466569. [PMC free article: PMC8343698] [PubMed: 34466569] [CrossRef]

Motaharifard MS, Effatpanah M, Karimi M, et al. Effect of sweet almond syrup versus methylphenidate in children with ADHD: A randomized triple-blind clinical trial. Complement Ther Clin Pract. 2019 Aug;36:170–5. doi: 10.1016/j.ctcp.2019.07.008. PMID: 31383435. [PubMed: 31383435] [CrossRef]

Moura O, Costa P, Simões MR. WISC-III Cognitive Profiles in Children with ADHD: Specific Cognitive Impairments and Diagnostic Utility. J Gen Psychol. 2019 Jul–Sep;146(3):258–82. doi: 10.1080/00221309.2018.1561410. PMID: 30729871. [PubMed: 30729871] [CrossRef]

Moura O, Pereira M, Alfaiate C, et al. Neurocognitive functioning in children with developmental dyslexia and attention-deficit/hyperactivity disorder: Multiple deficits and diagnostic accuracy. J Clin Exp Neuropsychol. 2017 Apr;39(3):296–312. doi: 10.1080/13803395.2016.1225007. PMID: 27617883. [PubMed: 27617883] [CrossRef]

Mouti A, Dryer R, Kohn M. Differentiating Autism Spectrum Disorder From ADHD Using the Social Communication Questionnaire. J Atten Disord. 2019 Jun;23(8):828–37. doi: 10.1177/1087054718781945. PMID: 29936891. [PubMed: 29936891] [CrossRef]

Mulhern S, Dworkin PH, Bernstein B. Do parental concerns predict a diagnosis of attention-deficit hyperactivity disorder? J Dev Behav Pediatr. 1994 Oct;15(5):348–52. PMID: 7868703. [PubMed: 7868703]

Muthuraman M, Moliadze V, Boecher L, et al. Multimodal alterations of directed connectivity profiles in patients with attention-deficit/hyperactivity disorders. Sci Rep. 2019 Dec 27;9(1):20028. doi: 10.1038/s41598-019-56398-8. PMID: 31882672. [PMC free article: PMC6934806] [PubMed: 31882672] [CrossRef]

Mwamba HM, Fourie PR, den Heever DV. PANDAS: Paediatric Attention-Deficit/Hyperactivity Disorder Application Software. Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:1444–7. doi: 10.1109/embc.2019.8857357. PMID: 31946165. [PubMed: 31946165] [CrossRef]

Myers K VSA, Zhou C, et al. Effectiveness of a telehealth service delivery model for treating attention-deficit/hyperactivity disorder: a community-based randomized controlled trial. J Am Acad Child Adolesc Psychiatry. 2015 Apr;54(4):263–74. doi: 10.1016/j.jaac.2015.01.009. [PMC free article: PMC4406418] [PubMed: 25791143] [CrossRef]

Nasser A, Liranso T, Adewole T, et al. A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder. J Clin Psychopharmacol. 2021 Jul–Aug 01;41(4):370–80. doi: 10.1097/jcp.0000000000001404. PMID: 34181360. [PMC free article: PMC8244935] [PubMed: 34181360] [CrossRef]

Nasser A, Liranso T, Adewole T, et al. A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children. Clin Ther. 2020 Aug;42(8):1452–66. doi: 10.1016/j.clinthera.2020.05.021. PMID: 32723670. [PubMed: 32723670] [CrossRef]

Nasser A, Liranso T, Adewole T, et al. A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended-Release) in Adolescents with ADHD. Psychopharmacol Bull. 2021 Mar 16;51(2):43–64. PMID: 34092822. [PMC free article: PMC8146561] [PubMed: 34092822]

Nasser A, Liranso T, Adewole T, et al. Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial. Clin Ther. 2021 Apr;43(4):684–700. doi: 10.1016/j.clinthera.2021.01.027. PMID: 33750646. [PubMed: 33750646] [CrossRef]

Nejati V. Program for attention rehabilitation and strengthening (PARS) improves executive functions in children with attention deficit-hyperactivity disorder (ADHD). Res Dev Disabil. 2021 Jun;113:103937. doi: 10.1016/j.ridd.2021.103937. PMID: 33756252. [PubMed: 33756252] [CrossRef]

Nejati V, Fallah F, Raskin S. Inhibitory Control Training Improves Attention Deficit-Hyperactivity Disorder Symptoms and Externalizing Behavior. Clin Child Psychol Psychiatry. 2022 Dec 6;28(3):13591045221144356. doi: 10.1177/13591045221144356. PMID: 36474404. [PubMed: 36474404] [CrossRef]

Neurofeedback Collaborative G. Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13-Month Follow-up. J Am Acad Child Adolesc Psychiatry. 2021 Jul;60(7):841–55. doi: 10.1016/j.jaac.2020.07.906. PMID: 32853703. [PMC free article: PMC7904968] [PubMed: 32853703] [CrossRef]

Newcorn JH, Harpin V, Huss M, et al. Extended-release guanfacine hydrochloride in 6-17-year olds with ADHD: a randomised-withdrawal maintenance of efficacy study. J Child Psychol Psychiatry. 2016 Jun;57(6):717–28. doi: 10.1111/jcpp.12492. PMID: 26871297. [PubMed: 26871297] [CrossRef]

Newcorn JH, Kratochvil CJ, Allen AJ, et al. Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. Am J Psychiatry. 2008 Jun;165(6):721–30. doi: 10.1176/appi.ajp.2007.05091676. PMID: 18281409. [PubMed: 18281409] [CrossRef]

Newcorn JH, Spencer TJ, Biederman J, et al. Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry. 2005 Mar;44(3):240–8. doi: 10.1097/00004583-200503000-00008. PMID: 15725968. [PubMed: 15725968] [CrossRef]

Newman E, Reddy LA. Diagnostic Utility of the Pediatric Attention Disorders Diagnostic Screener. J Atten Disord. 2017 Mar;21(5):372–80. doi: 10.1177/1087054714526431. PMID: 24639402. [PubMed: 24639402] [CrossRef]

Nolan EE, Volpe RJ, Gadow KD, et al. Developmental, Gender, and Comorbidity Differences in Clinically Referred Children with ADHD. Journal of Emotional and Behavioral Disorders. 1999 1999/01/01;7(1):11–20. doi: 10.1177/106342669900700102. [CrossRef]

O’Neill J, O’Connor MJ, Kalender G, et al. Combining neuroimaging and behavior to discriminate children with attention deficit-hyperactivity disorder with and without prenatal alcohol exposure. Brain Imaging Behav. 2021 Jun 5. doi: 10.1007/s11682-021-00477-w. PMID: 34089460. [PMC free article: PMC8643366] [PubMed: 34089460] [CrossRef]

Ogrim G KJ, Hestad K. The quantitative EEG theta/beta ratio in attention deficit/hyperactivity disorder and normal controls: sensitivity, specificity, and behavioral correlates. Psychiatry Res. 2012 Aug 15;198(3):482–8. doi: 10.1016/j.psychres.2011.12.041. [PubMed: 22425468] [CrossRef]

Oppenheimer J, Ojo O, Antonetty A, et al. Timely Interventions for Children with ADHD through Web-Based Monitoring Algorithms. Diseases. 2019 Feb 7;7(1). doi: 10.3390/diseases7010020. PMID: 30736492. [PMC free article: PMC6473761] [PubMed: 30736492] [CrossRef]

Öztekin I, Finlayson MA, Graziano PA, et al. Is there any incremental benefit to conducting neuroimaging and neurocognitive assessments in the diagnosis of ADHD in young children? A machine learning investigation. Developmental Cognitive Neuroscience. 2021 Jun 2021;49.

Öztoprak H, Toycan M, Alp YK, et al. Machine-based classification of ADHD and nonADHD participants using time/frequency features of event-related neuroelectric activity. Clin Neurophysiol. 2017 Dec;128(12):2400–10. doi: 10.1016/j.clinph.2017.09.105. PMID: 29096213. [PubMed: 29096213] [CrossRef]

Park J, Kim C, Ahn JH, et al. Clinical Use of Continuous Performance Tests to Diagnose Children With ADHD. J Atten Disord. 2019 Apr;23(6):531–40. doi: 10.1177/1087054716658125. PMID: 27412120. [PubMed: 27412120] [CrossRef]

Peijnenborgh JC, Hurks PP, Aldenkamp AP, et al. A Study on the Validity of a Computer-Based Game to Assess Cognitive Processes, Reward Mechanisms, and Time Perception in Children Aged 4-8 Years. JMIR Serious Games. 2016 Sep 22;4(2):e15. doi: 10.2196/games.5997. PMID: 27658428. [PMC free article: PMC5054232] [PubMed: 27658428] [CrossRef]

Pelham WE, Jr., Fabiano GA, Waxmonsky JG, et al. Treatment sequencing for childhood ADHD: a multiple-randomization study of adaptive medication and behavioral interventions. J Clin Child Adolesc Psychol. 2016 Jul–Aug;45(4):396–415. doi: 10.1080/15374416.2015.1105138. PMID: 26882332. [PMC free article: PMC4930381] [PubMed: 26882332] [CrossRef]

Pelsser LM, Frankena K, Toorman J, et al. Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): A randomised controlled trial. The Lancet. 2011;377(9764):494–503.

Pereda E, García-Torres M, Melián-Batista B, et al. The blessing of Dimensionality: Feature Selection outperforms functional connectivity-based feature transformation to classify ADHD subjects from EEG patterns of phase synchronisation. PLoS One. 2018;13(8):e0201660. doi: 10.1371/journal.pone.0201660. PMID: 30114248. [PMC free article: PMC6095525] [PubMed: 30114248] [CrossRef]

Perez-Alvarez F, Serra-Amaya C, Timoneda-Gallart CA. Cognitive versus behavioral ADHD phenotype: what is it all about? Neuropediatrics. 2009 Feb;40(1):32–8. doi: 10.1055/s-0029-1231055. PMID: 19639526. [PubMed: 19639526] [CrossRef]

Perugini EM, Harvey EA, Lovejoy DW, et al. The predictive power of combined neuropsychological measures for attention-deficit/hyperactivity disorder in children. Child Neuropsychol. 2000 Jun;6(2):101–14. doi: 10.1076/chin.6.2.101.7059. PMID: 16210207. [PubMed: 16210207] [CrossRef]

Pfiffner LJ HS, Owens E, et al. A two-site randomized clinical trial of integrated psychosocial treatment for ADHD-inattentive type. J Consult Clin Psychol. 2014 Dec;82(6):1115–27. doi: 10.1037/a0036887. [PMC free article: PMC4244306] [PubMed: 24865871] [CrossRef]

Pineda DA, Lopera F, Puerta IC, et al. Potential cognitive endophenotypes in multigenerational families: segregating ADHD from a genetic isolate. Atten Defic Hyperact Disord. 2011 Sep;3(3):291–9. doi: 10.1007/s12402-011-0061-3. PMID: 21779842. [PMC free article: PMC4131930] [PubMed: 21779842] [CrossRef]

Pongpitakdamrong A, Chirdkiatgumchai V, Ruangdaraganon N, et al. Effect of Iron Supplementation in Children with Attention-Deficit/Hyperactivity Disorder and Iron Deficiency: A Randomized Controlled Trial. J Dev Behav Pediatr. 2021 Jul 26;43(2):80–6. doi: 10.1097/dbp.0000000000000993. PMID: 34313619. [PubMed: 34313619] [CrossRef]

Power TJ, Doherty BJ, Panichelli-Mindel SM, et al. The Predictive Validity of Parent and Teacher Reports of ADHD Symptoms. Journal of Psychopathology and Behavioral Assessment. 1998 1998/03/01;20(1):57–81. doi: 10.1023/A:1023035426642. [CrossRef]

Power TJ MJ, Soffer SL, et al. A family-school intervention for children with ADHD: results of a randomized clinical trial. J Consult Clin Psychol. 2012 Aug;80(4):611–23. doi: 10.1037/a0028188. [PMC free article: PMC3404236] [PubMed: 22506793] [CrossRef]

Prasad S, Harpin V, Poole L, et al. A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Curr Med Res Opin. 2007 Feb;23(2):379–94. doi: 10.1185/030079906x167309. PMID: 17288692. [PubMed: 17288692] [CrossRef]

Preston AS, Fennell EB, Bussing R. Utility of a CPT in diagnosing ADHD among a representative sample of high-risk children: a cautionary study. Child Neuropsychol. 2005 Oct;11(5):459–69. doi: 10.1080/09297040591001067. PMID: 16306020. [PubMed: 16306020] [CrossRef]

Purper-Ouakil D, Blasco-Fontecilla H, Ros T, et al. Personalized at-home neurofeedback compared to long-acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trial. J Child Psychol Psychiatry. 2021 Jun 24. doi: 10.1111/jcpp.13462. PMID: 34165190. [PubMed: 34165190] [CrossRef]

Qian X, Loo BRY, Castellanos FX, et al. Brain-computer-interface-based intervention re-normalizes brain functional network topology in children with attention deficit/hyperactivity disorder. Transl Psychiatry. 2018 Aug 10;8(1):149. doi: 10.1038/s41398-018-0213-8. PMID: 30097579. [PMC free article: PMC6086861] [PubMed: 30097579] [CrossRef]

Qian Y, Fan Z, Gao B, et al. Efficacy and acceptability of a second dose of ecological executive skills training for children with ADHD: a randomized controlled study and follow-up. Eur Child Adolesc Psychiatry. 2021 Jun;30(6):921–35. doi: 10.1007/s00787-020-01571-y. PMID: 32596788. [PubMed: 32596788] [CrossRef]

Qin L, Liu H, Zhang H, et al. Evaluation of the diagnostic implications of Das-Naglieri cognitive assessment system in children with attention deficit hyperactivity disorder. BMC Psychiatry. 2018 Dec 12;18(1):386. doi: 10.1186/s12888-018-1970-x. PMID: 30541503. [PMC free article: PMC6292108] [PubMed: 30541503] [CrossRef]

Quintana H, Snyder SM, Purnell W, et al. Comparison of a standard psychiatric evaluation to rating scales and EEG in the differential diagnosis of attention-deficit/hyperactivity disorder. Psychiatry Res. 2007 Aug 30;152(2–3):211–22. doi: 10.1016/j.psychres.2006.04.015. PMID: 17451810. [PubMed: 17451810] [CrossRef]

Rafeiy-Torghabeh M, Ashraf-Ganjouei A, Moradi K, et al. Resveratrol adjunct to methylphenidate improves symptoms of attention-deficit/hyperactivity disorder: a randomized, double-blinded, placebo-controlled clinical trial. Eur Child Adolesc Psychiatry. 2021 May;30(5):799–807. doi: 10.1007/s00787-020-01562-z. PMID: 32449130. [PubMed: 32449130] [CrossRef]

Raghuveer R, Ruchi. Comparative efficacy of structured games and behavioural parent training on working memory in children with attention deficit hyperactivity disorder: A pilot study. Journal of Clinical and Diagnostic Research. 2020;14(7):YC01–YC4. doi: 10.7860/JCDR/2020/43576.13807. [CrossRef]

Rahmani M, Mahvelati A, Farajinia AH, et al. Comparison of Vitamin D, Neurofeedback, and Neurofeedback Combined with Vitamin D Supplementation in Children with Attention-Deficit/Hyperactivity Disorder. Arch Iran Med. 2022 May 1;25(5):285–393. doi: 10.34172/aim.2022.47. PMID: 35943003. [PubMed: 35943003] [CrossRef]

Raiker JS, Freeman AJ, Perez-Algorta G, et al. Accuracy of Achenbach Scales in the Screening of Attention-Deficit/Hyperactivity Disorder in a Community Mental Health Clinic. J Am Acad Child Adolesc Psychiatry. 2017 May;56(5):401–9. doi: 10.1016/j.jaac.2017.02.007. PMID: 28433089. [PMC free article: PMC5410964] [PubMed: 28433089] [CrossRef]

Rajabi S, Pakize A, Moradi N. Effect of combined neurofeedback and game-based cognitive training on the treatment of ADHD: A randomized controlled study. Applied Neuropsychology: Child. 2020 2020/07/02;9(3):193–205. doi: 10.1080/21622965.2018.1556101. PMID: 30734583. [PubMed: 30734583] [CrossRef]

Reddy LA, Alperin A, Lekwa A. Construct Validity and Diagnostic Utility of the Woodcock Johnson Tests of Cognitive Abilities and Clinical Clusters for Children with Attention Deficit/Hyperactivity Disorder: A Preliminary Investigation. European Journal of Psychology and Educational Research. 2021 01/01/;4(1):36–49. PMID: EJ1333596.

Rezaeezadeh M, Shamekhi S, Shamsi M. Attention Deficit Hyperactivity Disorder Diagnosis using non-linear univariate and multivariate EEG measurements: a preliminary study. Phys Eng Sci Med. 2020 Jun;43(2):577–92. doi: 10.1007/s13246-020-00858-3. PMID: 32524443. [PubMed: 32524443] [CrossRef]

Riaz A, Asad M, Alonso E, et al. DeepFMRI: End-to-end deep learning for functional connectivity and classification of ADHD using fMRI. J Neurosci Methods. 2020 Apr 1;335:108506. doi: 10.1016/j.jneumeth.2019.108506. PMID: 32001294. [PubMed: 32001294] [CrossRef]

Rielly NE, Cunningham CE, Richards JE, et al. Detecting Attention Deficit Hyperactivity Disorder in a communications clinic: diagnostic utility of the Gordon Diagnostic System. J Clin Exp Neuropsychol. 1999 Oct;21(5):685–700. doi: 10.1076/jcen.21.5.685.866. PMID: 10572287. [PubMed: 10572287] [CrossRef]

Riggs PD, Winhusen T, Davies RD, et al. Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. J Am Acad Child Adolesc Psychiatry. 2011 Sep;50(9):903–14. doi: 10.1016/j.jaac.2011.06.010. PMID: 21871372. [PMC free article: PMC3164797] [PubMed: 21871372] [CrossRef]

Rishel CW, Greeno C, Marcus SC, et al. Use of the Child Behavior Checklist as a Diagnostic Screening Tool in Community Mental Health. Research on Social Work Practice. 2005 2005/05/01;15(3):195–203. doi: 10.1177/1049731504270382. [CrossRef]

Robles R, de la Peña FR, Medina-Mora ME, et al. ICD-11 Guidelines for Mental and Behavioral Disorders of Children and Adolescents: Reliability and Clinical Utility. Psychiatr Serv. 2021 Aug 26;73(4):appips202000830. doi: 10.1176/appi.ps.202000830. PMID: 34433288. [PubMed: 34433288] [CrossRef]

Rodríguez C, Areces D, García T, et al. Comparison between two continuous performance tests for identifying ADHD: Traditional vs. Virtual reality. International Journal of Clinical and Health Psychology. 2018 Sep 2018 - Dec 2018;18(3):254–63. [PMC free article: PMC6225036] [PubMed: 30487931]

Roessner V, Walitza S, Riederer F, et al. Tetrahydroisoquinoline derivatives: A new perspective on monoaminergic dysfunction in children with ADHD? Behavioral and Brain Functions. 2007;3. doi: 10.1186/1744-9081-3-64. [CrossRef]

Rogers EA, Graves SJ, Freeman AJ, et al. Improving accuracy of ADHD subtype diagnoses with the ADHD symptom rating scale. Child Neuropsychol. 2022 Oct;28(7):962–78. doi: 10.1080/09297049.2022.2044768. PMID: 35287549. [PubMed: 35287549] [CrossRef]

Rothe J, Kattlun FA, Kaufmann J, et al. Effects of methylphenidate and physiotherapeutic treatment on graphomotor movements in children with ADHD. Eur Child Adolesc Psychiatry. 2023 Jan 23. doi: 10.1007/s00787-023-02144-5. PMID: 36688969. [PMC free article: PMC10806214] [PubMed: 36688969] [CrossRef]

Rubio Morell B, Hernández Expósito S. Differential long-term medication impact on executive function and delay aversion in ADHD. Appl Neuropsychol Child. 2019 Apr–Jun;8(2):140–57. doi: 10.1080/21622965.2017.1407653. PMID: 29244542. [PubMed: 29244542] [CrossRef]

Rucklidge JJ, Eggleston MJF, Johnstone JM, et al. Vitamin-mineral treatment improves aggression and emotional regulation in children with ADHD: a fully blinded, randomized, placebo-controlled trial. J Child Psychol Psychiatry. 2018 Mar;59(3):232–46. doi: 10.1111/jcpp.12817. PMID: 28967099. [PMC free article: PMC7779340] [PubMed: 28967099] [CrossRef]

Rucklidge JJ, Tannock R. Validity of the Brown ADD scales: an investigation in a predominantly inattentive ADHD adolescent sample with and without reading disabilities. J Atten Disord. 2002 Jan;5(3):155–64. doi: 10.1177/108705470200500303. PMID: 11911008. [PubMed: 11911008] [CrossRef]

Saito T, Yamashita Y, Tomoda A, et al. Using the drug repositioning approach to develop a novel therapy, tipepidine hibenzate sustained-release tablet (TS-141), for children and adolescents with attention-deficit/hyperactivity disorder. BMC Psychiatry. 2020 Nov 10;20(1):530. doi: 10.1186/s12888-020-02932-2. PMID: 33167920. [PMC free article: PMC7653993] [PubMed: 33167920] [CrossRef]

Salardini E, Zeinoddini A, Kohi A, et al. Agomelatine as a Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Double-Blind, Randomized Clinical Trial. J Child Adolesc Psychopharmacol. 2016 Aug;26(6):513–9. doi: 10.1089/cap.2016.0024. PMID: 27286139. [PubMed: 27286139] [CrossRef]

Salehi B, Imani R, Mohammadi MR, et al. Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):76–80. doi: 10.1016/j.pnpbp.2009.09.026. PMID: 19815048. [PubMed: 19815048] [CrossRef]

Salehi B, Mohammadbeigi A, Sheykholeslam H, et al. Omega-3 and Zinc supplementation as complementary therapies in children with attention-deficit/hyperactivity disorder. J Res Pharm Pract. 2016 Jan–Mar;5(1):22–6. doi: 10.4103/2279-042x.176561. PMID: 26985432. [PMC free article: PMC4776543] [PubMed: 26985432] [CrossRef]

Sallee FR, McGough J, Wigal T, et al. Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2009 Feb;48(2):155–65. doi: 10.1097/CHI.0b013e318191769e. PMID: 19106767. [PubMed: 19106767] [CrossRef]

Sangal RB, Owens J, Allen AJ, et al. Effects of atomoxetine and methylphenidate on sleep in children with ADHD. Sleep. 2006 Dec;29(12):1573–85. doi: 10.1093/sleep/29.12.1573. PMID: 17252888. [PubMed: 17252888] [CrossRef]

Sangal RB BJ, Lankford DA, Grinnell TA, Huang H. Eszopiclone for insomnia associated with attention-deficit/hyperactivity disorder. Pediatrics. 2014 Oct;134(4):e1095–103. doi: 10.1542/peds.2013-4221. PMID: 25266438. [PubMed: 25266438] [CrossRef]

Satin MS, Winsberg BG, Monetti CH, et al. A general population screen for attention deficit disorder with hyperactivity. J Am Acad Child Psychiatry. 1985 Nov;24(6):756–64. doi: 10.1016/s0002-7138(10)60120-3. PMID: 4067144. [PubMed: 4067144] [CrossRef]

Schatz AM, Ballantyne AO, Trauner DA. Sensitivity and specificity of a computerized test of attention in the diagnosis of Attention-Deficit/Hyperactivity Disorder. Assessment. 2001 Dec;8(4):357–65. doi: 10.1177/107319110100800401. PMID: 11785580. [PubMed: 11785580] [CrossRef]

Scheeringa MS. The Diagnostic Infant Preschool Assessment-Likert Version: Preparation, Concurrent Construct Validation, and Test-Retest Reliability. J Child Adolesc Psychopharmacol. 2020 Jun;30(5):326–34. doi: 10.1089/cap.2019.0168. PMID: 32159386. [PubMed: 32159386] [CrossRef]

Schertz M, Karni-Visel Y, Genizi J, et al. Transcranial Direct Current Stimulation (tDCS) in children with ADHD: A randomized, sham-controlled pilot study. J Psychiatr Res. 2022 Nov;155:302–12. doi: 10.1016/j.jpsychires.2022.08.022. PMID: 36174365. [PubMed: 36174365] [CrossRef]

Schirmer MD, Venkataraman A, Rekik I, et al. Neuropsychiatric disease classification using functional connectomics - results of the connectomics in neuroimaging transfer learning challenge. Med Image Anal. 2021 May;70:101972. doi: 10.1016/j.media.2021.101972. PMID: 33677261. [PMC free article: PMC9115580] [PubMed: 33677261] [CrossRef]

Schneider H, Ryan M, Mahone EM. Parent versus teacher ratings on the BRIEF-preschool version in children with and without ADHD. Child Neuropsychol. 2020 Jan;26(1):113–28. doi: 10.1080/09297049.2019.1617262. PMID: 31094642. [PMC free article: PMC6858515] [PubMed: 31094642] [CrossRef]

Schorr-Sapir I, Gershy N, Apter A, et al. Parent training in non-violent resistance for children with attention deficit hyperactivity disorder: a controlled outcome study. Eur Child Adolesc Psychiatry. 2021 Feb 2. doi: 10.1007/s00787-021-01723-8. PMID: 33528659. [PubMed: 33528659] [CrossRef]

Schramm SA, Hennig T, Linderkamp F. Training Problem Solving and Organizational Skills in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial. Journal of Cognitive Education and Psychology. 2016 01/01/;15(3):391–411. PMID: EJ1226769.

Schuck SEB, Emmerson NA, Abdullah MM, et al. A Randomized Controlled Trial of Traditional Psychosocial and Canine-Assisted Interventions for Children with ADHD. Human-Animal Interaction Bulletin. 2018;6(1):64–80.

Sciberras E, Mulraney M, Mensah F, et al. Sustained impact of a sleep intervention and moderators of treatment outcome for children with ADHD: a randomised controlled trial. Psychol Med. 2020 Jan;50(2):210–9. doi: 10.1017/s0033291718004063. PMID: 30654852. [PubMed: 30654852] [CrossRef]

Serrallach B, Groß C, Bernhofs V, et al. Neural biomarkers for dyslexia, ADHD, and ADD in the auditory cortex of children. Frontiers in Neuroscience. 2016;10(JUL). doi: 10.3389/fnins.2016.00324. [CrossRef]

Shang CY, Shih HH, Pan YL, et al. Comparative Efficacy of Methylphenidate and Atomoxetine on Social Adjustment in Youths with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2020 Apr;30(3):148–58. doi: 10.1089/cap.2019.0139. PMID: 31794244. [PubMed: 31794244] [CrossRef]

Shaywitz S, Shaywitz B, Wietecha L, et al. Effect of Atomoxetine Treatment on Reading and Phonological Skills in Children with Dyslexia or Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia in a Randomized, Placebo-Controlled Trial. J Child Adolesc Psychopharmacol. 2017 Feb;27(1):19–28. doi: 10.1089/cap.2015.0189. PMID: 27410907. [PMC free article: PMC5327054] [PubMed: 27410907] [CrossRef]

Shemmassian SK, Lee SS. Predictive Utility of Four Methods of Incorporating Parent and Teacher Symptom Ratings of ADHD for Longitudinal Outcomes. J Clin Child Adolesc Psychol. 2016;45(2):176–87. doi: 10.1080/15374416.2014.971457. PMID: 25643854. [PubMed: 25643854] [CrossRef]

Shemmassian SK, Lee SS. Comparative Validity of DSM-IV and Alternative Empirically Derived Approaches for the Assessment of ADHD. J Atten Disord. 2017 Mar;21(5):405–15. doi: 10.1177/1087054714522511. PMID: 24532800. [PubMed: 24532800] [CrossRef]

Shen L, Wang C, Tian Y, et al. Effects of Parent-Teacher Training on Academic Performance and Parental Anxiety in School-Aged Children With Attention-Deficit/Hyperactivity Disorder: A Cluster Randomized Controlled Trial in Shanghai, China. Front Psychol. 2021;12:733450. doi: 10.3389/fpsyg.2021.733450. PMID: 34955960. [PMC free article: PMC8695601] [PubMed: 34955960] [CrossRef]

Shuai L, Wang Y, Li W, et al. Executive Function Training for Preschool Children With ADHD: A Randomized Controlled Trial. J Atten Disord. 2020 Sep 23:1087054720956723. doi: 10.1177/1087054720956723. PMID: 32964771. [PubMed: 32964771] [CrossRef]

Sibley MH, Coxe SJ, Campez M, et al. High versus Low Intensity Summer Treatment for ADHD Delivered at Secondary School Transitions. J Clin Child Adolesc Psychol. 2018 Mar–Apr;47(2):248–65. doi: 10.1080/15374416.2018.1426005. PMID: 29498550. [PubMed: 29498550] [CrossRef]

Sibley MH, Graziano PA, Coxe S, et al. Effectiveness of Motivational Interviewing-Enhanced Behavior Therapy for Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized Community-Based Trial. J Am Acad Child Adolesc Psychiatry. 2021 Jun;60(6):745–56. doi: 10.1016/j.jaac.2020.07.907. PMID: 32861773. [PMC free article: PMC7907265] [PubMed: 32861773] [CrossRef]

Sibley MH, Graziano PA, Kuriyan AB, et al. Parent–teen behavior therapy + motivational interviewing for adolescents with ADHD. Journal of Consulting and Clinical Psychology. 2016 Aug 2016;84(8):699–712. doi: 10.1037/ccp0000106. PMID: 27077693. [PMC free article: PMC4949080] [PubMed: 27077693] [CrossRef]

Sibley MH, Rodriguez L, Coxe S, et al. Parent-Teen Group versus Dyadic Treatment for Adolescent ADHD: What Works for Whom? J Clin Child Adolesc Psychol. 2020 Jul–Aug;49(4):476–92. doi: 10.1080/15374416.2019.1585257. PMID: 30990088. [PubMed: 30990088] [CrossRef]

Siebelink NM, Bögels SM, Speckens AEM, et al. A randomised controlled trial (MindChamp) of a mindfulness-based intervention for children with ADHD and their parents. J Child Psychol Psychiatry. 2021 May 24. doi: 10.1111/jcpp.13430. PMID: 34030214. [PMC free article: PMC9292876] [PubMed: 34030214] [CrossRef]

Silverstein M, Hironaka LK, Feinberg E, et al. Using Clinical Data to Predict Accurate ADHD Diagnoses Among Urban Children. Clin Pediatr (Phila). 2016 Apr;55(4):326–32. doi: 10.1177/0009922815591882. PMID: 26130393. [PubMed: 26130393] [CrossRef]

Simões EN, Carvalho ALN, Schmidt SL. The Role of Visual and Auditory Stimuli in Continuous Performance Tests: Differential Effects on Children With ADHD. J Atten Disord. 2021 Jan;25(1):53–62. doi: 10.1177/1087054718769149. PMID: 29671360. [PubMed: 29671360] [CrossRef]

Simonoff E, Taylor E, Baird G, et al. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability. J Child Psychol Psychiatry. 2013 May;54(5):527–35. doi: 10.1111/j.1469-7610.2012.02569.x. PMID: 22676856. [PubMed: 22676856] [CrossRef]

Sinai ISoMaM, Health NIoM. Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach. 2012.

Singer HS, Brown J, Quaskey S, et al. The treatment of attention-deficit hyperactivity disorder in Tourette’s syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Pediatrics. 1995 Jan;95(1):74–81. PMID: 7770313. [PubMed: 7770313]

Skogli EW, Teicher MH, Andersen PN, et al. ADHD in girls and boys--gender differences in co-existing symptoms and executive function measures. BMC Psychiatry. 2013 Nov 9;13:298. doi: 10.1186/1471-244X-13-298. PMID: 24206839. [PMC free article: PMC3827008] [PubMed: 24206839] [CrossRef]

Slaby I, Hain HS, Abrams D, et al. An electronic health record (EHR) phenotype algorithm to identify patients with attention deficit hyperactivity disorders (ADHD) and psychiatric comorbidities. J Neurodev Disord. 2022 Jun 11;14(1):37. doi: 10.1186/s11689-022-09447-9. PMID: 35690720. [PMC free article: PMC9188139] [PubMed: 35690720] [CrossRef]

Slobodin O, Yahav I, Berger I. A Machine-Based Prediction Model of ADHD Using CPT Data. Front Hum Neurosci. 2020;14:560021. doi: 10.3389/fnhum.2020.560021. PMID: 33093829. [PMC free article: PMC7528635] [PubMed: 33093829] [CrossRef]

Smit S, Mikami AY, Normand S. Effects of the Parental Friendship Coaching Intervention on Parental Emotion Socialization of Children with ADHD. Res Child Adolesc Psychopathol. 2021 May 26. doi: 10.1007/s10802-021-00818-9. PMID: 34037888. [PubMed: 34037888] [CrossRef]

Smith BH, Pelham WE, Gnagy E, et al. The reliability, validity, and unique contributions of self-report by adolescents receiving treatment for attention-deficit/hyperactivity disorder. J Consult Clin Psychol. 2000 Jun;68(3):489–99. doi: 10.1037/0022-006x.68.3.489. PMID: 10883565. [PubMed: 10883565] [CrossRef]

Smith JL, Johnstone SJ, Barry RJ. Aiding diagnosis of attention-deficit/hyperactivity disorder and its subtypes: discriminant function analysis of event-related potential data. J Child Psychol Psychiatry. 2003 Oct;44(7):1067–75. doi: 10.1111/1469-7610.00191. PMID: 14531589. [PubMed: 14531589] [CrossRef]

Smith SR, Wingenfeld SA, Hilsenroth MJ, et al. The Use of the Devereux Scales of Mental Disorders in the Assessment of Attention-Deficit/Hyperactivity Disorder and Conduct Disorder. Journal of Psychopathology and Behavioral Assessment. 2000 2000/09/01;22(3):237–55. doi: 10.1023/A:1007510216543. [CrossRef]

Snyder SM, Quintana H, Sexson SB, et al. Blinded, multi-center validation of EEG and rating scales in identifying ADHD within a clinical sample. Psychiatry Res. 2008 Jun 30;159(3):346–58. doi: 10.1016/j.psychres.2007.05.006. PMID: 18423617. [PubMed: 18423617] [CrossRef]

Soliva JC FJ, Bielsa A, et al. Quantitative MR analysis of caudate abnormalities in pediatric ADHD: proposal for a diagnostic test. Psychiatry Res. 2010 Jun 30;182(3):238–43. doi: 10.1016/j.pscychresns.2010.01.013. [PubMed: 20488672] [CrossRef]

Sonuga-Barke EJ DD, Thompson M, et al. Parent-based therapies for preschool attention-deficit/hyperactivity disorder: a randomized, controlled trial with a community sample. J Am Acad Child Adolesc Psychiatry. 2001;40(4):402–8. [PubMed: 11314565]

Sonuga-Barke EJ TM, Daley D, et al. Parent training for Attention Deficit/Hyperactivity Disorder: is it as effective when delivered as routine rather than as specialist care? Br J Clin Psychol. 2004;43(Pt 4):4–57.

Sonuga-Barke EJS, Barton J, Daley D, et al. A comparison of the clinical effectiveness and cost of specialised individually delivered parent training for preschool attention-deficit/hyperactivity disorder and a generic, group-based programme: a multi-centre, randomised controlled trial of the New Forest Parenting Programme versus Incredible Years. Eur Child Adolesc Psychiatry. 2018 Jun;27(6):797–809. doi: 10.1007/s00787-017-1054-3. PMID: 29086103. [PMC free article: PMC5973956] [PubMed: 29086103] [CrossRef]

Spencer AE, Plasencia N, Sun Y, et al. Screening for Attention-Deficit/Hyperactivity Disorder and Comorbidities in a Diverse, Urban Primary Care Setting. Clin Pediatr (Phila). 2018 Oct;57(12):1442–52. doi: 10.1177/0009922818787329. PMID: 30003797. [PubMed: 30003797] [CrossRef]

Spencer T, Heiligenstein JH, Biederman J, et al. Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2002a Dec;63(12):1140–7. doi: 10.4088/jcp.v63n1209. PMID: 12523874. [PubMed: 12523874] [CrossRef]

Spencer T, Heiligenstein JH, Biederman J, et al. Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2002b Dec;63(12):1140–7. doi: 10.4088/jcp.v63n1209. PMID: 12523874. [PubMed: 12523874] [CrossRef]

Spencer TJ, Sallee FR, Gilbert DL, et al. Atomoxetine Treatment of ADHD in Children with Comorbid Tourette Syndrome. Journal of Attention Disorders. 2008 01/01/;11(4):470–81. doi: 10.1177/1087054707306109. PMID: 17934184. [PubMed: 17934184] [CrossRef]

Spencer TJ, Wilens TE, Biederman J, et al. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther. 2006 Feb;28(2):266–79. doi: 10.1016/j.clinthera.2006.02.011. PMID: 16678648. [PubMed: 16678648] [CrossRef]

Sprafkin J, Gadow KD. Choosing an attention-deficit/hyperactivity disorder rating scale: is item randomization necessary? J Child Adolesc Psychopharmacol. 2007 Feb;17(1):75–84. doi: 10.1089/cap.2006.0035. PMID: 17343555. [PubMed: 17343555] [CrossRef]

Sprafkin J, Volpe RJ, Gadow KD, et al. A DSM-IV-referenced screening instrument for preschool children: the Early Childhood Inventory-4. J Am Acad Child Adolesc Psychiatry. 2002 May;41(5):604–12. doi: 10.1097/00004583-200205000-00018. PMID: 12014793. [PubMed: 12014793] [CrossRef]

Sprich SE, Safren SA, Finkelstein D, et al. A randomized controlled trial of cognitive behavioral therapy for ADHD in medication-treated adolescents. J Child Psychol Psychiatry. 2016 Nov;57(11):1218–26. doi: 10.1111/jcpp.12549. PMID: 26990084. [PMC free article: PMC5026858] [PubMed: 26990084] [CrossRef]

Steele M WM, Swanson J, Wang J, Prinzo RS, Binder CE. A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder. Can J Clin Pharmacol. 2006 Winter;13(1):e50–62. PMID: 16456216. [PubMed: 16456216]

Steiner NJ FE, Rene KM, et al. In-school neurofeedback training for ADHD: sustained improvements from a randomized control trial. Pediatrics. 2014 Mar;133(3):483–92. doi: 10.1542/peds.2013-2059. [PubMed: 24534402] [CrossRef]

Stepanova E, Findling RL, Kaplin D, et al. An Examination of Blood Cell Membrane Potential as a Diagnostic Test of Attention Deficit Disorder in Children. J Atten Disord. 2021 Jan;25(1):73–80. doi: 10.1177/1087054718772169. PMID: 29707999. [PubMed: 29707999] [CrossRef]

Stevanovic D, Nasic S, Doric A, et al. The Structure and Diagnostic Accuracy of the QbTest in Pediatric ADHD: A Retrospective Clinical Study. J Atten Disord. 2023 May 18:10870547231174035. doi: 10.1177/10870547231174035. PMID: 37199293. [PubMed: 37199293] [CrossRef]

Storebo OJ GC, Winkel P, et al. Social-skills and parental training plus standard treatment versus standard treatment for children with ADHD--the randomised SOSTRA trial. PLoS One. 2012;7(6):e37280. doi: 10.1371/journal.pone.0037280. [PMC free article: PMC3380035] [PubMed: 22745657] [CrossRef]

Straub L, Bateman BT, Hernandez-Diaz S, et al. Validity of claims-based algorithms to identify neurodevelopmental disorders in children. Pharmacoepidemiol Drug Saf. 2021 Dec;30(12):1635–42. doi: 10.1002/pds.5369. PMID: 34623720. [PMC free article: PMC8578450] [PubMed: 34623720] [CrossRef]

Strehl U, Aggensteiner P, Wachtlin D, et al. Neurofeedback of Slow Cortical Potentials in Children with Attention-Deficit/Hyperactivity Disorder: A Multicenter Randomized Trial Controlling for Unspecific Effects. Front Hum Neurosci. 2017;11:135. doi: 10.3389/fnhum.2017.00135. PMID: 28408873. [PMC free article: PMC5374218] [PubMed: 28408873] [CrossRef]

Su Y, Yang L, Stein MA, et al. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up. J Child Adolesc Psychopharmacol. 2016 May;26(4):362–71. doi: 10.1089/cap.2015.0031. PMID: 26779845. [PubMed: 26779845] [CrossRef]

Sugaya LS, Salum GA, de Sousa Gurgel W, et al. Efficacy and safety of methylphenidate and behavioural parent training for children aged 3-5 years with attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled, and sham behavioural parent training-controlled trial. Lancet Child Adolesc Health. 2022 Dec;6(12):845–56. doi: 10.1016/s2352-4642(22)00279-6. PMID: 36306807. [PMC free article: PMC9731509] [PubMed: 36306807] [CrossRef]

Sullivan JR, Riccio CA. Diagnostic group differences in parent and teacher ratings on the BRIEF and Conners’ Scales. J Atten Disord. 2007 Nov;11(3):398–406. doi: 10.1177/1087054707299399. PMID: 17932389. [PubMed: 17932389] [CrossRef]

Sun H, Chen Y, Huang Q, et al. Psychoradiologic Utility of MR Imaging for Diagnosis of Attention Deficit Hyperactivity Disorder: A Radiomics Analysis. Radiology. 2018 May;287(2):620–30. doi: 10.1148/radiol.2017170226. PMID: 29165048. [PubMed: 29165048] [CrossRef]

Supernus Pharmaceuticals I. Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1). 2016.

Svanborg P, Thernlund G, Gustafsson PA, et al. Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in stimulant-naïve Swedish children and adolescents. Eur Child Adolesc Psychiatry. 2009 Apr;18(4):240–9. doi: 10.1007/s00787-008-0725-5. PMID: 19156355. [PubMed: 19156355] [CrossRef]

Swanson JM, Greenhill LL, Lopez FA, et al. Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. J Clin Psychiatry. 2006 Jan;67(1):137–47. doi: 10.4088/jcp.v67n0120. PMID: 16426100. [PubMed: 16426100] [CrossRef]

Takahashi M, Takita Y, Yamazaki K, et al. A randomized, double-blind, placebo-controlled study of atomoxetine in Japanese children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009 Aug;19(4):341–50. doi: 10.1089/cap.2008.0154. PMID: 19702486. [PubMed: 19702486] [CrossRef]

Tallberg P, Råstam M, Wenhov L, et al. Incremental clinical utility of continuous performance tests in childhood ADHD - an evidence-based assessment approach. Scand J Psychol. 2019 Feb;60(1):26–35. doi: 10.1111/sjop.12499. PMID: 30452083. [PMC free article: PMC7379623] [PubMed: 30452083] [CrossRef]

Tamm L, Denton CA, Epstein JN, et al. Comparing treatments for children with ADHD and word reading difficulties: A randomized clinical trial. J Consult Clin Psychol. 2017 May;85(5):434–46. doi: 10.1037/ccp0000170. PMID: 28333510. [PMC free article: PMC5398920] [PubMed: 28333510] [CrossRef]

Tamm L, Epstein JN, Peugh JL, et al. Preliminary data suggesting the efficacy of attention training for school-aged children with ADHD. Dev Cogn Neurosci. 2013 Apr;4:16–28. doi: 10.1016/j.dcn.2012.11.004. PMID: 23219490. [PMC free article: PMC3617931] [PubMed: 23219490] [CrossRef]

Tan ML, Foong SC, Foong WC, et al. Tocotrienol-rich fractions (TRF) supplementation in school-going children with Attention Deficit/Hyperactive Disorder (ADHD): a randomized controlled trial. BMC Nutrition. 2016 2016/03/21;2(1):14. doi: 10.1186/s40795-016-0055-9. [CrossRef]

Tang S, Liu X, Nie L, et al. Three-dimensional pseudocontinuous arterial spin labeling perfusion imaging shows cerebral blood flow perfusion decline in attention-deficit/hyperactivity disorder children. Frontiers in Psychiatry. 2023;14. doi: 10.3389/fpsyt.2023.1064647. [CrossRef]

Tang Y, Sun J, Wang C, et al. ADHD classification using auto-encoding neural network and binary hypothesis testing. Artificial Intelligence in Medicine. 2022;123. doi: 10.1016/j.artmed.2021.102209. [CrossRef]

Ter-Minassian L, Viani N, Wickersham A, et al. Assessing machine learning for fair prediction of ADHD in school pupils using a retrospective cohort study of linked education and healthcare data. BMJ Open. 2022 Dec 5;12(12):e058058. doi: 10.1136/bmjopen-2021-058058. PMID: 36576182. [PMC free article: PMC9723859] [PubMed: 36576182] [CrossRef]

Tian X, Liu X, Wang Y, et al. Urinary Metabolomic Study in a Healthy Children Population and Metabolic Biomarker Discovery of Attention-Deficit/Hyperactivity Disorder (ADHD). Frontiers in Psychiatry. 2022;13. doi: 10.3389/fpsyt.2022.819498. [CrossRef]

Tillman R, Geller B. A brief screening tool for a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry. 2005 Jun;162(6):1214–6. doi: 10.1176/appi.ajp.162.6.1214. PMID: 15930075. [PubMed: 15930075] [CrossRef]

Tiwawatpakorn N, Worachotekamjorn J, Tassanakijpanich N. Effectiveness of Parenting Training on Emotional and Behavioral Problems in First through Fourth Grade Thai Children with ADHD: A Randomized Controlled Study. Psychol Rep. 2021 Jun 22:332941211026846. doi: 10.1177/00332941211026846. PMID: 34154470. [PubMed: 34154470] [CrossRef]

Trebatická J, Kopasová S, Hradecná Z, et al. Treatment of ADHD with French maritime pine bark extract, Pycnogenol. Eur Child Adolesc Psychiatry. 2006 Sep;15(6):329–35. doi: 10.1007/s00787-006-0538-3. PMID: 16699814. [PubMed: 16699814] [CrossRef]

Tripp G, Schaughency EA, Clarke B. Parent and teacher rating scales in the evaluation of attention-deficit hyperactivity disorder: contribution to diagnosis and differential diagnosis in clinically referred children. J Dev Behav Pediatr. 2006 Jun;27(3):209–18. doi: 10.1097/00004703-200606000-00006. PMID: 16775518. [PubMed: 16775518] [CrossRef]

Tris Pharma I. TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD). 2014.

Tutty S, Gephart H, Wurzbacher K. Enhancing behavioral and social skill functioning in children newly diagnosed with attention-deficit hyperactivity disorder in a pediatric setting. J Dev Behav Pediatr. 2003 Feb;24(1):51–7. doi: 10.1097/00004703-200302000-00010. PMID: 12584485. [PubMed: 12584485] [CrossRef]

Tzang RF, Chang YC, Tsai GE, et al. Sarcosine treatment for oppositional defiant disorder symptoms of attention deficit hyperactivity disorder children. J Psychopharmacol. 2016 Oct;30(10):976–82. doi: 10.1177/0269881116658986. PMID: 27443598. [PubMed: 27443598] [CrossRef]

Uyulan C, Erguzel TT, Turk O, et al. A Class Activation Map-Based Interpretable Transfer Learning Model for Automated Detection of ADHD from fMRI Data. Clin EEG Neurosci. 2023 Mar;54(2):151–9. doi: 10.1177/15500594221122699. PMID: 36052402. [PubMed: 36052402] [CrossRef]

Vahid A, Bluschke A, Roessner V, et al. Deep Learning Based on Event-Related EEG Differentiates Children with ADHD from Healthy Controls. J Clin Med. 2019 Jul 19;8(7). doi: 10.3390/jcm8071055. PMID: 31330961. [PMC free article: PMC6679086] [PubMed: 31330961] [CrossRef]

Vaidyanathan S, Chandrasekaran V, Kandasamy P. Comparison of brief group behavioural parent training with individual parent training for preschool children with attention deficit hyperactivity disorder: A randomized feasibility study. Early Interv Psychiatry. 2023 Apr 11. doi: 10.1111/eip.13420. PMID: 37041696. [PubMed: 37041696] [CrossRef]

Valero M, Cebolla A, Colomer C. Mindfulness Training for Children with ADHD and Their Parents: A Randomized Control Trial. J Atten Disord. 2021 Jun 30:10870547211027636. doi: 10.1177/10870547211027636. PMID: 34189992. [PubMed: 34189992] [CrossRef]

van der Donk M, Hiemstra-Beernink AC, Tjeenk-Kalff A, et al. Cognitive training for children with ADHD: a randomized controlled trial of cogmed working memory training and ‘paying attention in class’. Front Psychol. 2015;6:1081. doi: 10.3389/fpsyg.2015.01081. PMID: 26284005. [PMC free article: PMC4516808] [PubMed: 26284005] [CrossRef]

Van der Heijden KB, Smits MG, Van Someren EJ, et al. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. J Am Acad Child Adolesc Psychiatry. 2007 Feb;46(2):233–41. doi: 10.1097/01.chi.0000246055.76167.0d. PMID: 17242627. [PubMed: 17242627] [CrossRef]

van der Oord S, Prins PJ, Oosterlaan J, et al. Does brief, clinically based, intensive multimodal behavior therapy enhance the effects of methylphenidate in children with ADHD? Eur Child Adolesc Psychiatry. 2007 Feb;16(1):48–57. doi: 10.1007/s00787-006-0574-z. PMID: 16972117. [PubMed: 16972117] [CrossRef]

van Stralen JPM. A Controlled Trial of Extended-Release Guanfacine and Psychostimulants on Executive Function and ADHD. J Atten Disord. 2020 Jan;24(2):318–25. doi: 10.1177/1087054717751197. PMID: 29313415. [PubMed: 29313415] [CrossRef]

Varela Casal P, Lorena Esposito F, Morata Martínez I, et al. Clinical Validation of Eye Vergence as an Objective Marker for Diagnosis of ADHD in Children. J Atten Disord. 2019 Apr;23(6):599–614. doi: 10.1177/1087054717749931. PMID: 29357741. [PubMed: 29357741] [CrossRef]

Vogt C, Shameli A. Assessments for attention-deficit hyperactivity disorder: Use of objective measurements. The Psychiatrist. 2011;35(10):380–3. doi: 10.1192/pb.bp.110.032144. [CrossRef]

Voigt RG, Llorente AM, Jensen CL, et al. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J Pediatr. 2001 Aug;139(2):189–96. doi: 10.1067/mpd.2001.116050. PMID: 11487742. [PubMed: 11487742] [CrossRef]

Volpe RJ DG, Jitendra AK, et al. Consultation-based academic interventions for children with attention deficit hyperactivity disorder: effects on reading and mathematics outcomes at 1-year follow-up. School Psych Rev. 2009;38(1):5–13.

Wang LJ, Li SC, Lee MJ, et al. Blood-bourne microRNA biomarker evaluation in attention-deficit/hyperactivity disorder of han chinese individuals: An exploratory study. Frontiers in Psychiatry. 2018;9(MAY). doi: 10.3389/fpsyt.2018.00227. [CrossRef]

Wang Y, Zheng Y, Du Y, et al. Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial. Aust N Z J Psychiatry. 2007 Mar;41(3):222–30. doi: 10.1080/00048670601057767. PMID: 17464703. [PubMed: 17464703] [CrossRef]

Wassenberg R, Max JE, Koele SL, et al. Classifying psychiatric disorders after traumatic brain injury and orthopaedic injury in children: adequacy of K-SADS versus CBCL. Brain Inj. 2004 Apr;18(4):377–90. doi: 10.1080/02699050310001617325. PMID: 14742151. [PubMed: 14742151] [CrossRef]

Weber W, Vander Stoep A, McCarty RL, et al. Hypericum perforatum (St John’s wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial. Jama. 2008 Jun 11;299(22):2633–41. doi: 10.1001/jama.299.22.2633. PMID: 18544723. [PMC free article: PMC2587403] [PubMed: 18544723] [CrossRef]

Webster RE. Attending Patterns of ADHD Children on the Learning Efficiency Test-II. 2000.

Wehmeier PM, Schacht A, Ulberstad F, et al. Does atomoxetine improve executive function, inhibitory control, and hyperactivity? Results from a placebo-controlled trial using quantitative measurement technology. J Clin Psychopharmacol. 2012 Oct;32(5):653–60. doi: 10.1097/JCP.0b013e318267c304. PMID: 22926599. [PubMed: 22926599] [CrossRef]

Weisman O, Schonherz Y, Harel T, et al. Testing the Efficacy of a Smartphone Application in Improving Medication Adherence, Among Children with ADHD. Isr J Psychiatry Relat Sci. 2018;55(2):59–63. PMID: 30368489. [PubMed: 30368489]

Weiss M, Hechtman L, Turgay A, et al. Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2007 Oct;17(5):675–88. doi: 10.1089/cap.2006.0101. PMID: 17979587. [PubMed: 17979587] [CrossRef]

Weiss M, Tannock R, Kratochvil C, et al. A Randomized, Placebo-Controlled Study of Once-Daily Atomoxetine in the School Setting in Children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry. 2005 07/01/;44(7):647–55. doi: 10.1097/01.chi.0000163280.47221.c9. PMID: 15968233. [PubMed: 15968233] [CrossRef]

Weiss MD, Cutler AJ, Kollins SH, et al. Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension. J Child Adolesc Psychopharmacol. 2021 Nov;31(9):610–22. doi: 10.1089/cap.2021.0034. PMID: 34637343. [PubMed: 34637343] [CrossRef]

Wennberg B, Janeslätt G, Kjellberg A, et al. Effectiveness of time-related interventions in children with ADHD aged 9-15 years: a randomized controlled study. Eur Child Adolesc Psychiatry. 2018 Mar;27(3):329–42. doi: 10.1007/s00787-017-1052-5. PMID: 28956183. [PMC free article: PMC5852175] [PubMed: 28956183] [CrossRef]

Westerberg H, Hirvikoski T, Forssberg H, et al. Visuo-spatial working memory span: a sensitive measure of cognitive deficits in children with ADHD. Child Neuropsychol. 2004 Sep;10(3):155–61. doi: 10.1080/09297040409609806. PMID: 15590494. [PubMed: 15590494] [CrossRef]

Weyandt LL, Willis WG. Executive functions in school‐aged children: Potential efficacy of tasks in discriminating clinical groups. Developmental Neuropsychology. 1994 1994/01/01;10(1):27–38. doi: 10.1080/87565649409540564. [CrossRef]

Wietecha LA, Williams DW, Herbert M, et al. Atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009 Dec;19(6):719–30. doi: 10.1089/cap.2008.074. PMID: 20035590. [PubMed: 20035590] [CrossRef]

Wigal S, Swanson JM, Feifel D, et al. A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2004 Nov;43(11):1406–14. doi: 10.1097/01.chi.0000138351.98604.92. PMID: 15502600. [PubMed: 15502600] [CrossRef]

Wigal SB, Wigal T, Schuck S, et al. Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011 Apr;21(2):121–31. doi: 10.1089/cap.2010.0047. PMID: 21488750. [PMC free article: PMC3080768] [PubMed: 21488750] [CrossRef]

Wilens TE, Boellner SW, López FA, et al. Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2008 Jun;47(6):700–8. doi: 10.1097/CHI.0b013e31816bffdf. PMID: 18434918. [PubMed: 18434918] [CrossRef]

Wilens TE, Gault LM, Childress A, et al. Safety and efficacy of ABT-089 in pediatric attention-deficit/hyperactivity disorder: results from two randomized placebo-controlled clinical trials. J Am Acad Child Adolesc Psychiatry. 2011 Jan;50(1):73–84.e1. doi: 10.1016/j.jaac.2010.10.001. PMID: 21156272. [PMC free article: PMC3757954] [PubMed: 21156272] [CrossRef]

Wilens TE, Spencer TJ, Biederman J. Short- and long-term cardiovascular effects of mixed amphetamine salts extended-release in adolescents with ADHD. CNS Spectrums. 2005;10(10 SUPPL. 15):22–30. doi: 10.1017/s1092852900014115. [PubMed: 16273027] [CrossRef]

Wilens TE BO, Brams M, Cutler AJ, Childress A, Rugino T, Lyne A, Grannis K, Youcha S. A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2012 Jan;51(1):74–85.e2. doi: 10.1016/j.jaac.2011.10.012. PMID: 22176941. [PubMed: 22176941] [CrossRef]

Wilens TE RB, Sikirica V, Harper L, Young JL, Bloomfield R, Lyne A, Rynkowski G, Cutler AJ. A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2015 Nov;54(11):916–25.e2. doi: 10.1016/j.jaac.2015.08.016. PMID: 26506582. [PubMed: 26506582] [CrossRef]

Wilkes-Gillan S, Bundy A, Cordier R, et al. A Randomised Controlled Trial of a Play-Based Intervention to Improve the Social Play Skills of Children with Attention Deficit Hyperactivity Disorder (ADHD). PLoS One. 2016;11(8):e0160558. doi: 10.1371/journal.pone.0160558. PMID: 27529693. [PMC free article: PMC4987013] [PubMed: 27529693] [CrossRef]

Wodka EL, Loftis C, Mostofsky SH, et al. Prediction of ADHD in boys and girls using the D-KEFS. Arch Clin Neuropsychol. 2008 May;23(3):283–93. doi: 10.1016/j.acn.2007.12.004. PMID: 18243646. [PMC free article: PMC2427435] [PubMed: 18243646] [CrossRef]

Wolraich ML, Greenhill LL, Pelham W, et al. Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics. 2001 Oct;108(4):883–92. doi: 10.1542/peds.108.4.883. PMID: 11581440. [PubMed: 11581440] [CrossRef]

Wood AC, Asherson P, Rijsdijk F, et al. Is overactivity a core feature in ADHD? Familial and receiver operating characteristic curve analysis of mechanically assessed activity level. J Am Acad Child Adolesc Psychiatry. 2009 Oct;48(10):1023–30. doi: 10.1097/CHI.0b013e3181b54612. PMID: 19701105. [PubMed: 19701105] [CrossRef]

Wu Y, Xu L, Wu Z, et al. Computer-based multiple component cognitive training in children with ADHD: a pilot study. Child and Adolescent Psychiatry and Mental Health. 2023;17(1). doi: 10.1186/s13034-022-00553-z. [CrossRef]

Yang J, Yoon BM, Lee MS, et al. Adherence with electronic monitoring and symptoms in children with attention deficit hyperactivity disorder. Psychiatry Investigation. 2012;9(3):263–8. doi: 10.4306/pi.2012.9.3.263. [PMC free article: PMC3440476] [PubMed: 22993526] [CrossRef]

Yao D, Guo X, Zhao Q, et al. Discriminating ADHD From Healthy Controls Using a Novel Feature Selection Method Based on Relative Importance and Ensemble Learning. Annu Int Conf IEEE Eng Med Biol Soc. 2018 Jul;2018:4632–5. doi: 10.1109/embc.2018.8513155. PMID: 30441383. [PubMed: 30441383] [CrossRef]

Yasumura A, Omori M, Fukuda A, et al. Applied Machine Learning Method to Predict Children With ADHD Using Prefrontal Cortex Activity: A Multicenter Study in Japan. J Atten Disord. 2020 Dec;24(14):2012–20. doi: 10.1177/1087054717740632. PMID: 29154696. [PubMed: 29154696] [CrossRef]

Yeh SC, Lin SY, Wu EH, et al. A Virtual-Reality System Integrated With Neuro-Behavior Sensing for Attention-Deficit/Hyperactivity Disorder Intelligent Assessment. IEEE Trans Neural Syst Rehabil Eng. 2020 Sep;28(9):1899–907. doi: 10.1109/tnsre.2020.3004545. PMID: 32746303. [PubMed: 32746303] [CrossRef]

Yoo JH, Kim JI, Kim BN, et al. Exploring characteristic features of attention-deficit/hyperactivity disorder: findings from multi-modal MRI and candidate genetic data. Brain Imaging Behav. 2020 Dec;14(6):2132–47. doi: 10.1007/s11682-019-00164-x. PMID: 31321662. [PubMed: 31321662] [CrossRef]

Young J, Rugino T, Dammerman R, et al. Efficacy of guanfacine extended release assessed during the morning, afternoon, and evening using a modified Conners’ Parent Rating Scale-revised: Short Form. J Child Adolesc Psychopharmacol. 2014 Oct;24(8):435–41. doi: 10.1089/cap.2013.0134. PMID: 25286026. [PMC free article: PMC4203148] [PubMed: 25286026] [CrossRef]

Zadehbagheri F, Hosseini E, Bagheri-Hosseinabadi Z, et al. Profiling of miRNAs in serum of children with attention-deficit hyperactivity disorder shows significant alterations. J Psychiatr Res. 2019 Feb;109:185–92. doi: 10.1016/j.jpsychires.2018.12.013. PMID: 30557705. [PubMed: 30557705] [CrossRef]

Zarinara AR, Mohammadi MR, Hazrati N, et al. Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial. Hum Psychopharmacol. 2010 Nov;25(7–8):530–5. doi: 10.1002/hup.1148. PMID: 20860068. [PubMed: 20860068] [CrossRef]

Zavadenko NN, Suvorinova NY, Vakula IN, et al. Pharmacotherapy of Attention Deficit Hyperactivity Disorder in Children: Results of a Multicenter, Double-Blind, Placebo-Controlled Trial of Hopantenic Acid. Neuroscience and Behavioral Physiology. 2019;49(1):129–35. doi: 10.1007/s11055-018-0705-2. [CrossRef]

Zelko FA. Comparison of parent-completed behavior rating scales: differentiating boys with ADD from psychiatric and normal controls. J Dev Behav Pediatr. 1991 Feb;12(1):31–7. PMID: 2016400. [PubMed: 2016400]

Zelnik N B-BO, Miari W, et al. Is the test of variables of attention reliable for the diagnosis of attention-deficit hyperactivity disorder (ADHD)? J Child Neurol. 2012 Jun;27(6):703–7. doi: 10.1177/0883073811423821. PMID: 22378668. [PubMed: 22378668] [CrossRef]

Zheng X, Shen L, Jiang L, et al. Parent and Teacher Training Increases Medication Adherence for Primary School Children With Attention-Deficit/Hyperactivity Disorder. Front Pediatr. 2020;8:486353. doi: 10.3389/fped.2020.486353. PMID: 33240827. [PMC free article: PMC7680838] [PubMed: 33240827] [CrossRef]

Zhou D, Liao Z, Chen R. Deep Learning Enabled Diagnosis of Children’s ADHD Based on the Big Data of Video Screen Long-Range EEG. J Healthc Eng. 2022;2022:5222136. doi: 10.1155/2022/5222136. PMID: 35419186. [PMC free article: PMC9001066] [PubMed: 35419186] [CrossRef]

Zhou X, Reynolds CR, Zhu J, et al. Evidence-based assessment of ADHD diagnosis in children and adolescents. Appl Neuropsychol Child. 2018 Apr–Jun;7(2):150–6. doi: 10.1080/21622965.2017.1284661. PMID: 28631964. [PubMed: 28631964] [CrossRef]

Zhu C. Effects of Musicotherapy Combined with Cognitive Behavioral Intervention on the Cognitive Ability of Children with Attention Deficit Hyperactivity Disorder. Psychiatr Danub. 2022 Summer;34(2):288–95. doi: 10.24869/psyd.2022.288. PMID: 35772139. [PubMed: 35772139] [CrossRef]

Zhu P, Pan J, Cai QQ, et al. MicroRNA profile as potential molecular signature for attention deficit hyperactivity disorder in children. Biomarkers. 2022 May;27(3):230–9. doi: 10.1080/1354750x.2021.2024600. PMID: 34989306. [PubMed: 34989306] [CrossRef]

Zhu X, Sun X, Zhang Y, et al. A randomized parallel-controlled study of curative effect and safety of atomoxetine and methylphenidate in treatment of ADHD in children. International Journal of Clinical and Experimental Medicine. 2017;10(6):9576–82.

Zhuo L, Zhao X, Zhai Y, et al. Transcutaneous electrical acupoint stimulation for children with attention-deficit/hyperactivity disorder: a randomized clinical trial. Transl Psychiatry. 2022 Apr 21;12(1):165. doi: 10.1038/s41398-022-01914-0. PMID: 35449191. [PMC free article: PMC9022403] [PubMed: 35449191] [CrossRef]

Zulueta A, Díaz-Orueta U, Crespo-Eguilaz N, et al. Virtual reality-based assessment and rating scales in ADHD diagnosis. Psicología Educativa. 2019 2019;25(1):13–22.

AbbVie, AbbVie. A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD). 2007.

Abikoff H. Tailored psychosocial treatments for ADHD: the search for a good fit. J Clin Child Psychol. 2001 Mar;30(1):122–5. doi: 10.1207/s15374424jccp3001_14. PMID: 11294070. [PubMed: 11294070] [CrossRef]

Abikoff H, Hechtman L, Klein RG, et al. Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry. 2004 Jul;43(7):820–9. doi: 10.1097/01.chi.0000128797.91601.1a. PMID: 15213583. [PubMed: 15213583] [CrossRef]

Acosta MT, Swanson J, Stehli A, et al. ADGRL3 (LPHN3) variants are associated with a refined phenotype of ADHD in the MTA study. Mol Genet Genomic Med. 2016 Sep;4(5):540–7. doi: 10.1002/mgg3.230. PMID: 27652281. [PMC free article: PMC5023939] [PubMed: 27652281] [CrossRef]

Adalio CJ, Owens EB, McBurnett K, et al. Processing Speed Predicts Behavioral Treatment Outcomes in Children with Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive Type. J Abnorm Child Psychol. 2018 May;46(4):701–11. doi: 10.1007/s10802-017-0336-z. PMID: 28791531. [PMC free article: PMC5807232] [PubMed: 28791531] [CrossRef]

Addrenex Pharmaceuticals Inc. Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD). 2007.

Addrenex Pharmaceuticals Inc. CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD. 2008.

ADHD-200 Consortium. The ADHD-200 Sample. 2011. http://fcon_1000​.projects​.nitrc.org/indi/adhd200/6. Accessed on July 20 2022.

ADHD-200 Consortium. The ADHD-200 Global Competition. 2012. http://fcon_1000​.projects​.nitrc.org/indi/adhd200/results​.html Accessed on July 20 2022.

Aggensteiner PM, Brandeis D, Millenet S, et al. Slow cortical potentials neurofeedback in children with ADHD: comorbidity, self-regulation and clinical outcomes 6 months after treatment in a multicenter randomized controlled trial. Eur Child Adolesc Psychiatry. 2019 Aug;28(8):1087–95. doi: 10.1007/s00787-018-01271-8. PMID: 30610380. [PubMed: 30610380] [CrossRef]

Akili Interactive Labs Inc. Software Treatment for Actively Reducing Severity of ADHD. 2016.

Alza Corporation D, USA. A Multicenter Study Comparing the Efficacy and Safety of OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder.

Aman MG, Bukstein OG, Gadow KD, et al. What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit/hyperactivity disorder? J Am Acad Child Adolesc Psychiatry. 2014 Jan;53(1):47–60 e1. doi: 10.1016/j.jaac.2013.09.022. PMID: 24342385. [PMC free article: PMC3984501] [PubMed: 24342385] [CrossRef]

Ann Robert H Lurie Children’s Hospital of Chicago, Health NIoM. Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care Settings. 2003.

Arjona Valladares A, Gomez CM, Rodriguez-Martinez EI, et al. Attention-deficit/hyperactivity disorder in children and adolescents: An event-related potential study of working memory. Eur J Neurosci. 2020 Nov;52(10):4356–69. doi: 10.1111/ejn.14767. PMID: 32367647. [PubMed: 32367647] [CrossRef]

Armin A, Alireza Khorrami M, Mohammad Reza M, et al. Detecting ADHD Children using the Attention Continuity as Nonlinear Feature of EEG. Frontiers in Biomedical Technologies. 2016 06/30;3(1–2).

Arnold LE, Abiko MHB, Cantwell DP, et al. NIMH Collaborative Multimodal Treatment Study of Children with ADHD (MTA): design, methodology, and protocol evolution. Journal of Attention Disorders. 1997;2(3):141–58.

Arnold LE, Abikoff HB, Cantwell DP, et al. National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. Arch Gen Psychiatry. 1997 Sep;54(9):865–70. doi: 10.1001/archpsyc.1997.01830210113015. PMID: 9294378. [PubMed: 9294378] [CrossRef]

Arnold LE, Chuang S, Davies M, et al. Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures. J Abnorm Child Psychol. 2004 Feb;32(1):39–51. doi: 10.1023/b:jacp.0000007579.61289.31. PMID: 14998110. [PubMed: 14998110] [CrossRef]

Arnold LE, Elliot M, Sachs L, et al. Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. J Consult Clin Psychol. 2003 Aug;71(4):713–27. doi: 10.1037/0022-006x.71.4.713. PMID: 12924677. [PubMed: 12924677] [CrossRef]

Arnold LE, Gadow KD, Farmer CA, et al. Comorbid anxiety and social avoidance in treatment of severe childhood aggression: response to adding risperidone to stimulant and parent training; mediation of disruptive symptom response. J Child Adolesc Psychopharmacol. 2015 Apr;25(3):203–12. doi: 10.1089/cap.2014.0104. PMID: 25885010. [PMC free article: PMC4403224] [PubMed: 25885010] [CrossRef]

author N. Methylphenidate: growth retardation. Prescrire Int. 2011 Oct;20(120):238–9. PMID: 21970086. [PubMed: 21970086]

Babes-Bolyai University. Psychotherapy, atomoxetine, or combined treatment for ADHD in children. 2018. https://www​.isrctn.com​/ISRCTN92640175?q=ISRCTN92640175&filters​=&sort​=&offset​=1&totalResults​=1&page=1&pageSize=10. Accessed on October 11 2022.

Babinski DE, Waschbusch DA, Waxmonsky JG. Sex and Pubertal Status Moderate the Association Between ADHD and Depression Symptoms: An Examination From Preadolescence Through Late Adolescence. J Clin Psychiatry. 2019 May 21;80(3). doi: 10.4088/JCP.18m12548. PMID: 31120201. [PubMed: 31120201] [CrossRef]

Bakhtyari M, Mirzaei S. ADHD detection using dynamic connectivity patterns of EEG data and ConvLSTM with attention framework. Biomedical Signal Processing and Control. 2022;76. doi: 10.1016/j.bspc.2022.103708. [CrossRef]

Banaschewski T, Johnson M, Lecendreux M, et al. Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder. CNS Drugs. 2014 Dec;28(12):1191–203. doi: 10.1007/s40263-014-0193-z. PMID: 25139785. [PMC free article: PMC4246127] [PubMed: 25139785] [CrossRef]

Bansal R, Staib LH, Whiteman R, et al. ROC-based assessments of 3D cortical surface-matching algorithms. Neuroimage. 2005 Jan 1;24(1):150–62. doi: 10.1016/j.neuroimage.2004.08.054. PMID: 15588606. [PubMed: 15588606] [CrossRef]

Baren M, Swanson J, Wigal SB. Lack of effect of different breakfast conditions on the pharmacokinetics and efficacy of OROS (R) methylphenidate HCl extended-release tablets in children with ADHD. Pediatric Research. 2000 04/01;47:23A–A.

Barnes G, Wilkes-Gillan S, Bundy A, et al. The social play, social skills and parent-child relationships of children with ADHD 12 months following a RCT of a play-based intervention. Aust Occup Ther J. 2017 Dec;64(6):457–65. doi: 10.1111/1440-1630.12417. PMID: 29044556. [PubMed: 29044556] [CrossRef]

Barney S, Sibley MH, Coxe SJ, et al. High Versus Low Intensity Summer Adolescent ADHD Treatment Effects on Internalizing, Social, and Self-Esteem Problems. J Clin Child Adolesc Psychol. 2022 May 26:1–8. doi: 10.1080/15374416.2022.2062761. PMID: 35617099. [PubMed: 35617099] [CrossRef]

Baweja R, Waschbusch DA, Pelham WE, 3rd, et al. The Impact of Persistent Irritability on the Medication Treatment of Paediatric Attention Deficit Hyperactivity Disorder. Front Psychiatry. 2021;12:699687. doi: 10.3389/fpsyt.2021.699687. PMID: 34366928. [PMC free article: PMC8333707] [PubMed: 34366928] [CrossRef]

Bellec P, Chu C, Chouinard-Decorte F, et al. The Neuro Bureau ADHD-200 Preprocessed repository. Neuroimage. 2017 Jan;144(Pt B):275–86. doi: 10.1016/j.neuroimage.2016.06.034. PMID: 27423255. [PubMed: 27423255] [CrossRef]

Berger I, Shenberger IY, Slobodin O. A machine-based prediction model of adhd using cpt data. Neurology. 2020;94(15).

Bernanke J, Luna A, Chang L, et al. Structural brain measures among children with and without ADHD in the Adolescent Brain and Cognitive Development Study cohort: a cross-sectional US population-based study. Lancet Psychiatry. 2022 Mar;9(3):222–31. doi: 10.1016/s2215-0366(21)00505-8. PMID: 35143759. [PubMed: 35143759] [CrossRef]

Bethlehem RAI, Romero-Garcia R, Mak E, et al. Structural Covariance Networks in Children with Autism or ADHD. Cereb Cortex. 2017 Aug 1;27(8):4267–76. doi: 10.1093/cercor/bhx135. PMID: 28633299. [PMC free article: PMC5903412] [PubMed: 28633299] [CrossRef]

Bezmialem Vakif University, University M. Comparison of Treadmill and Whole Body Vibration Training in Children With Attention Deficit Hyperactivity Disorder. 2018.

Biederman J, Faraone SV, Keenan K, et al. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples. Arch Gen Psychiatry. 1992 Sep;49(9):728–38. doi: 10.1001/archpsyc.1992.01820090056010. PMID: 1514878. [PubMed: 1514878] [CrossRef]

Biederman J, Melmed RD, Patel A, et al. Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD. CNS Spectr. 2008 Dec;13(12):1047–55. doi: 10.1017/s1092852900017107. PMID: 19179940. [PubMed: 19179940] [CrossRef]

Biederman J, Wozniak J, Tarko L, et al. Re-examining the risk for switch from unipolar to bipolar major depressive disorder in youth with ADHD: a long term prospective longitudinal controlled study. J Affect Disord. 2014 Jan;152–154:347–51. doi: 10.1016/j.jad.2013.09.036. PMID: 24144583. [PMC free article: PMC3867291] [PubMed: 24144583] [CrossRef]

Bigorra A, Garolera M, Guijarro S, et al. Impact of working memory training on hot executive functions (decision-making and theory of mind) in children with ADHD: A randomized controlled trial. Neuropsychiatry. 2016;6(5):251–63. doi: 10.4172/Neuropsychiatry.1000147. [CrossRef]

Bilder RM, Loo SK, McGough JJ, et al. Cognitive effects of stimulant, guanfacine, and combined treatment in child and adolescent attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 2016 Aug 2016;55(8):667–73. doi: 10.1016/j.jaac.2016.05.016. PMID: 27453080. [PMC free article: PMC4964604] [PubMed: 27453080] [CrossRef]

Bioulac S, Purper-Ouakil D, Ros T, et al. Personalized at-home neurofeedback compared with long-acting methylphenidate in an european non-inferiority randomized trial in children with ADHD. BMC Psychiatry. 2019 Aug 1;19(1):237. doi: 10.1186/s12888-019-2218-0. PMID: 31370811. [PMC free article: PMC6676623] [PubMed: 31370811] [CrossRef]

Blume F, Hudak J, Dresler T, et al. NIRS-based neurofeedback training in a virtual reality classroom for children with attention-deficit/hyperactivity disorder: study protocol for a randomized controlled trial. Trials. 2017 Jan 24;18(1):41. doi: 10.1186/s13063-016-1769-3. PMID: 28118856. [PMC free article: PMC5259870] [PubMed: 28118856] [CrossRef]

Boston Children’s Hospital. Using an Online Patient Monitoring System to Improve Care for Children With Chronic Conditions. 2014.

Boyer B, Geurts HM, Prins PJ, et al. Two novel CBTs for adolescents with ADHD: the value of planning skills. Eur Child Adolesc Psychiatry. 2015 Sep;24(9):1075–90. doi: 10.1007/s00787-014-0661-5. [PubMed: 25549767] [CrossRef]

Boyer BE, Doove LL, Geurts HM, et al. Qualitative Treatment-Subgroup Interactions in a Randomized Clinical Trial of Treatments for Adolescents with ADHD: Exploring What Cognitive-Behavioral Treatment Works for Whom. PLoS One. 2016;11(3):e0150698. doi: 10.1371/journal.pone.0150698. PMID: 26977602. [PMC free article: PMC4792426] [PubMed: 26977602] [CrossRef]

Breaux RP, Langberg JM, Bourchtein E, et al. Brief homework intervention for adolescents with ADHD: Trajectories and predictors of response. School Psychology. 2019 Mar 2019;34(2):201–11. doi: 10.1037/spq0000287. PMID: 30284890. [PubMed: 30284890] [CrossRef]

Brinkman WB, Simon JO, Epstein JN. Reasons Why Children and Adolescents With Attention-Deficit/Hyperactivity Disorder Stop and Restart Taking Medicine. Acad Pediatr. 2018 Apr;18(3):273–80. doi: 10.1016/j.acap.2017.09.005. PMID: 28919571. [PMC free article: PMC5847416] [PubMed: 28919571] [CrossRef]

Brown RT, Perwien A, Faries DE, et al. Atomoxetine in the management of children with ADHD: effects on quality of life and school functioning. Clin Pediatr (Phila). 2006 Nov;45(9):819–27. doi: 10.1177/0009922806294219. PMID: 17041169. [PubMed: 17041169] [CrossRef]

Bukstein OG, Kolko DJ. Effects of methylphenidate on aggressive urban children with attention deficit hyperactivity disorder. J Clin Child Psychol. 1998 Oct;27(3):340–51. doi: 10.1207/s15374424jccp2703_10. PMID: 9789193. [PubMed: 9789193] [CrossRef]

Bul KCM, Doove LL, Franken IHA, et al. A serious game for children with Attention Deficit Hyperactivity Disorder: Who benefits the most? PLoS One. 2018;13(3):e0193681. doi: 10.1371/journal.pone.0193681. PMID: 29543891. [PMC free article: PMC5854282] [PubMed: 29543891] [CrossRef]

Cannon M, Pelham WH, Sallee FR, et al. Effects of clonidine and methylphenidate on family quality of life in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009 Oct;19(5):511–7. doi: 10.1089/cap.2009.0008. PMID: 19877975. [PMC free article: PMC2830226] [PubMed: 19877975] [CrossRef]

Carey WB. What the multimodal treatment study of children with attention deficit/hyperactivity disorder did and did not say about the use of methylphenidate for attention deficits. Pediatrics. 2000 Apr;105(4 Pt 1):863–4. doi: 10.1542/peds.105.4.863. PMID: 10742336. [PubMed: 10742336] [CrossRef]

Cash S, Rogge C, Schrader C, et al. Effects of Trainer Continuity and Experience on Neurofeedback Treatment of ADHD in Children. J Atten Disord. 2023 Apr 9:10870547231167565. doi: 10.1177/10870547231167565. PMID: 37032553. [PubMed: 37032553] [CrossRef]

Castro-Cabrera P, Gomez-Garcia J, Restrepo F, et al. Evaluation of feature extraction techniques on event-related potentials for detection of attention-deficit/hyperactivity disorder. Annu Int Conf IEEE Eng Med Biol Soc. 2010;2010:851–4. doi: 10.1109/iembs.2010.5626862. PMID: 21096317. [PubMed: 21096317] [CrossRef]

Centre IH, Research CIoH. Strongest Families (Formerly Family Help Program): Pediatric Attention Deficit/Hyperactivity Disorder. 2003.

Chen C, Wu EH, Chen Y, et al. Neuronal Correlates of Task Irrelevant Distractions Enhance the Detection of Attention Deficit/Hyperactivity Disorder. IEEE Transactions on Neural Systems and Rehabilitation Engineering. 2023:1-. doi: 10.1109/TNSRE.2023.3241649. [PubMed: 36166567] [CrossRef]

Chen CC, Wu EH, Chen YQ, et al. Neuronal Correlates of Task Irrelevant Distractions Enhance the Detection of Attention Deficit/Hyperactivity Disorder. IEEE Trans Neural Syst Rehabil Eng. 2023 Feb 1;Pp. doi: 10.1109/tnsre.2023.3241649. PMID: 37022368. [PubMed: 37022368] [CrossRef]

Chen M, Li H, Fan H, et al. ConCeptCNN: A novel multi-filter convolutional neural network for the prediction of neurodevelopmental disorders using brain connectome. Med Phys. 2022 May;49(5):3171–84. doi: 10.1002/mp.15545. PMID: 35246986. [PMC free article: PMC9164760] [PubMed: 35246986] [CrossRef]

Chen M, Li H, Wang J, et al. A multichannel deep neural network model analyzing multiscale functional brain connectome data for attention deficit hyperactivity disorder detection. Radiology: Artificial Intelligence. 2020;2(1). doi: 10.1148/ryai.2019190012. [CrossRef]

Chen Y, Gao Y, Jiang A, et al. ADHD classification combining biomarker detection with attention auto-encoding neural network. Biomedical Signal Processing and Control. 2023;84. doi: 10.1016/j.bspc.2023.104733. [CrossRef]

Children’s Hospital Medical Center C. Methylphenidate for Attention Problems After Pediatric TBI. 2013.

Children’s Hospital Medical Center Cincinnati NCsH, National Institute of Mental Health,. Evaluation of an Intervention for Improving Community-based Pediatric Attention-Deficit Hyperactivity Disorder (ADHD) Care. 2010.

Children’s Hospital of Philadelphia. Educating and Supporting Primary Care Providers in the Implementation of Evidence-based Practices for ADHD. 2014.

Children’s Hospital of Philadelphia, Institute P-COR. Communication to Improve Shared Decision-Making in ADHD. 2016.

Childress AC, Arnold V, Adeyi B, et al. The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trial. J Atten Disord. 2014 Feb;18(2):123–32. doi: 10.1177/1087054712448252. PMID: 22740112. [PubMed: 22740112] [CrossRef]

Childress AC, Lloyd E, Johnson SA, Jr., et al. A Long-Term, Open-Label Safety and Tolerability Study of Lisdexamfetamine Dimesylate in Children Aged 4-5 Years with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2022 Mar;32(2):98–106. doi: 10.1089/cap.2021.0138. PMID: 35230142. [PMC free article: PMC8971990] [PubMed: 35230142] [CrossRef]

China Medical University Hospital, National Science Council T, London KsC. Omega-3 Polyunsaturated Fatty Acids in Youth With ADHD. 2016.

Chovanová Z, Muchová J, Sivonová M, et al. Effect of polyphenolic extract, Pycnogenol, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder. Free Radic Res. 2006 Sep;40(9):1003–10. doi: 10.1080/10715760600824902. PMID: 17015282. [PubMed: 17015282] [CrossRef]

Chow JC, Ouyang CS, Tsai CL, et al. Entropy-Based Quantitative Electroencephalogram Analysis for Diagnosing Attention-Deficit Hyperactivity Disorder in Girls. Clin EEG Neurosci. 2019 May;50(3):172–9. doi: 10.1177/1550059418814983. PMID: 30497294. [PubMed: 30497294] [CrossRef]

Christiansen H, Reh V, Schmidt MH, et al. Slow cortical potential neurofeedback and self-management training in outpatient care for children with ADHD: study protocol and first preliminary results of a randomized controlled trial. Front Hum Neurosci. 2014;8:943. doi: 10.3389/fnhum.2014.00943. PMID: 25505396. [PMC free article: PMC4244863] [PubMed: 25505396] [CrossRef]

Cochrane Central Register of Controlled Trials. The effect of acupuncture on ADHD. https://trialsearch​.who​.int/Trial2.aspx?TrialID=KCT0000019. 2010. PMID: CN-01870268.

Coghill D, Banaschewski T, Lecendreux M, Soutullo C, Johnson M, Zuddas A, Anderson C, Civil R, Higgins N, Lyne A, Squires L. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder. Eur Neuropsychopharmacol. 2013 Oct;23(10):1208–18. doi: 10.1016/j.euroneuro.2012.11.012. PMID: 23332456. [PubMed: 23332456] [CrossRef]

Coghill D, Banaschewski T, Lecendreux M, Zuddas A, Dittmann RW, Otero IH, Civil R, Bloomfield R, Squires LA. Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial. Eur Child Adolesc Psychiatry. 2014 Feb;23(2):61–8. doi: 10.1007/s00787-013-0421-y. PMID: 23708466. [PMC free article: PMC3918120] [PubMed: 23708466] [CrossRef]

Coghill DR, Banaschewski T, Lecendreux M, et al. Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial. Neuropsychiatr Dis Treat. 2014;10:2039–47. doi: 10.2147/NDT.S68273. PMID: 25378930. [PMC free article: PMC4219557] [PubMed: 25378930] [CrossRef]

Coghill DR, Werner-Kiechle T, Farahbakhshian S, et al. Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses. Eur Child Adolesc Psychiatry. 2021 May;30(5):809–21. doi: 10.1007/s00787-020-01586-5. PMID: 32691164. [PMC free article: PMC8060241] [PubMed: 32691164] [CrossRef]

Conners CK, Epstein JN, March JS, et al. Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. J Am Acad Child Adolesc Psychiatry. 2001 Feb;40(2):159–67. doi: 10.1097/00004583-200102000-00010. PMID: 11211364. [PubMed: 11211364] [CrossRef]

Consortium HD. The ADHD-200 Consortium: A Model to Advance the Translational Potential of Neuroimaging in Clinical Neuroscience. Front Syst Neurosci. 2012;6:62. doi: 10.3389/fnsys.2012.00062. PMID: 22973200. [PMC free article: PMC3433679] [PubMed: 22973200] [CrossRef]

Crippa A, Agostoni C, Mauri M, et al. Polyunsaturated Fatty Acids Are Associated With Behavior But Not With Cognition in Children With and Without ADHD: An Italian study. J Atten Disord. 2018 Aug;22(10):971–83. doi: 10.1177/1087054716629215. PMID: 26861157. [PubMed: 26861157] [CrossRef]

Crosbie J, Arnold P, Paterson A, et al. Response inhibition and ADHD traits: correlates and heritability in a community sample. J Abnorm Child Psychol. 2013 Apr;41(3):497–507. doi: 10.1007/s10802-012-9693-9. PMID: 23315233. [PMC free article: PMC3600128] [PubMed: 23315233] [CrossRef]

Cutler AJ, Brams M, Bukstein O, et al. Response/remission with guanfacine extended-release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2014 Oct;53(10):1092–101. doi: 10.1016/j.jaac.2014.08.001. PMID: 25245353. [PubMed: 25245353] [CrossRef]

D. M. Results from a double-blind study of atomoxetine, OROS methylphenidate, and placebo. 51st Annual Meeting of the American Academy of Child and Adolescent Psychiatry; 2004 October 19–24; Washington, DC.

Dalhousie University. Classroom-based Distance Intervention for Teachers of Children With Attention Deficit Hyperactivity Disorder. 2012.

Danielson ML, Bitsko RH, Holbrook JR, et al. Community-Based Prevalence of Externalizing and Internalizing Disorders among School-Aged Children and Adolescents in Four Geographically Dispersed School Districts in the United States. Child Psychiatry Hum Dev. 2021 Jun;52(3):500–14. doi: 10.1007/s10578-020-01027-z. PMID: 32734339. [PMC free article: PMC8016018] [PubMed: 32734339] [CrossRef]

Davidson F, Cherry K, Corkum P. Validating the Behavior Rating Inventory of Executive Functioning for children with ADHD and their typically developing peers. Applied Neuropsychology: Child. 2016 Apr 2016;5(2):127–37. [PubMed: 26110907]

Dawson AE, Wymbs BT, Marshall SA, et al. The Role of Parental ADHD in Sustaining the Effects of a Family-School Intervention for ADHD. J Clin Child Adolesc Psychol. 2016;45(3):305–19. doi: 10.1080/15374416.2014.963858. PMID: 25496523. [PMC free article: PMC4466093] [PubMed: 25496523] [CrossRef]

Department of Research and Technology GUoMS. Survey the effect of behavioral education to parents on sleep situation of school-age children. 2013. https://en​.irct.ir/trial/12954. Accessed on October 6 2022.

Dey S, Rao AR, Shah M. Attributed graph distance measure for automatic detection of attention deficit hyperactive disordered subjects. Frontiers in Neural Circuits. 2014 2014-June-16;8. doi: 10.3389/fncir.2014.00064. [CrossRef]

Dickerson Mayes S, Calhoun SL, Crowell EW. WISC-III freedom from distractibility as a measure of attention in children with and without Attention Deficit Hyperactivity Disorder. Journal of Attention Disorders. 1998;2(4):217–27. doi: 10.1177/108705479800200402. [CrossRef]

Dickerson Mayes S, Calhoun SL, Crowell EW. Clinical validity and interpretation of the Gordon Diagnostic System in ADHD assessments. Child Neuropsychol. 2001 Mar;7(1):32–41. doi: 10.1076/chin.7.1.32.3151. PMID: 11815879. [PubMed: 11815879] [CrossRef]

Dittmann RW, Cardo E, Nagy P, et al. Treatment response and remission in a double-blind, randomized, head-to-head study of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit hyperactivity disorder. CNS Drugs. 2014 Nov;28(11):1059–69. doi: 10.1007/s40263-014-0188-9. PMID: 25038977. [PMC free article: PMC4221603] [PubMed: 25038977] [CrossRef]

Döpfner M, Ise E, Breuer D, et al. Long-Term Course After Adaptive Multimodal Treatment for Children With ADHD: An 8-Year Follow-Up. J Atten Disord. 2020 Jan;24(1):145–62. doi: 10.1177/1087054716659138. PMID: 27449186. [PubMed: 27449186] [CrossRef]

Döpfner M, Mandler J, Breuer D, et al. Children with Attention-Deficit/Hyperactivity Disorder Grown Up: An 18-Year Follow-Up after Multimodal Treatment. J Atten Disord. 2021 Nov;25(13):1801–17. doi: 10.1177/1087054720948133. PMID: 32772881. [PubMed: 32772881] [CrossRef]

Dose C, Hautmann C, Bürger M, et al. Negative parenting behaviour as a mediator of the effects of telephone-assisted self-help for parents of pharmacologically treated children with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry. 2021 Jun;30(6):861–75. doi: 10.1007/s00787-020-01565-w. PMID: 32488456. [PMC free article: PMC8140965] [PubMed: 32488456] [CrossRef]

Dovis S, Maric M, Prins PJM, et al. Does executive function capacity moderate the outcome of executive function training in children with ADHD? Atten Defic Hyperact Disord. 2019 Dec;11(4):445–60. doi: 10.1007/s12402-019-00308-5. PMID: 31123915. [PubMed: 31123915] [CrossRef]

Doyle AE, Biederman J, Seidman LJ, et al. Diagnostic efficiency of neuropsychological test scores for discriminating boys with and without attention deficit-hyperactivity disorder. J Consult Clin Psychol. 2000 Jun;68(3):477–88. doi: 10.1037/0022-006x.68.3.477. PMID: 10883564. [PubMed: 10883564] [CrossRef]

Du J, Wang L, Jie B, et al. Network-based classification of ADHD patients using discriminative subnetwork selection and graph kernel PCA. Comput Med Imaging Graph. 2016 Sep;52:82–8. doi: 10.1016/j.compmedimag.2016.04.004. PMID: 27166430. [PubMed: 27166430] [CrossRef]

DuPaul GJ, Jitendra AK, Volpe RJ, et al. Consultation-based academic interventions for children with ADHD: effects on reading and mathematics achievement. J Abnorm Child Psychol. 2006 Oct;34(5):635–48. doi: 10.1007/s10802-006-9046-7. PMID: 17029027. [PubMed: 17029027] [CrossRef]

Durell TM, Pumariega AJ, Rothe EM, et al. Effects of open-label atomoxetine on African-American and Caucasian pediatric outpatients with attention-deficit/hyperactivity disorder. Ann Clin Psychiatry. 2009 Jan–Mar;21(1):26–37. PMID: 19239830. [PubMed: 19239830]

Duric NE, IB. Characteristics of Norwegian children suffering from ADHD symptoms: ADHD and primary health care. Psychiatry Res. 2011 Aug 15;3(3):402–5. doi: 10.1016/j.psychres.2011.05.008. PMID: 21621851. [PubMed: 21621851] [CrossRef]

Duric NS, Aßmus J, Elgen IB. Self-reported efficacy of neurofeedback treatment in a clinical randomized controlled study of ADHD children and adolescents. Neuropsychiatr Dis Treat. 2014;10:1645–54. doi: 10.2147/ndt.S66466. PMID: 25214789. [PMC free article: PMC4159126] [PubMed: 25214789] [CrossRef]

Duric NS AJ, Gundersen D, et al. Neurofeedback for the treatment of children and adolescents with ADHD: a randomized and controlled clinical trial using parental reports. BMC Psychiatry. 2012;12:107. doi: 10.1186/1471-244x-12-107. [PMC free article: PMC3441233] [PubMed: 22877086] [CrossRef]

Dvorsky M, Tamm L, Denton CA, et al. Trajectories of Response to Treatments in Children with ADHD and Word Reading Difficulties. Res Child Adolesc Psychopathol. 2021 Aug;49(8):1015–30. doi: 10.1007/s10802-021-00815-y. PMID: 33772416. [PMC free article: PMC10568448] [PubMed: 33772416] [CrossRef]

Eli Lilly and Company. Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder. 2004.

Eli Lilly and Company. Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHD. 2004.

Eli Lilly and Company. Comparison of Atomoxetine Versus Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD). 2007.

Eli Lilly and Company. A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents. 2007.

Eli Lilly and Company. Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia. 2008.

Eli Lilly and Company. A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder. 2009.

Eli Lilly Company. Evaluation of Continuous Symptom Treatment of ADHD. 2003.

Eli Lilly Company. Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD). 2005.

Elliott GR, Blasey C, Rekshan W, et al. Cognitive Testing to Identify Children With ADHD Who Do and Do Not Respond to Methylphenidate. J Atten Disord. 2017 Dec;21(14):1151–60. doi: 10.1177/1087054714543924. PMID: 25122732. [PubMed: 25122732] [CrossRef]

Enzymotec. The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder. 2007.

Escobar R, Montoya A, Polavieja P, et al. Evaluation of patients’ and parents’ quality of life in a randomized placebo-controlled atomoxetine study in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009 Jun;19(3):253–63. doi: 10.1089/cap.2008.0109. PMID: 19519260. [PubMed: 19519260] [CrossRef]

Etz-HaChayim Clinic (Israel). A randomised, double-blind, placebo-controlled clinical trial of a Compound Herbal Preparation (CHP) in the treatment of children with Attention-Deficit Hyperactivity Disorder (ADHD). 2007. https://www​.isrctn.com​/ISRCTN10628149?q=ISRCTN10628149&filters​=&sort​=&offset​=1&totalResults​=1&page=1&pageSize=10. Accessed on October 11 2022.

Evans SW, Allan D, Xiang J, et al. Organization interventions as a mediator of change in grades in the Challenging Horizons Program. J Sch Psychol. 2021 Aug;87:18–27. doi: 10.1016/j.jsp.2021.05.001. PMID: 34303445. [PMC free article: PMC8316678] [PubMed: 34303445] [CrossRef]

Faculty of Rehabilitation SBUoMS. The effect of neurofeedback training on aggression and impulsivity in elementary boy students with attention deficit / hyperactivity disorders. 2018. https://en​.irct.ir/trial/23385. Accessed on October 6 2022.

Faraone SV, Biederman J, Lehman BK, et al. Evidence for the independent familial transmission of attention deficit hyperactivity disorder and learning disabilities: results from a family genetic study. Am J Psychiatry. 1993 Jun;150(6):891–5. doi: 10.1176/ajp.150.6.891. PMID: 8494064. [PubMed: 8494064] [CrossRef]

Faraone SV, Biederman J, Lehman BK, et al. Intellectual performance and school failure in children with attention deficit hyperactivity disorder and in their siblings. J Abnorm Psychol. 1993 Nov;102(4):616–23. doi: 10.1037/0021-843X.102.4.616. PMID: 8282932. [PubMed: 8282932] [CrossRef]

Faraone SV, Biederman J, Zimmerman B. Correspondence of parent and teacher reports in medication trials. Eur Child Adolesc Psychiatry. 2005 Feb;14(1):20–7. doi: 10.1007/s00787-005-0415-5. PMID: 15756512. [PubMed: 15756512] [CrossRef]

Faraone SV, Childress AC, Gomeni R, et al. Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the Day. J Child Adolesc Psychopharmacol. 2023 Feb;33(1):14–9. doi: 10.1089/cap.2022.0093. PMID: 36730749. [PMC free article: PMC9963474] [PubMed: 36730749] [CrossRef]

Faraone SV, Gomeni R, Hull JT, et al. Early response to SPN-812 (viloxazine extended-release) can predict efficacy outcome in pediatric subjects with ADHD: a machine learning post-hoc analysis of four randomized clinical trials. Psychiatry Res. 2021 Feb;296:113664. doi: 10.1016/j.psychres.2020.113664. PMID: 33418457. [PubMed: 33418457] [CrossRef]

Farmer CA, Brown NV, Gadow KD, et al. Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2015 Apr;25(3):213–24. doi: 10.1089/cap.2014.0109. PMID: 25885011. [PMC free article: PMC4403232] [PubMed: 25885011] [CrossRef]

Fernandez de la Cruz L, Simonoff E, McGough JJ, et al. Treatment of children with attention-deficit/hyperactivity disorder (ADHD) and irritability: results from the multimodal treatment study of children with ADHD (MTA). J Am Acad Child Adolesc Psychiatry. 2015 Jan;54(1):62–70 e3. doi: 10.1016/j.jaac.2014.10.006. PMID: 25524791. [PMC free article: PMC4284308] [PubMed: 25524791] [CrossRef]

Findling RL, Adeyi B, Chen G, et al. Clinical response and symptomatic remission in children treated with lisdexamfetamine dimesylate for attention-deficit/hyperactivity disorder. CNS Spectrums. 2010;15(9):559–68. doi: 10.1017/S1092852900000535. [CrossRef]

Findling RL, Katic A, Rubin R, et al. A 6-month, open-label, extension study of the tolerability and effectiveness of the methylphenidate transdermal system in adolescents diagnosed with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2010 Oct;20(5):365–75. doi: 10.1089/cap.2009.0122. PMID: 20973707. [PubMed: 20973707] [CrossRef]

Findling RL, McBurnett K, White C, et al. Guanfacine extended release adjunctive to a psychostimulant in the treatment of comorbid oppositional symptoms in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2014 Jun;24(5):245–52. doi: 10.1089/cap.2013.0103. PMID: 24945085. [PMC free article: PMC4064735] [PubMed: 24945085] [CrossRef]

Findling RL, Townsend L, Brown NV, et al. The Treatment of Severe Childhood Aggression Study: 12 Weeks of Extended, Blinded Treatment in Clinical Responders. J Child Adolesc Psychopharmacol. 2017 Feb;27(1):52–65. doi: 10.1089/cap.2016.0081. PMID: 28212067. [PMC free article: PMC5327034] [PubMed: 28212067] [CrossRef]

Findling RL, Wigal SB, Bukstein OG, et al. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials. Clin Ther. 2009 Aug;31(8):1844–55. doi: 10.1016/j.clinthera.2009.08.002. PMID: 19808143. [PubMed: 19808143] [CrossRef]

Florida International University. STAND Community Trial. 2015.

Forehand R, Parent J, Peisch VD, et al. Do parental ADHD symptoms reduce the efficacy of parent training for preschool ADHD? A secondary analysis of a randomized controlled trial. Behav Res Ther. 2017 Oct;97:163–9. doi: 10.1016/j.brat.2017.08.002. PMID: 28800444. [PMC free article: PMC5600708] [PubMed: 28800444] [CrossRef]

Forehand R, Parent J, Sonuga-Barke E, et al. Which Type of Parent Training Works Best for Preschoolers with Comorbid ADHD and ODD? A Secondary Analysis of a Randomized Controlled Trial Comparing Generic and Specialized Programs. J Abnorm Child Psychol. 2016 Nov;44(8):1503–13. doi: 10.1007/s10802-016-0138-8. PMID: 26909683. [PMC free article: PMC4996757] [PubMed: 26909683] [CrossRef]

Foundation OHaSUOSUUoLNUoNMFfEiMHCW. Micronutrients for Attention-Deficit Hyperactivity Disorder in Youth (MADDY) Study. 2018.

Fu C, Chen S, Qian A, et al. Larger thalamus correlated with inattentive severity in the inattentive subtype of ADHD without comorbidity. Psychiatry Res. 2021 Jul 16;304:114079. doi: 10.1016/j.psychres.2021.114079. PMID: 34333322. [PubMed: 34333322] [CrossRef]

Fujian Maternity and Child Health Hospital AHoFMU. Research on Children’s Psychological Behavior Development Monitoring and Information Network System Management. 2022. https://www​.chictr.org​.cn/hvshowproject.aspx?id=161110. Accessed on October 11 2022.

Gadow KD, Arnold LE, Molina BS, et al. Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression. J Am Acad Child Adolesc Psychiatry. 2014 Sep;53(9):948–59 e1. doi: 10.1016/j.jaac.2014.05.008. PMID: 25151418. [PMC free article: PMC4145805] [PubMed: 25151418] [CrossRef]

Gadow KD, Brown NV, Arnold LE, et al. Severely Aggressive Children Receiving Stimulant Medication Versus Stimulant and Risperidone: 12-Month Follow-Up of the TOSCA Trial. J Am Acad Child Adolesc Psychiatry. 2016 Jun;55(6):469–78. doi: 10.1016/j.jaac.2016.03.014. PMID: 27238065. [PMC free article: PMC4886346] [PubMed: 27238065] [CrossRef]

Galanter CA, Carlson GA, Jensen PS, et al. Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. J Child Adolesc Psychopharmacol. 2003 Summer;13(2):123–36. doi: 10.1089/104454603322163844. PMID: 12880507. [PubMed: 12880507] [CrossRef]

Gallagher R, Sibley MH. ORGANIZATIONAL SKILLS AND EXECUTIVE FUNCTION TREATMENT FOR CHILDREN AND TEENS WITH ADHD: UPDATE AND TRAINING IN TWO EMPIRICALLY SUPPORTED INTERVENTIONS. Journal of the American Academy of Child and Adolescent Psychiatry. 2022;61(10):S119. doi: 10.1016/j.jaac.2022.07.485. [CrossRef]

Gasior M, Findling R, Childress A, et al. Double-blind, placebo-controlled efficacy and safety study of lisdexamfetamine dimesylate in adolescents with attention-deficit/ hyperactivity disorder. Neuropsychopharmacology. 2010;35:S103–S4. doi: 10.1038/npp.2010.216. [CrossRef]

Geladé K, Janssen TW, Bink M, et al. Behavioral Effects of Neurofeedback Compared to Stimulants and Physical Activity in Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial. J Clin Psychiatry. 2016 Oct;77(10):e1270–e7. doi: 10.4088/JCP.15m10149. PMID: 27631143. [PubMed: 27631143] [CrossRef]

Geladé K, Janssen TWP, Bink M, et al. A 6-month follow-up of an RCT on behavioral and neurocognitive effects of neurofeedback in children with ADHD. Eur Child Adolesc Psychiatry. 2018 May;27(5):581–93. doi: 10.1007/s00787-017-1072-1. PMID: 29098467. [PubMed: 29098467] [CrossRef]

Gevensleben H, Holl B, Albrecht B, et al. Is neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trial. J Child Psychol Psychiatry. 2009 Jul;50(7):780–9. doi: 10.1111/j.1469-7610.2008.02033.x. PMID: 19207632. [PubMed: 19207632] [CrossRef]

Ghasemi E, Ebrahimi M, Ebrahimie E. Machine learning models effectively distinguish attention-deficit/hyperactivity disorder using event-related potentials. Cognitive Neurodynamics. 2022;16(6):1335–49. doi: 10.1007/s11571-021-09746-2. [PMC free article: PMC9666608] [PubMed: 36408064] [CrossRef]

Ghiassian S, Greiner R, Jin P, et al. Using Functional or Structural Magnetic Resonance Images and Personal Characteristic Data to Identify ADHD and Autism. PLoS One. 2016;11(12):e0166934. doi: 10.1371/journal.pone.0166934. PMID: 28030565. [PMC free article: PMC5193362] [PubMed: 28030565] [CrossRef]

Ghuman JK RM, Vitiello B, et al. Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007;17(5):563–80. [PubMed: 17979578]

Goh PK, Martel MM, Barkley RA. Clarifying ADHD and sluggish cognitive tempo item relations with impairment: A network analysis. Journal of Abnormal Child Psychology. 2020 Aug 2020;48(8):1047–61. [PubMed: 32445104]

Gonzalez J, Mendez LD, Manas S, et al. Performance analysis of univariate and multivariate EEG measurements in the diagnosis of ADHD. Clin Neurophysiol. 2013 Jun;124(6):1139–50. doi: 10.1016/j.clinph.2012.12.006. [PubMed: 23332776] [CrossRef]

Göteborg University. Long-term Effects of Medication for ADHD (LMA). 2017. https://clinicaltrials.gov/ct2/show/NCT03250013?term=NCT03250013&draw=2&rank=1. Accessed on October 11 2022.

Gray KM, Riggs PD, Min SJ, et al. Cigarette and cannabis use trajectories among adolescents in treatment for attention-deficit/hyperactivity disorder and substance use disorders. Drug Alcohol Depend. 2011 Sep 1;117(2–3):242–7. doi: 10.1016/j.drugalcdep.2011.02.005. PMID: 21411243. [PMC free article: PMC3128687] [PubMed: 21411243] [CrossRef]

Green CD, Dvorsky MR, Langberg JM, et al. The Impact of Social Determinants of Health on the Efficacy of School-Based Interventions for Adolescents with ADHD. School Ment Health. 2020 Sep;12(3):580–94. doi: 10.1007/s12310-020-09367-w. PMID: 34093886. [PMC free article: PMC8174022] [PubMed: 34093886] [CrossRef]

Greene RW, Ablon JS. What does the MTA study tell us about effective psychosocial treatment for ADHD? J Clin Child Psychol. 2001 Mar;30(1):114–21. doi: 10.1207/s15374424jccp3001_13. PMID: 11294069. [PubMed: 11294069] [CrossRef]

Greenhill L KS, Abikoff H, et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry. 2006;45(11):1284–93. [PubMed: 17023867]

Greenhill LL. Editorial: Does a Diagnosis of Attention-Deficit/Hyperactivity Disorder in Childhood Determine an Increased Risk for Future Criminality? J Am Acad Child Adolesc Psychiatry. 2019 Apr;58(4):401–2. doi: 10.1016/j.jaac.2019.01.008. PMID: 30768386. [PubMed: 30768386] [CrossRef]

Greenhill LL, Abikoff HB, Arnold LE, et al. Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry. 1996 Oct;35(10):1304–13. doi: 10.1097/00004583-199610000-00017. PMID: 8885584. [PubMed: 8885584] [CrossRef]

Greenhill LL, Swanson JM, Hechtman L, et al. Trajectories of Growth Associated With Long-Term Stimulant Medication in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2020 Aug;59(8):978–89. doi: 10.1016/j.jaac.2019.06.019. PMID: 31421233. [PMC free article: PMC7021562] [PubMed: 31421233] [CrossRef]

Greenhill LL, Swanson JM, Vitiello B, et al. Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J Am Acad Child Adolesc Psychiatry. 2001 Feb;40(2):180–7. doi: 10.1097/00004583-200102000-00012. PMID: 11211366. [PubMed: 11211366] [CrossRef]

Grodzinsky GM, Barkley RA. Predictive power of frontal lobe tests in the diagnosis of attention deficit hyperactivity disorder. Clin Neuropsychol. 1999 Feb;13(1):12–21. doi: 10.1076/clin.13.1.12.1983. PMID: 10937644. [PubMed: 10937644] [CrossRef]

Grondhuis SN, Farmer CA, Arnold LE, et al. Standardized Observation Analogue Procedure in the Treatment of Severe Childhood Aggression Study. J Child Adolesc Psychopharmacol. 2020 Feb;30(1):48–54. doi: 10.1089/cap.2019.0109. PMID: 31730370. [PMC free article: PMC7041312] [PubMed: 31730370] [CrossRef]

Groves NB, Chan ESM, Marsh CL, et al. Does central executive training and/or inhibitory control training improve emotion regulation for children with attention-deficit/hyperactivity disorder? A randomized controlled trial. Front Psychiatry. 2022;13:1034722. doi: 10.3389/fpsyt.2022.1034722. PMID: 36561637. [PMC free article: PMC9763728] [PubMed: 36561637] [CrossRef]

Haack LM, Villodas M, McBurnett K, et al. Parenting as a Mechanism of Change in Psychosocial Treatment for Youth with ADHD, Predominantly Inattentive Presentation. J Abnorm Child Psychol. 2017 Jul;45(5):841–55. doi: 10.1007/s10802-016-0199-8. PMID: 27628742. [PMC free article: PMC5352559] [PubMed: 27628742] [CrossRef]

Haack LM, Villodas MT, McBurnett K, et al. Parenting Mediates Symptoms and Impairment in Children With ADHD-Inattentive Type. J Clin Child Adolesc Psychol. 2016;45(2):155–66. doi: 10.1080/15374416.2014.958840. PMID: 25411896. [PMC free article: PMC4465882] [PubMed: 25411896] [CrossRef]

Hadassah Medical Organization. New Continuous Performance Tests (CPT) for the Diagnosis of Pediatric Attention Deficit/Hyperactivity Disorder (ADHD). 2008.

Hadassah Medical Organization. Effectiveness of a Cognitive-functional (Cog-Fun) Intervention for Children With ADHD. 2013.

Häge A, Alm B, Banaschewski T, et al. Does the efficacy of parent-child training depend on maternal symptom improvement? Results from a randomized controlled trial on children and mothers both affected by attention-deficit/hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. 2018 Aug;27(8):1011–21. doi: 10.1007/s00787-018-1109-0. PMID: 29362929. [PubMed: 29362929] [CrossRef]

Hagler DJ, Jr., Hatton S, Cornejo MD, et al. Image processing and analysis methods for the Adolescent Brain Cognitive Development Study. Neuroimage. 2019 Nov 15;202:116091. doi: 10.1016/j.neuroimage.2019.116091. PMID: 31415884. [PMC free article: PMC6981278] [PubMed: 31415884] [CrossRef]

Hahn-Markowitz J, Berger I, Manor I, et al. Impact of the Cognitive-Functional (Cog-Fun) Intervention on Executive Functions and Participation Among Children With Attention Deficit Hyperactivity Disorder: A Randomized Controlled Trial. Am J Occup Ther. 2017 Sep/Oct;71(5):7105220010p1–p9. doi: 10.5014/ajot.2017.022053. PMID: 28809658. [PubMed: 28809658] [CrossRef]

Hall CL, James M, Brown S, et al. Protocol investigating the clinical utility of an objective measure of attention, impulsivity and activity (QbTest) for optimising medication management in children and young people with ADHD ‘QbTest Utility for Optimising Treatment in ADHD’ (QUOTA): a feasibility randomised controlled trial. BMJ Open. 2018 Feb 15;8(2):e021104. doi: 10.1136/bmjopen-2017-021104. PMID: 29453304. [PMC free article: PMC5829926] [PubMed: 29453304] [CrossRef]

Hall CL, Valentine AZ, Walker GM, et al. Study of user experience of an objective test (QbTest) to aid ADHD assessment and medication management: a multi-methods approach. BMC Psychiatry. 2017 Feb 10;17(1):66. doi: 10.1186/s12888-017-1222-5. PMID: 28183284. [PMC free article: PMC5301349] [PubMed: 28183284] [CrossRef]

Handen BL, Janosky J, McAuliffe S. Long-term follow-up of children with mental retardation/borderline intellectual functioning and ADHD. J Abnorm Child Psychol. 1997 Aug;25(4):287–95. doi: 10.1023/a:1025760302598. PMID: 9304445. [PubMed: 9304445] [CrossRef]

Hansen L, Thomsen PH. [How to treat ADHD/DAMP? Is there a conclusive answer? A critical survey of the MTA trial?]. Ugeskr Laeger. 2005 Nov 28;167(48):4555–9. PMID: 16324436. [PubMed: 16324436]

Harfterkamp M, Buitelaar JK, Minderaa RB, et al. Atomoxetine in autism spectrum disorder: no effects on social functioning; some beneficial effects on stereotyped behaviors, inappropriate speech, and fear of change. J Child Adolesc Psychopharmacol. 2014 Nov;24(9):481–5. doi: 10.1089/cap.2014.0026. PMID: 25369243. [PubMed: 25369243] [CrossRef]

Hasslinger J, Jonsson U, Bölte S. Immediate and Sustained Effects of Neurofeedback and Working Memory Training on Cognitive Functions in Children and Adolescents with ADHD: A Multi-Arm Pragmatic Randomized Controlled Trial. J Atten Disord. 2022 Sep;26(11):1492–506. doi: 10.1177/10870547211063645. PMID: 35034510. [PMC free article: PMC9277335] [PubMed: 35034510] [CrossRef]

Hasslinger J, Souto MDA, Hellstadius LF, et al. Neurofeedback in ADHD: A qualitative study of strategy use in slow cortical potential training. PLoS ONE. 2020 Jun 4, 2020;15(6):e0233343. doi: 10.1371/journal.pone.0233343. PMID: 32497051. [PMC free article: PMC7272030] [PubMed: 32497051] [CrossRef]

Hautmann C, Döpfner M, Katzmann J, et al. Sequential treatment of ADHD in mother and child (AIMAC study): importance of the treatment phases for intervention success in a randomized trial. BMC Psychiatry. 2018 Dec 13;18(1):388. doi: 10.1186/s12888-018-1963-9. PMID: 30545333. [PMC free article: PMC6293507] [PubMed: 30545333] [CrossRef]

Hazell P, Zhang S, Wolańczyk T, et al. Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry. 2006 Mar;15(2):105–10. doi: 10.1007/s00787-006-0506-y. PMID: 16523251. [PubMed: 16523251] [CrossRef]

Health D, Authority H, Psychiatry. AAoCA. Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder. 2005.

Hechtman L, Abikoff H, Klein RG, et al. Children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment: impact on parental practices. J Am Acad Child Adolesc Psychiatry. 2004 Jul;43(7):830–8. doi: 10.1097/01.chi.0000128785.52698.19. PMID: 15213584. [PubMed: 15213584] [CrossRef]

Hechtman L, Abikoff H, Klein RG, et al. Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry. 2004 Jul;43(7):812–9. doi: 10.1097/01.chi.0000128796.84202.eb. PMID: 15213582. [PubMed: 15213582] [CrossRef]

Hechtman L, Etcovitch J, Platt R, et al. Does multimodal treatment of ADHD decrease other diagnoses? Clinical Neuroscience Research. 2005;5(5–6):273–82. doi: 10.1016/j.cnr.2005.09.007. [CrossRef]

Hela Pharma AB. Placebo controlled, randomised, double-blind, multicentre study of PlusEPA (a PUFA, Polyunsaturated Fatty Acids, supplement) as treatment for ADHD (combined type) with co-morbidity in Swedish children ages 7-12. 2004. https://www​.clinicaltrialsregister​.eu/ctr-search​/trial/2004-003853-13/SE. Accessed on October 12 2022.

Hemamy M, Heidari-Beni M, Askari G, et al. Effect of Vitamin D and Magnesium Supplementation on Behavior Problems in Children with Attention-Deficit Hyperactivity Disorder. Int J Prev Med. 2020;11:4. doi: 10.4103/ijpvm.IJPVM_546_17. PMID: 32089804. [PMC free article: PMC7011463] [PubMed: 32089804] [CrossRef]

Hinshaw SP. Moderators and mediators of treatment outcome for youth with ADHD: understanding for whom and how interventions work. J Pediatr Psychol. 2007 Jul;32(6):664–75. doi: 10.1093/jpepsy/jsl055. PMID: 17264086. [PubMed: 17264086] [CrossRef]

Hinshaw SP, Arnold LE. Attention-deficit hyperactivity disorder, multimodal treatment, and longitudinal outcome: evidence, paradox, and challenge. Wiley Interdiscip Rev Cogn Sci. 2015 Jan–Feb;6(1):39–52. doi: 10.1002/wcs.1324. PMID: 26262927. [PubMed: 26262927] [CrossRef]

Hinshaw SP, March JS, Abikoff H, et al. Comprehensive assessment of childhood Attention-Deficit Hyperactivity Disorder in the context of a multisite, multimodal clinical trial. Journal of Attention Disorders. 1997;1(4):217–34. doi: 10.1177/108705479700100403. [CrossRef]

Hinshaw SP OE, Wells KC, et al. Family processes and treatment outcome in the MTA: negative/ineffective parenting practices in relation to multimodal treatment. J Abnorm Child Psychol. 2000 Dec;28(6):555–68. doi: 10.1023/a:1005183115230. PMID: 11104317. [PubMed: 11104317] [CrossRef]

Hiscock H SE, Mensah F, et al. Impact of a behavioural sleep intervention on symptoms and sleep in children with attention deficit hyperactivity disorder, and parental mental health: randomised controlled trial. BMJ. 2015;350:h68. doi: 10.1136/bmj.h68. [PMC free article: PMC4299655] [PubMed: 25646809] [CrossRef]

Hollis C, Hall CL, Guo B, et al. The impact of a computerised test of attention and activity (QbTest) on diagnostic decision-making in children and young people with suspected attention deficit hyperactivity disorder: single-blind randomised controlled trial. J Child Psychol Psychiatry. 2018 Dec;59(12):1298–308. doi: 10.1111/jcpp.12921. PMID: 29700813. [PMC free article: PMC6124643] [PubMed: 29700813] [CrossRef]

Hollway JA, Aman MG, Mendoza-Burcham MI, et al. Caregiver Satisfaction with a Multisite Trial of Atomoxetine and Parent Training for Attention-Deficit/Hyperactivity Disorder and Behavioral Noncompliance in Children with Autism Spectrum Disorder. J Child Adolesc Psychopharmacol. 2016 Nov;26(9):807–14. doi: 10.1089/cap.2015.0130. PMID: 26797318. [PMC free article: PMC5116688] [PubMed: 26797318] [CrossRef]

Holtmann M, Pniewski B, Wachtlin D, et al. Neurofeedback in children with attention-deficit/hyperactivity disorder (ADHD)--a controlled multicenter study of a non-pharmacological treatment approach. BMC Pediatr. 2014 Aug 13;14:202. doi: 10.1186/1471-2431-14-202. PMID: 25123917. [PMC free article: PMC4134464] [PubMed: 25123917] [CrossRef]

Hong SS, Cho SH. Acupuncture for attention deficit hyperactivity disorder (ADHD): study protocol for a randomised controlled trial. Trials. 2011 Jul 11;12:173. doi: 10.1186/1745-6215-12-173. PMID: 21745388. [PMC free article: PMC3148992] [PubMed: 21745388] [CrossRef]

Hornstra R, Dekkers TJ, Bosmans G, et al. Attachment Representation Moderates the Effectiveness of Behavioral Parent Training Techniques for Children with ADHD: Evidence from a Randomized Controlled Microtrial. Res Child Adolesc Psychopathol. 2022 Sep;50(9):1151–64. doi: 10.1007/s10802-022-00921-5. PMID: 35362776. [PMC free article: PMC9525431] [PubMed: 35362776] [CrossRef]

Hovik KT, Saunes BK, Aarlien AK, et al. RCT of working memory training in ADHD: long-term near-transfer effects. PLoS One. 2013;8(12):e80561. doi: 10.1371/journal.pone.0080561. PMID: 24352414. [PMC free article: PMC3857172] [PubMed: 24352414] [CrossRef]

Howard AL, Kennedy TM, Macdonald EP, et al. Depression and ADHD-Related Risk for Substance Use in Adolescence and Early Adulthood: Concurrent and Prospective Associations in the MTA. J Abnorm Child Psychol. 2019 Dec;47(12):1903–16. doi: 10.1007/s10802-019-00573-y. PMID: 31273568. [PMC free article: PMC6842691] [PubMed: 31273568] [CrossRef]

Howard AL, Kennedy TM, Mitchell JT, et al. Early substance use in the pathway from childhood attention-deficit/hyperactivity disorder (ADHD) to young adult substance use: Evidence of statistical mediation and substance specificity. Psychol Addict Behav. 2020 Mar;34(2):281–92. doi: 10.1037/adb0000542. PMID: 31886682. [PMC free article: PMC9812258] [PubMed: 31886682] [CrossRef]

Howard AL, Strickland NJ, Murray DW, et al. Progression of impairment in adolescents with attention-deficit/hyperactivity disorder through the transition out of high school: Contributions of parent involvement and college attendance. J Abnorm Psychol. 2016 Feb;125(2):233–47. doi: 10.1037/abn0000100. PMID: 26854508. [PMC free article: PMC4852731] [PubMed: 26854508] [CrossRef]

Hoza B GA, Mrug S, et al. Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder. J Clin Child Adolesc Psychol. 2005;34(1):74–86. [PubMed: 15677282]

Huss M, Dirks B, Gu J, et al. Long-term safety and efficacy of guanfacine extended release in children and adolescents with ADHD. Eur Child Adolesc Psychiatry. 2018 Oct;27(10):1283–94. doi: 10.1007/s00787-018-1113-4. PMID: 29442229. [PubMed: 29442229] [CrossRef]

Hustus CL, Evans SW, Owens JS, et al. An evaluation of 504 and individualized education programs for high school students with attention deficit hyperactivity disorder. School Psychology Review. 2020 2020;49(3):333–45.

Icahn School of Medicine at Mount Sinai, Health NIoM. Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children. 2005.

Ichikawa H, Miyajima T, Yamashita Y, et al. Long-term study of lisdexamfetamine dimesylate in Japanese children and adolescents with attention-deficit/hyperactivity disorder. Neuropsychopharmacol Rep. 2020 Mar;40(1):52–62. doi: 10.1002/npr2.12091. PMID: 31814294. [PMC free article: PMC7292222] [PubMed: 31814294] [CrossRef]

IRCCS Eugenio Medea, srl D. The Effects of DHA on Attention Deficit and Hyperactivity Disorder. 2012.

Irwin Harper LN, Groves NB, Marsh CL, et al. Does training working memory or inhibitory control produce far-transfer improvements in set shifting for children with ADHD? A randomized controlled trial. Child Neuropsychol. 2022 Nov 4;29(5):1–21. doi: 10.1080/09297049.2022.2138301. PMID: 36331068. [PubMed: 35236234] [CrossRef]

Itani S, Lecron F, Fortemps P. A multi-level classification framework for multi-site medical data: Application to the ADHD-200 collection. Expert Systems with Applications. 2018 2018/01/01/;91:36–45. doi: 10.1016/j.eswa.2017.08.044. [CrossRef]

Itani S, Rossignol M, Lecron F, et al. Towards interpretable machine learning models for diagnosis aid: A case study on attention deficit/hyperactivity disorder. PLoS One. 2019;14(4):e0215720. doi: 10.1371/journal.pone.0215720. PMID: 31022245. [PMC free article: PMC6483231] [PubMed: 31022245] [CrossRef]

Jain R, Duncan D, Babcock T, et al. Lisdexamfetamine dimesylate (LDX) in children with ADHD after suboptimal response to methylphenidate. European Child and Adolescent Psychiatry. 2011;20:S126–S7. doi: 10.1007/s00787-011-0181-5. [CrossRef]

Jaite C, van Noort BM, Vloet TD, et al. A multicentre randomized controlled trial on trans-generational attention deficit/hyperactivity disorder (ADHD) in mothers and children (AIMAC): an exploratory analysis of predictors and moderators of treatment outcome. Z Kinder Jugendpsychiatr Psychother. 2019 Jan;47(1):49–65. doi: 10.1024/1422-4917/a000602. PMID: 30084719. [PubMed: 30084719] [CrossRef]

Jans T, Graf E, Jacob C, et al. A randomized controlled multicentre trial on the treatment for ADHD in mothers and children: enrolment and basic characteristics of the study sample. Atten Defic Hyperact Disord. 2013 Mar;5(1):29–40. doi: 10.1007/s12402-012-0092-4. PMID: 23070786. [PubMed: 23070786] [CrossRef]

Jans T, Jacob C, Warnke A, et al. Does intensive multimodal treatment for maternal ADHD improve the efficacy of parent training for children with ADHD? A randomized controlled multicenter trial. J Child Psychol Psychiatry. 2015 Dec;56(12):1298–313. doi: 10.1111/jcpp.12443. PMID: 26123832. [PubMed: 26123832] [CrossRef]

Janssen TW, Bink M, Geladé K, et al. A randomized controlled trial into the effects of neurofeedback, methylphenidate, and physical activity on EEG power spectra in children with ADHD. J Child Psychol Psychiatry. 2016 May;57(5):633–44. doi: 10.1111/jcpp.12517. PMID: 26748531. [PubMed: 26748531] [CrossRef]

Janssen TW, Bink M, Geladé K, et al. A Randomized Controlled Trial Investigating the Effects of Neurofeedback, Methylphenidate, and Physical Activity on Event-Related Potentials in Children with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2016 May;26(4):344–53. doi: 10.1089/cap.2015.0144. PMID: 26771913. [PubMed: 26771913] [CrossRef]

Janssen TWP, Bink M, Weeda WD, et al. Learning curves of theta/beta neurofeedback in children with ADHD. Eur Child Adolesc Psychiatry. 2017 May;26(5):573–82. doi: 10.1007/s00787-016-0920-8. PMID: 27866283. [PMC free article: PMC5394134] [PubMed: 27866283] [CrossRef]

Janssen TWP, Geladé K, Bink M, et al. Long-term effects of theta/beta neurofeedback on EEG power spectra in children with attention deficit hyperactivity disorder. Clin Neurophysiol. 2020 Jun;131(6):1332–41. doi: 10.1016/j.clinph.2020.02.020. PMID: 32304847. [PubMed: 32304847] [CrossRef]

Janssen-Ortho Inc. C. An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder Children.

Jarratt KP, Riccio CA, Siekierski BM. Assessment of attention deficit hyperactivity disorder (ADHD) using the BASC and BRIEF. Appl Neuropsychol. 2005;12(2):83–93. doi: 10.1207/s15324826an1202_4. PMID: 16083397. [PubMed: 16083397] [CrossRef]

Jensen PS, Hinshaw SP, Kraemer HC, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry. 2001 Feb;40(2):147–58. doi: 10.1097/00004583-200102000-00009. PMID: 11211363. [PubMed: 11211363] [CrossRef]

Jensen PS, Hinshaw SP, Swanson JM, et al. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr. 2001 Feb;22(1):60–73. doi: 10.1097/00004703-200102000-00008. PMID: 11265923. [PubMed: 11265923] [CrossRef]

Jensen PS, Hoagwood KE, Roper M, et al. The Services for Children and Adolescents-Parent Interview: Development and Performance Characteristics. Journal of the American Academy of Child and Adolescent Psychiatry. 2004 11/01/;43(11):1334–N. doi: 10.1097/01.chi.0000139557.16830.4e. PMID: EJ696660. [PubMed: 15502592] [CrossRef]

Jitendra A, DuPaul G, Volpe R, et al. Consultation-based academic intervention for children with attention deficit hyperactivity disorder: school functioning outcomes. School Psych Rev. 2007;36(2):217–36.

Johnson JA, Jakubovski E, Reed MO, et al. Predictors of Long-Term Risky Driving Behavior in the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2017 Oct;27(8):747–54. doi: 10.1089/cap.2017.0025. PMID: 28771386. [PMC free article: PMC5651934] [PubMed: 28771386] [CrossRef]

Johnson M MJ, Ostlund S, et al. Fatty acids in ADHD: plasma profiles in a placebo-controlled study of Omega 3/6 fatty acids in children and adolescents. Atten Defic Hyperact Disord. 2012 Dec;4(4):199–204. doi: 10.1007/s12402-012-0084-4. [PubMed: 22753087] [CrossRef]

Johnstone JM, Leung B, Gracious B, et al. Rationale and design of an international randomized placebo-controlled trial of a 36-ingredient micronutrient supplement for children with ADHD and irritable mood: The Micronutrients for ADHD in Youth (MADDY) study. Contemp Clin Trials Commun. 2019 Dec;16:100478. doi: 10.1016/j.conctc.2019.100478. PMID: 31763491. [PMC free article: PMC6859218] [PubMed: 31763491] [CrossRef]

Joseph Blader, Texas Uo, Health N, et al. Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study). 2008.

Joseph HM, Farmer C, Kipp H, et al. Attendance and Engagement in Parent Training Predict Child Behavioral Outcomes in Children Pharmacologically Treated for Attention-Deficit/Hyperactivity Disorder and Severe Aggression. J Child Adolesc Psychopharmacol. 2019 Mar;29(2):90–9. doi: 10.1089/cap.2018.0119. PMID: 30592635. [PMC free article: PMC6442260] [PubMed: 30592635] [CrossRef]

JPM van Stralen Medicine Professional. Efficacy of GXR as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD. 2013.

Karakter Kinder- en Jeugdpsychiatrie, Gezondheid FP, Commission E, et al. Mindfulness Training for Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Mindful Parenting. 2016.

Karalunas SL, Gustafsson HC, Dieckmann NF, et al. Heterogeneity in development of aspects of working memory predicts longitudinal attention deficit hyperactivity disorder symptom change. Journal of Abnormal Psychology. 2017 Aug 2017;126(6):774–92. [PMC free article: PMC5657320] [PubMed: 28782975]

Karolinska Institutet, Stockholm R, Child, et al. Neurofeedback and Working Memory Training for Children and Adolescents With ADHD. 2013.

Karpouzis F, Pollard H, Bonello R. A randomised controlled trial of the Neuro Emotional Technique (NET) for childhood Attention Deficit Hyperactivity Disorder (ADHD): a protocol. Trials. 2009 Jan 27;10:6. doi: 10.1186/1745-6215-10-6. PMID: 19173743. [PMC free article: PMC2646715] [PubMed: 19173743] [CrossRef]

Kelly C, Castellanos FX, Tomaselli O, et al. Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults. Neuroimage Clin. 2017;13:188–200. doi: 10.1016/j.nicl.2016.09.012. PMID: 27995073. [PMC free article: PMC5153452] [PubMed: 27995073] [CrossRef]

Kennedy TM, Howard AL, Mitchell JT, et al. Adult substance use as a function of growth in peer use across adolescence and young adulthood in the context of ADHD: Findings from the MTA. Addict Behav. 2019 Dec;99:106106. doi: 10.1016/j.addbeh.2019.106106. PMID: 31473568. [PMC free article: PMC6791771] [PubMed: 31473568] [CrossRef]

Kerson C. A proposed multisite double-blind randomized clinical trial of neurofeedback for ADHD: need, rationale, and strategy. J Atten Disord. 2013 Jul;17(5):420–36. doi: 10.1177/1087054713482580. PMID: 23590978. [PubMed: 23590978] [CrossRef]

Kerson C, Roley-Roberts ME, deBeus RJ, et al. 39.3 NEUROCOGNITIVE OUTCOMES IN A RANDOMIZED CONTROLLED TRIAL OF NEUROFEEDBACK FOR ADHD. Journal of the American Academy of Child and Adolescent Psychiatry. 2020;59(10):S326. doi: 10.1016/j.jaac.2020.07.779. [CrossRef]

Khare SK, Acharya UR. An explainable and interpretable model for attention deficit hyperactivity disorder in children using EEG signals. Computers in Biology and Medicine. 2023;155. doi: 10.1016/j.compbiomed.2023.106676. [CrossRef]

Khoram-Abad University of Medical Sciences. Comparison of Methylphenidate with the Combanition of Methylphenidate (MPH) and Crocus sativus (Saffron) in the treatment of children and adolescents with Attention-Deficit Hyperactivity Disorder (ADHD): a Randomized, Double Blind Clinical Trial. 2020. https://www​.irct.ir/trial/39997. Accessed on October 11 2022.

Khoshnoud S, Nazari MA, Shamsi M. Functional brain dynamic analysis of ADHD and control children using nonlinear dynamical features of EEG signals. J Integr Neurosci. 2018 Aug 15;17(1):11–7. doi: 10.31083/jin-170033. PMID: 29172003. [PubMed: 29172003] [CrossRef]

Kibby MY, Dyer SM, Vadnais SA, et al. Visual processing in reading disorders and attention-deficit/hyperactivity disorder and its contribution to basic reading ability. Front Psychol. 2015;6:1635. doi: 10.3389/fpsyg.2015.01635. PMID: 26579020. [PMC free article: PMC4621384] [PubMed: 26579020] [CrossRef]

Kibby MY, Lee SE, Dyer SM. Reading performance is predicted by more than phonological processing. Frontiers in Psychology. 2014 2014-September-19;5. doi: 10.3389/fpsyg.2014.00960. [CrossRef]

Kim E, Song J, Kyeong S, et al. Subgroups identification of attention-deficit/hyperactivity disorder in dimensions of symptom severity and intelligence using topological data analysis and their functional network modular organizations. Journal of the American Academy of Child and Adolescent Psychiatry. 2016;55(10):S223. doi: 10.1016/j.jaac.2016.09.376. [CrossRef]

Kim WP, Kim HJ, Pack SP, et al. Machine Learning-Based Prediction of Attention-Deficit/Hyperactivity Disorder and Sleep Problems With Wearable Data in Children. JAMA Netw Open. 2023 Mar 1;6(3):e233502. doi: 10.1001/jamanetworkopen.2023.3502. PMID: 36930149. [PMC free article: PMC10024208] [PubMed: 36930149] [CrossRef]

Klein RG, Abikoff H, Hechtman L, et al. Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2004 Jul;43(7):792–801. doi: 10.1097/01.chi.0000128798.91601.fe. PMID: 15213580. [PubMed: 15213580] [CrossRef]

Kollins S, Greenhill L, Swanson J, et al. Rationale, Design, and Methods of the Preschool ADHD Treatment Study (PATS). Journal of the American Academy of Child and Adolescent Psychiatry. 2006 11/01/;45(11):1275–83. doi: 10.1097/01.chi.0000235074.86919.dc. PMID: EJ754439. [PubMed: 17023869] [CrossRef]

Kratochvil CJ, May DE, Silva SG, et al. Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study. J Child Adolesc Psychopharmacol. 2009 Oct;19(5):519–27. doi: 10.1089/cap.2008.0143. PMID: 19877976. [PMC free article: PMC2830214] [PubMed: 19877976] [CrossRef]

Kurdistan University of Medical Sciences. omega-3 supplement in attention deficit hyperactivity disorder. 2017. https://trialsearch​.who​.int/Trial2.aspx?TrialID​=IRCT2016060128182N2. Accessed on October 12 2022.

Laezer KL, Tischer I, Gaertner B, et al. Expensive Long-Term Psychotherapy vsCost-Effective Combined Behavioral Therapy/Medication Treatment: Comparison of Total Treatment Costs of Children with ADHD and ODD. Gesundheitsokonomie und Qualitatsmanagement. 2015;20(4):178–85. doi: 10.1055/s-0034-1398880. [CrossRef]

Langberg JM, Dvorsky MR, Molitor SJ, et al. Overcoming the research-to-practice gap: A randomized trial with two brief homework and organization interventions for students with ADHD as implemented by school mental health providers. J Consult Clin Psychol. 2018 Jan;86(1):39–55. doi: 10.1037/ccp0000265. PMID: 29172596. [PubMed: 29172596] [CrossRef]

Langberg JM, Evans SW, Schultz BK, et al. Trajectories and predictors of response to the challenging Horizons program for adolescents with ADHD. Behavior Therapy. 2016 May 2016;47(3):339–54. doi: 10.1016/j.beth.2016.01.001. PMID: 27157028. [PMC free article: PMC6548192] [PubMed: 27157028] [CrossRef]

Langberg JM AL, Flowers AM, et al. Parent-reported homework problems in the MTA study: evidence for sustained improvement with behavioral treatment. J Clin Child Adolesc Psychol. 2010;39(2):220–33. [PMC free article: PMC3086047] [PubMed: 20390813]

Lange AM, Daley D, Frydenberg M, et al. The Effectiveness of Parent Training as a Treatment for Preschool Attention-Deficit/Hyperactivity Disorder: Study Protocol for a Randomized Controlled, Multicenter Trial of the New Forest Parenting Program in Everyday Clinical Practice. JMIR Res Protoc. 2016 Apr 13;5(2):e51. doi: 10.2196/resprot.5319. PMID: 27076496. [PMC free article: PMC4848388] [PubMed: 27076496] [CrossRef]

Larsen LB, Daley D, Lange AM, et al. Functional somatic symptoms in preschool attention-deficit/hyperactivity disorder: a secondary analysis of data from a randomized controlled trial of parent training. Eur Child Adolesc Psychiatry. 2022 Jun 24. doi: 10.1007/s00787-022-02025-3. PMID: 35748937. [PubMed: 35748937] [CrossRef]

Larsen LB, Daley D, Lange AM, et al. Effect of Parent Training on Health-Related Quality of Life in Preschool Children With Attention-Deficit/Hyperactivity Disorder: A Secondary Analysis of Data From a Randomized Controlled Trial. J Am Acad Child Adolesc Psychiatry. 2021 Jun;60(6):734–44.e3. doi: 10.1016/j.jaac.2020.04.014. PMID: 32505701. [PubMed: 32505701] [CrossRef]

Lee W, Lee S, Lee D, et al. Deep Learning-Based ADHD and ADHD-RISK Classification Technology through the Recognition of Children’s Abnormal Behaviors during the Robot-Led ADHD Screening Game. Sensors (Basel). 2022 Dec 27;23(1). doi: 10.3390/s23010278. PMID: 36616875. [PMC free article: PMC9824867] [PubMed: 36616875] [CrossRef]

Lim CG, Lee TS, Guan C, et al. A brain-computer interface based attention training program for treating attention deficit hyperactivity disorder. PLoS One. 2012;7(10):e46692. doi: 10.1371/journal.pone.0046692. PMID: 23115630. [PMC free article: PMC3480363] [PubMed: 23115630] [CrossRef]

Lo HH, Wong SY, Wong JY, et al. The effect of a family-based mindfulness intervention on children with attention deficit and hyperactivity symptoms and their parents: design and rationale for a randomized, controlled clinical trial (Study protocol). BMC Psychiatry. 2016 Mar 15;16:65. doi: 10.1186/s12888-016-0773-1. PMID: 26980323. [PMC free article: PMC4791862] [PubMed: 26980323] [CrossRef]

Loo SK, Bilder RM, Cho AL, et al. Effects of d-Methylphenidate, Guanfacine, and Their Combination on Electroencephalogram Resting State Spectral Power in Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2016 Aug;55(8):674–82.e1. doi: 10.1016/j.jaac.2016.04.020. PMID: 27453081. [PMC free article: PMC5003618] [PubMed: 27453081] [CrossRef]

Lopez FA, Ginsberg LD, Arnold V. Effect of lisdexamfetamine dimesylate on parent-rated measures in children aged 6 to 12 years with attention-deficit/hyperactivity disorder: a secondary analysis. Postgrad Med. 2008 Sep;120(3):89–102. doi: 10.3810/pgm.2008.09.1910. PMID: 18824828. [PubMed: 18824828] [CrossRef]

Lu B, Marcus S. Evaluating long-term effects of a psychiatric treatment using instrumental variable and matching approaches. Health Serv Outcomes Res Methodol. 2012 Dec 1;12(4):288–301. doi: 10.1007/s10742-012-0101-2. PMID: 23483774. [PMC free article: PMC3587666] [PubMed: 23483774] [CrossRef]

Mackay Memorial Hospital. Placebo-Controlled Trial With GlyTI-M Among Children With Attention Deficit Hyperactivity Disorder (ADHD). 2012.

Mafi M, Radfar S. High Dimensional Convolutional Neural Network for EEG Connectivity-Based Diagnosis of ADHD. J Biomed Phys Eng. 2022 Dec;12(6):645–54. doi: 10.31661/jbpe.v0i0.2108-1380. PMID: 36569562. [PMC free article: PMC9759645] [PubMed: 36569562] [CrossRef]

Mannuzza S, Klein RG, Truong NL, et al. Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. Am J Psychiatry. 2008 May;165(5):604–9. doi: 10.1176/appi.ajp.2008.07091465. PMID: 18381904. [PMC free article: PMC2967384] [PubMed: 18381904] [CrossRef]

Manor I, Magen A, Keidar D, et al. Safety of phosphatidylserine containing omega3 fatty acids in ADHD children: a double-blind placebo-controlled trial followed by an open-label extension. Eur Psychiatry. 2013 Aug;28(6):386–91. doi: 10.1016/j.eurpsy.2012.11.001. [PubMed: 23312676] [CrossRef]

Månsson AG, Elmose M, Dalsgaard S, et al. The influence of participation in target-shooting sport for children with inattentive, hyperactive and impulsive symptoms - A controlled study of best practice. BMC Psychiatry. 2017 Mar 28;17(1):115. doi: 10.1186/s12888-017-1283-5. PMID: 28351351. [PMC free article: PMC5371218] [PubMed: 28351351] [CrossRef]

March JS, Swanson JM, Arnold LE, et al. Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA). J Abnorm Child Psychol. 2000 Dec;28(6):527–41. doi: 10.1023/a:1005179014321. PMID: 11104315. [PubMed: 11104315] [CrossRef]

Massachusetts General Hospital, Health NIoM. Skills Training for Adolescents With ADHD. 2009.

Matthijssen AM, Dietrich A, Bierens M, et al. Effects of Discontinuing Methylphenidate on Strengths and Difficulties, Quality of Life and Parenting Stress. J Child Adolesc Psychopharmacol. 2020 Apr;30(3):159–65. doi: 10.1089/cap.2019.0147. PMID: 31880479. [PubMed: 31880479] [CrossRef]

Matza LS, Rentz AM, Secnik K, et al. The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder. J Dev Behav Pediatr. 2004 Jun;25(3):166–74. doi: 10.1097/00004703-200406000-00005. PMID: 15194901. [PubMed: 15194901] [CrossRef]

McAuley T, Chen S, Goos L, et al. Is the behavior rating inventory of executive function more strongly associated with measures of impairment or executive function? J Int Neuropsychol Soc. 2010 May;16(3):495–505. doi: 10.1017/s1355617710000093. PMID: 20188014. [PubMed: 20188014] [CrossRef]

McBurnett K, Clemow D, Williams D, et al. Atomoxetine-Related Change in Sluggish Cognitive Tempo Is Partially Independent of Change in Attention-Deficit/Hyperactivity Disorder Inattentive Symptoms. J Child Adolesc Psychopharmacol. 2017 Feb;27(1):38–42. doi: 10.1089/cap.2016.0115. PMID: 27845858. [PubMed: 27845858] [CrossRef]

McGonnell M, Corkum P, McKinnon M, et al. Doing it right: an interdisciplinary model for the diagnosis of ADHD. J Can Acad Child Adolesc Psychiatry. 2009 Nov;18(4):283–6. PMID: 19881936. [PMC free article: PMC2765379] [PubMed: 19881936]

McNorgan C, Judson C, Handzlik D, et al. Linking ADHD and Behavioral Assessment Through Identification of Shared Diagnostic Task-Based Functional Connections. Frontiers in Physiology. 2020;11. doi: 10.3389/fphys.2020.583005. [CrossRef]

Mehri M, Chehrzad MM, Maleki M, et al. The effect of behavioral parent training of children with attention deficit hyperactivity disorder on parents’ mental health. Neurology Psychiatry and Brain Research. 2020;37:53–9. doi: 10.1016/j.npbr.2020.06.003. [CrossRef]

Mendes SL, Pinaya WHL, Pan P, et al. Estimating Gender and Age from Brain Structural MRI of Children and Adolescents: A 3D Convolutional Neural Network Multitask Learning Model. Comput Intell Neurosci. 2021;2021:5550914. doi: 10.1155/2021/5550914. PMID: 34122531. [PMC free article: PMC8172319] [PubMed: 34122531] [CrossRef]

Mensia Technologies SA, Instrument EUHS. Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity Disorder. 2016.

Meppelink R, de Bruin EI, Bögels SM. Meditation or Medication? Mindfulness training versus medication in the treatment of childhood ADHD: a randomized controlled trial. BMC Psychiatry. 2016 Jul 26;16:267. doi: 10.1186/s12888-016-0978-3. PMID: 27460004. [PMC free article: PMC4962453] [PubMed: 27460004] [CrossRef]

Meyer J, Zetterqvist V, Unenge Hallerbäck M, et al. Moderators of long-term treatment outcome when comparing two group interventions for adolescents with ADHD: who benefits more from DBT-based skills training? BMC Psychiatry. 2022 Dec 6;22(1):767. doi: 10.1186/s12888-022-04435-8. PMID: 36474201. [PMC free article: PMC9724371] [PubMed: 36474201] [CrossRef]

Miao B, Zhang LL, Guan JL, et al. Classification of ADHD Individuals and Neurotypicals Using Reliable RELIEF: A Resting-State Study. IEEE Access. 2019;7:62163–71. doi: 10.1109/ACCESS.2019.2915988. [CrossRef]

Michelini G, Lenartowicz A, Diaz-Fong JP, et al. Methylphenidate, Guanfacine, and Combined Treatment Effects on Electroencephalography Correlates of Spatial Working Memory in Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2023 Jan;62(1):37–47. doi: 10.1016/j.jaac.2022.06.017. PMID: 35963558. [PMC free article: PMC10829974] [PubMed: 35963558] [CrossRef]

Michelini G, Lenartowicz A, Vera JD, et al. Electrophysiological and Clinical Predictors of Methylphenidate, Guanfacine, and Combined Treatment Outcomes in Children With Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2022 Aug 10. doi: 10.1016/j.jaac.2022.08.001. PMID: 35963559. [PMC free article: PMC9911553] [PubMed: 35963559] [CrossRef]

Michelson D, Buitelaar JK, Danckaerts M, et al. Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry. 2004 Jul;43(7):896–904. doi: 10.1097/01.chi.0000125089.35109.81. PMID: 15213591. [PubMed: 15213591] [CrossRef]

Mikami AY, Hinshaw SP, Arnold LE, et al. Bulimia nervosa symptoms in the multimodal treatment study of children with ADHD. Int J Eat Disord. 2010 Apr;43(3):248–59. doi: 10.1002/eat.20692. PMID: 19378318. [PubMed: 19378318] [CrossRef]

Mikami AY, Normand S, Hudec KL, et al. Treatment of friendship problems in children with attention-deficit/hyperactivity disorder: Initial results from a randomized clinical trial. J Consult Clin Psychol. 2020 Oct;88(10):871–85. doi: 10.1037/ccp0000607. PMID: 33048569. [PubMed: 33048569] [CrossRef]

Mitchell JT, Howard AL, Belendiuk KA, et al. Cigarette Smoking Progression Among Young Adults Diagnosed With ADHD in Childhood: A 16-year Longitudinal Study of Children With and Without ADHD. Nicotine Tob Res. 2019 Apr 17;21(5):638–47. doi: 10.1093/ntr/nty045. PMID: 29538764. [PMC free article: PMC6468128] [PubMed: 29538764] [CrossRef]

Mitchell JT, Weisner TS, Jensen PS, et al. How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning. J Atten Disord. 2018 Jul;22(9_suppl):49s–60s. doi: 10.1177/1087054716685842. PMID: 28166690. [PMC free article: PMC5538943] [PubMed: 28166690] [CrossRef]

Mizuno Y, Jung M, Fujisawa T, et al. Structural classification feature in children with ADHD using machine learning approach. No To Hattatsu. 2019;51:S223. doi: 10.11251/ojjscn.51.S1. [CrossRef]

Mohammadi MR, Khaleghi A, Nasrabadi AM, et al. EEG classification of ADHD and normal children using non-linear features and neural network. Biomedical Engineering Letters. 2016;6(2):66–73. doi: 10.1007/s13534-016-0218-2. [CrossRef]

Mohr-Jensen C, Müller Bisgaard C, Boldsen SK, et al. Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence and the Risk of Crime in Young Adulthood in a Danish Nationwide Study. J Am Acad Child Adolesc Psychiatry. 2019 Apr;58(4):443–52. doi: 10.1016/j.jaac.2018.11.016. PMID: 30768385. [PubMed: 30768385] [CrossRef]

Molina BS, Hinshaw SP, Eugene Arnold L, et al. Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry. 2013 Mar;52(3):250–63. doi: 10.1016/j.jaac.2012.12.014. PMID: 23452682. [PMC free article: PMC3589108] [PubMed: 23452682] [CrossRef]

Molina BS, Pelham WE, Gnagy EM, et al. Attention-deficit/hyperactivity disorder risk for heavy drinking and alcohol use disorder is age specific. Alcohol Clin Exp Res. 2007 Apr;31(4):643–54. doi: 10.1111/j.1530-0277.2007.00349.x. PMID: 17374044. [PMC free article: PMC2680082] [PubMed: 17374044] [CrossRef]

Molina BSG, Flory K, Hinshaw SP, et al. Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):1028–40. doi: 10.1097/chi.0b013e3180686d96. PMID: 17667481. [PubMed: 17667481] [CrossRef]

Molina BSG, Hinshaw SP, Swanson JW, et al. The MTA at 8 Years: Prospective Follow-Up of Children Treated for Combined-Type ADHD in a Multisite Study. Journal of the American Academy of Child & Adolescent Psychiatry. 2009 05/01/;48(5):484–500. doi: 10.1097/CHI.0b013e31819c23d0. PMID: 19318991. [PMC free article: PMC3063150] [PubMed: 19318991] [CrossRef]

Molina BSG, Howard AL, Swanson JM, et al. Substance use through adolescence into early adulthood after childhood-diagnosed ADHD: findings from the MTA longitudinal study. J Child Psychol Psychiatry. 2018 Jun;59(6):692–702. doi: 10.1111/jcpp.12855. PMID: 29315559. [PMC free article: PMC5985671] [PubMed: 29315559] [CrossRef]

Molina BSG, Howard AL, Swanson JM, et al. “Substance use through adolescence into early adulthood after childhood-diagnosed ADHD: Findings from the MTA longitudinal study”: Erratum. Journal of Child Psychology and Psychiatry. 2018 Nov 2018 2018-11-08;59(11):e1–e4. doi: 10.1111/jcpp.12970. PMID: 2130900386; 2018-53193-001. [CrossRef]

Morgan JE, Dvorsky MR, Meza JI, et al. Co-Occurring Psychopathology Moderates Social Skills Improvement in a Randomized Controlled Trial of a Collaborative School-Home Intervention for Children with ADHD. J Clin Child Adolesc Psychol. 2020 Sep 15:1–13. doi: 10.1080/15374416.2020.1815206. PMID: 32930610. [PMC free article: PMC7956906] [PubMed: 32930610] [CrossRef]

MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999 Dec;56(12):1073–86. doi: 10.1001/archpsyc.56.12.1073. PMID: 10591283. [PubMed: 10591283] [CrossRef]

MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999 Dec;56(12):1088–96. doi: 10.1001/archpsyc.56.12.1088. PMID: 10591284. [PubMed: 10591284] [CrossRef]

MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics. 2004 Apr;113(4):754–61. doi: 10.1542/peds.113.4.754. PMID: 15060224. [PubMed: 15060224] [CrossRef]

MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics. 2004 Apr;113(4):762–9. doi: 10.1542/peds.113.4.762. PMID: 15060225. [PubMed: 15060225] [CrossRef]

Murdoch Children’s Research Institute (Australia). Sleeping Sound with Attention deficit hyperactivity disorder (ADHD). 2014. https://www​.isrctn.com​/ISRCTN50834814?q=ISRCTN50834814&filters​=&sort​=&offset​=1&totalResults​=1&page=1&pageSize=10. Accessed on October 11 2022.

Murdoch Childrens Research Institute (MCRI) (Australia). Can a sleep intervention improve outcomes for children with attention-deficit hyperactivity disorder (ADHD)? ; 2010. https://www​.isrctn.com​/ISRCTN68819261?q=ISRCTN68819261&filters​=&sort​=&offset​=2&totalResults​=2&page=1&pageSize=10. Accessed on October 11 2022.

Myers K, Vander Stoep A, Lobdell C. Feasibility of conducting a randomized controlled trial of telemental health with children diagnosed with attention-deficit/hyperactivity disorder in underserved communities. J Child Adolesc Psychopharmacol. 2013 Aug;23(6):372–8. doi: 10.1089/cap.2013.0020. PMID: 23952183. [PMC free article: PMC3749708] [PubMed: 23952183] [CrossRef]

Nagy P, Häge A, Coghill DR, et al. Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate. Eur Child Adolesc Psychiatry. 2016 Feb;25(2):141–9. doi: 10.1007/s00787-015-0718-0. PMID: 25999292. [PMC free article: PMC4735245] [PubMed: 25999292] [CrossRef]

National Brain Mapping Lab. First National EEG Data Analysis Competition with Clinical Application. 2019. https://nbml​.ir/en/scientific-tournament​/First-Iranian-EEG-competition. Accessed on October 10 2022.

National Center for Complementary Integrative Health. Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD). 2005.

National Healthcare Group Singapore D-NGMS, Agency for Science Technology Research, Singapore Clinical Research Institute. Brain-Computer Interface (BCI) Based Intervention for Attention Deficit Hyperactivity Disorder (ADHD). 2011.

National Institute of Mental Health. Treatment of Severe Childhood Aggression (The TOSCA Study). 2008.

National Taiwan University Hospital, National Science Council T. Pharmacogenetic Studies on Attention Deficit Hyperactivity Disorder. 2009.

Nebraska Uo, Health NIoM. Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children. 2005.

Nejati V. Cognitive rehabilitation in children with attention deficit- hyperactivity disorder: Transferability to untrained cognitive domains and behavior. Asian J Psychiatr. 2020 Mar;49:101949. doi: 10.1016/j.ajp.2020.101949. PMID: 32114377. [PubMed: 32114377] [CrossRef]

New York State Psychiatric Institute, National Institute of Mental Health. Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS). 2001.

Newcorn JH, Halperin JM, Jensen PS, et al. Symptom profiles in children with ADHD: effects of comorbidity and gender. J Am Acad Child Adolesc Psychiatry. 2001 Feb;40(2):137–46. doi: 10.1097/00004583-200102000-00008. PMID: 11214601. [PubMed: 11214601] [CrossRef]

Newcorn JH, Michelson D, Kratochvil CJ, et al. Low-dose atomoxetine for maintenance treatment of attention-deficit/hyperactivity disorder. Pediatrics. 2006 Dec;118(6):e1701–6. doi: 10.1542/peds.2005-2999. PMID: 17101710. [PubMed: 17101710] [CrossRef]

Newcorn JH, Stein MA, Childress AC, et al. Randomized, double-blind trial of guanfacine extended release in children with attention-deficit/hyperactivity disorder: morning or evening administration. J Am Acad Child Adolesc Psychiatry. 2013 Sep;52(9):921–30. doi: 10.1016/j.jaac.2013.06.006. PMID: 23972694. [PubMed: 23972694] [CrossRef]

Newcorn JH, Stein MA, Cooper KM. Dose-response characteristics in adolescents with attention-deficit/hyperactivity disorder treated with OROS methylphenidate in a 4-week, open-label, dose-titration study. J Child Adolesc Psychopharmacol. 2010 Jun;20(3):187–96. doi: 10.1089/cap.2009.0102. PMID: 20578931. [PubMed: 20578931] [CrossRef]

Nguyen RD, Smyth M, Zhu L, et al. Convolutional neural networks classification of pediatric refractory epilepsy with RsMRI latency imaging. Journal of Neurosurgery. 2019;131(1):38. doi: 10.3171/2019.7.JNS.AANS2019abstracts. [CrossRef]

Nieweg EH. [Does ADHD medication stop working after 2-3 years? On the surprising, but little-known follow-up of the MTA study]. Tijdschr Psychiatr. 2010;52(4):245–54. PMID: 20503165. [PubMed: 20503165]

Nobel E, Hoekstra PJ, Brunnekreef JA, et al. Correction to: Home-based parent training for school-aged children with attention-deficit/hyperactivity disorder and behavior problems with remaining impairing disruptive behaviors after routine treatment: a randomized controlled trial. Eur Child Adolesc Psychiatry. 2022 Oct 31. doi: 10.1007/s00787-022-02102-7. PMID: 36315259. [PubMed: 36315259] [CrossRef]

Noven Therapeutics. Safety and Efficacy of MTS Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHD. 2004.

Noven Therapeutics NP, Inc.,. Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD. 2005.

Nutrition and Food security research center SSUoMS, Yazd, Iran,. The effect of the DASH diet on the severity of attention deficit and hyperactivity disorder (ADHD) symptoms in children. 2018. https://en​.irct.ir/trial/12623. Accessed on October 6 2022.

NYU Langone Health. Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA). 1998.

NYU Langone Health. Parent Training for Attention Deficit Hyperactivity Disorder (ADHD) Preschoolers. 2007.

Ohio State University, Health NIoM, Carolina UoN. Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD. 2014.

Ohio University, University L. Multisite Study of High School-based Treatment for Adolescents With ADHD. 2015.

Oregon Health Science University, University OS, Lethbridge Uo, et al. Micronutrients for ADHD in Youth (MADDY) Study. 2018.

Ortho-McNeil Janssen Scientific Affairs LLC. Lab School Day Study for CONCERTA of Older Children With ADHD. 2008.

Owens EB, Hinshaw SP, Kraemer HC, et al. Which treatment for whom for ADHD? Moderators of treatment response in the MTA. J Consult Clin Psychol. 2003 Jun;71(3):540–52. doi: 10.1037/0022-006x.71.3.540. PMID: 12795577. [PubMed: 12795577] [CrossRef]

Padmavathy TV, Vinothkumar M, Vimal Kumar MN. Modified cuckoo search-cascade forest (Mcs-cf) for attention deficit hyperactivity disorder (adhd) diagnosis. NeuroQuantology. 2020;18(7):83–94. doi: 10.14704/nq.2020.18.7.NQ20196. [CrossRef]

Pagani LS, Harbec M-J, Fortin G, et al. Childhood exercise as medicine: Extracurricular sport diminishes subsequent ADHD symptoms. Preventive Medicine: An International Journal Devoted to Practice and Theory. 2020 Dec 2020;141.

Palumbo DR, Sallee FR, Pelham WE, Jr., et al. Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. J Am Acad Child Adolesc Psychiatry. 2008 Feb;47(2):180–8. doi: 10.1097/chi.0b013e31815d9af7. PMID: 18182963. [PubMed: 18182963] [CrossRef]

Papadopulos E, Jensen PS, Chait AR, et al. Medication Adherence in the MTA: Saliva Methylphenidate Sample versus Parent Report and Mediating Effect of Concomitant Behavior Treatment. Journal of the American Academy of Child & Adolescent Psychiatry. 2009 05/01/;48(5):501–M. PMID: EJ846168. [PubMed: 19307987]

Pardoe HR, Kucharsky Hiess R, Kuzniecky R. Motion and morphometry in clinical and nonclinical populations. Neuroimage. 2016 Jul 15;135:177–85. doi: 10.1016/j.neuroimage.2016.05.005. PMID: 27153982. [PubMed: 27153982] [CrossRef]

Paulo UoS, Tecnológico CNdDCe. Early Interventions in Children With Attention Deficit/Hyperactivity Disorder. 2016.

Peking University. Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) Children. 2008.

Pelham WE, Jr. The NIMH multimodal treatment study for attention-deficit hyperactivity disorder: just say yes to drugs alone? Can J Psychiatry. 1999 Dec;44(10):981–90. doi: 10.1177/070674379904401004. PMID: 10637677. [PubMed: 10637677] [CrossRef]

Pelsser L, Stobernack T, Frankena K. Physical Complaints Decrease after Following a Few-Foods Diet in Children with ADHD. Nutrients. 2022 Jul 24;14(15). doi: 10.3390/nu14153036. PMID: 35893890. [PMC free article: PMC9332265] [PubMed: 35893890] [CrossRef]

Perez Algorta G, MacPherson HA, Arnold LE, et al. Maternal personality traits moderate treatment response in the Multimodal Treatment Study of attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry. 2020 Nov;29(11):1513–24. doi: 10.1007/s00787-019-01460-z. PMID: 31863182. [PMC free article: PMC7596006] [PubMed: 31863182] [CrossRef]

Perkins ER, Joyner KJ, Foell J, et al. Assessing general versus specific liability for externalizing problems in adolescence: Concurrent and prospective prediction of symptoms of conduct disorder, ADHD, and substance use. J Psychopathol Clin Sci. 2022 Oct;131(7):793–807. doi: 10.1037/abn0000743. PMID: 36222627. [PMC free article: PMC9710196] [PubMed: 36222627] [CrossRef]

Peterson BS. Form determines function: new methods for identifying the neuroanatomical loci of circuit-based disturbances in childhood disorders. J Am Acad Child Adolesc Psychiatry. 2010 Jun;49(6):533–8. doi: 10.1016/j.jaac.2010.03.010. PMID: 20494263. [PMC free article: PMC2891511] [PubMed: 20494263] [CrossRef]

Pharmaceuticals NR, Shire. Phase 3 Randomized Double-Blind Placebo-Controlled Study of NRP104 in Children Aged 6-12 With ADHD. 2004.

Plessen KJ, Bansal R, Zhu H, et al. Hippocampus and amygdala morphology in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2006 Jul;63(7):795–807. doi: 10.1001/archpsyc.63.7.795. PMID: 16818869. [PMC free article: PMC2367150] [PubMed: 16818869] [CrossRef]

Qi S, Schumann G, Bustillo J, et al. Reward Processing in Novelty Seekers: A Transdiagnostic Psychiatric Imaging Biomarker. Biol Psychiatry. 2021 Jan 30;90(8):529–39. doi: 10.1016/j.biopsych.2021.01.011. PMID: 33875230. [PMC free article: PMC8322149] [PubMed: 33875230] [CrossRef]

Qiu H, Liang X. Change in Sleep Latency as a Mediator of the Effect of Physical Activity Intervention on Executive Functions Among Children with ADHD: A Secondary Analysis from a Randomized Controlled Trial. J Autism Dev Disord. 2023 May 31. doi: 10.1007/s10803-023-06018-2. PMID: 37256478. [PubMed: 37256478] [CrossRef]

Quinn PO, Rapoport JL. One-year follow-up of hyperactive boys treated with imipramine or methylphenidate. Am J Psychiatry. 1975 Mar;132(3):241–5. doi: 10.1176/ajp.132.3.241. PMID: 1090193. [PubMed: 1090193] [CrossRef]

Qureshi MN, Min B, Jo HJ, et al. Multiclass Classification for the Differential Diagnosis on the ADHD Subtypes Using Recursive Feature Elimination and Hierarchical Extreme Learning Machine: Structural MRI Study. PLoS One. 2016;11(8):e0160697. doi: 10.1371/journal.pone.0160697. PMID: 27500640. [PMC free article: PMC4976974] [PubMed: 27500640] [CrossRef]

Qureshi MNI, Oh J, Min B, et al. Multi-modal, Multi-measure, and Multi-class Discrimination of ADHD with Hierarchical Feature Extraction and Extreme Learning Machine Using Structural and Functional Brain MRI. Front Hum Neurosci. 2017;11:157. doi: 10.3389/fnhum.2017.00157. PMID: 28420972. [PMC free article: PMC5378777] [PubMed: 28420972] [CrossRef]

Raine A, Ang RP, Choy O, et al. Omega-3 (omega-3) and social skills interventions for reactive aggression and childhood externalizing behavior problems: a randomized, stratified, double-blind, placebo-controlled, factorial trial. Psychol Med. 2019 Jan;49(2):335–44. doi: 10.1017/S0033291718000983. PMID: 29743128. [PubMed: 29743128] [CrossRef]

Reed MO, Jakubovski E, Johnson JA, et al. Predictors of Long-Term School-Based Behavioral Outcomes in the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2017 May;27(4):296–309. doi: 10.1089/cap.2015.0168. PMID: 28253029. [PMC free article: PMC5439457] [PubMed: 28253029] [CrossRef]

Reeves G, Anthony B. Multimodal treatments versus pharmacotherapy alone in children with psychiatric disorders: implications of access, effectiveness, and contextual treatment. Paediatr Drugs. 2009;11(3):165–9. doi: 10.2165/00148581-200911030-00002. PMID: 19445545. [PMC free article: PMC5312750] [PubMed: 19445545] [CrossRef]

Region Syddanmark. Cognitive Training in Children With Attention Deficit/ Hyperactivity Disorder (ADHD). 2013.

Region Zealand, Hospital ZU, Copenhagen Trial Unit CfCIR, et al. Social Skills Training and Standard Treatment Versus Standard Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD). 2009.

Research Institute for Islamic and Complementary Medicine. Comparison of efficacy of auricular acupuncture with a control group in childhood with Attention-deficit/hyperactivity disorder. 2019. https://en​.irct.ir/trial/41872. Accessed on October 6 2022.

Rezaei M, Zare H, Hakimdavoodi H, et al. Classification of drug-naive children with attention-deficit/hyperactivity disorder from typical development controls using resting-state fMRI and graph theoretical approach. Frontiers in Human Neuroscience. 2022;16. doi: 10.3389/fnhum.2022.948706. [CrossRef]

Rhodes Pharmaceuticals LP. PRC-063 in Adolescent ADHD. 2014. https://clinicaltrials.gov/ct2/show/NCT02139111?term=NCT02139111&draw=2&rank=1. Accessed on October 11 2022.

Rhodes Pharmaceuticals LP. Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD. 2014. https://clinicaltrials.gov/ct2/show/NCT02168127?term=NCT02168127&draw=2&rank=1. Accessed on October 11 2022.

Riaz A, Alonso E, Slabaugh G. Phenotypic Integrated Framework for Classification of ADHD Using fMRI; 2016.

Riaz A, Asad M, Alonso E, et al. Fusion of fMRI and non-imaging data for ADHD classification. Comput Med Imaging Graph. 2018 Apr;65:115–28. doi: 10.1016/j.compmedimag.2017.10.002. PMID: 29137838. [PubMed: 29137838] [CrossRef]

Deep fMRI: AN end-to-end deep network for classification of fMRI data. 2018 IEEE 15th International Symposium on Biomedical Imaging (ISBI 2018); 2018 4-7 April 2018.

Richters JE, Arnold LE, Jensen PS, et al. NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale. J Am Acad Child Adolesc Psychiatry. 1995 Aug;34(8):987–1000. doi: 10.1097/00004583-199508000-00008. PMID: 7665456. [PubMed: 7665456] [CrossRef]

Ricketts EJ, Sturm A, McMakin DL, et al. Changes in Sleep Problems Across Attention-Deficit/Hyperactivity Disorder Treatment: Findings from the Multimodal Treatment of Attention-Deficit/Hyperactivity Disorder Study. J Child Adolesc Psychopharmacol. 2018 Dec;28(10):690–8. doi: 10.1089/cap.2018.0038. PMID: 30388029. [PMC free article: PMC7364298] [PubMed: 30388029] [CrossRef]

Riddle MA, Yershova K, Lazzaretto D, et al. The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up. J Am Acad Child Adolesc Psychiatry. 2013 Mar;52(3):264–78.e2. doi: 10.1016/j.jaac.2012.12.007. PMID: 23452683. [PMC free article: PMC3660093] [PubMed: 23452683] [CrossRef]

Rockhill CM, Carlisle LL, Qu P, et al. Primary Care Management of Children with Attention-Deficit/Hyperactivity Disorder Appears More Assertive Following Brief Psychiatric Intervention Compared with Single Session Consultation. J Child Adolesc Psychopharmacol. 2020 Jun;30(5):285–92. doi: 10.1089/cap.2020.0013. PMID: 32167784. [PMC free article: PMC7310318] [PubMed: 32167784] [CrossRef]

Rockhill CM, Tse YJ, Fesinmeyer MD, et al. Telepsychiatrists’ Medication Treatment Strategies in the Children’s Attention-Deficit/Hyperactivity Disorder Telemental Health Treatment Study. J Child Adolesc Psychopharmacol. 2016 Oct;26(8):662–71. doi: 10.1089/cap.2015.0017. PMID: 26258927. [PMC free article: PMC5069727] [PubMed: 26258927] [CrossRef]

Roger deBeus P, Cowley B, Ptukha A, et al. 30.1 EEG Learning Parameters in the ICAN Double-Blind RCT of Neurofeedback for ADHD. Journal of the American Academy of Child and Adolescent Psychiatry. 2022;61(10):S322. doi: 10.1016/j.jaac.2022.07.721. [CrossRef]

Rojas-Líbano D, Wainstein G, Carrasco X, et al. A pupil size, eye-tracking and neuropsychological dataset from ADHD children during a cognitive task. Sci Data. 2019 Apr 11;6(1):25. doi: 10.1038/s41597-019-0037-2. PMID: 30975993. [PMC free article: PMC6472382] [PubMed: 30975993] [CrossRef]

Roley-Roberts ME, Pan X, Bergman R, et al. For Which Children with ADHD is TBR Neurofeedback Effective? Comorbidity as a Moderator. Appl Psychophysiol Biofeedback. 2022 Dec 16. doi: 10.1007/s10484-022-09575-x. PMID: 36526924. [PubMed: 36526924] [CrossRef]

Rooney M, Hinshaw S, McBurnett K, et al. Parent Adherence in Two Behavioral Treatment Strategies for the Predominantly Inattentive Presentation of ADHD. J Clin Child Adolesc Psychol. 2018;47(sup1):S233–s41. doi: 10.1080/15374416.2016.1236341. PMID: 27808556. [PubMed: 27808556] [CrossRef]

Roozbeh Psychiatric Hospital TUoMS. Ginkgo biloba in the treatment of ADHD in child and adolescent: a randomized clinical trial. 2009. https://en​.irct.ir/trial/856. Accessed on October 6 2022.

Roozbeh Psychiatric Hospital TUoMS. Comparing the efficacy of Resveratrol and Ritalin with Ritaline pelacebo in treating children with ADHD in a randomized double-blinded clinical trial. 2018. https://en​.irct.ir/trial/35596. Accessed on October 6 2022.

Roozbeh Psychiatric Hospital TUoMS. Tipeptidine as adjuvant therapy in children with ADHD: A double blind and randomised trial. 2018. https://en​.irct.ir/trial/30360. Accessed on October 6 2022.

Rosenau PT, Openneer TJC, Matthijssen AM, et al. Effects of methylphenidate on executive functioning in children and adolescents with ADHD after long-term use: a randomized, placebo-controlled discontinuation study. J Child Psychol Psychiatry. 2021 Mar 28. doi: 10.1111/jcpp.13419. PMID: 33778945. [PMC free article: PMC9292145] [PubMed: 33778945] [CrossRef]

Roy A, Garner AA, Epstein JN, et al. Effects of Childhood and Adult Persistent Attention-Deficit/Hyperactivity Disorder on Risk of Motor Vehicle Crashes: Results From the Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2020 Aug;59(8):952–63. doi: 10.1016/j.jaac.2019.08.007. PMID: 31445873. [PMC free article: PMC9747063] [PubMed: 31445873] [CrossRef]

Roy A, Hechtman L, Arnold LE, et al. Childhood Predictors of Adult Functional Outcomes in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder (MTA). J Am Acad Child Adolesc Psychiatry. 2017 Aug;56(8):687–95.e7. doi: 10.1016/j.jaac.2017.05.020. PMID: 28735698. [PMC free article: PMC5555165] [PubMed: 28735698] [CrossRef]

Rucklidge JJ, Eggleston MJF, Darling KA, et al. Can we predict treatment response in children with ADHD to a vitamin-mineral supplement? An investigation into pre-treatment nutrient serum levels, MTHFR status, clinical correlates and demographic variables. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:181–92. doi: 10.1016/j.pnpbp.2018.09.007. PMID: 30217770. [PubMed: 30217770] [CrossRef]

Sanofi. Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia. 2006.

Sayer GR, McGough JJ, Levitt J, et al. Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2016 Dec;26(10):882–8. doi: 10.1089/cap.2015.0264. PMID: 27483130. [PMC free article: PMC5178010] [PubMed: 27483130] [CrossRef]

Saylor K, Williams DW, Schuh KJ, et al. Effects of atomoxetine on self-reported high-risk behaviors and health-related quality of life in adolescents with ADHD. Curr Med Res Opin. 2010 Sep;26(9):2087–95. doi: 10.1185/03007995.2010.493747. PMID: 20642391. [PubMed: 20642391] [CrossRef]

Schachar R, Chen S, Crosbie J, et al. Comparison of the predictive validity of hyperkinetic disorder and attention deficit hyperactivity disorder. Journal of the Canadian Academy of Child and Adolescent Psychiatry. 2007;16(2):90–100. [PMC free article: PMC2242647] [PubMed: 18392157]

Scholte EM, van Berckelaer-Onnes IA, van der Ploeg JD. DSM-IV related ADHD symptom ratings by professional caretakers in residential treatment centres. J Child Psychol Psychiatry. 2001 Mar;42(3):341–6. PMID: 11321203. [PubMed: 11321203]

School of Public Health SJTU. Effect of the intervention combining medicine and education on school-age children with attention deficit hyperactivity disorder. 2018. https://www​.chictr.org​.cn/hvshowproject.aspx?id=12683. Accessed on October 12 2022.

Schuck SEB, Johnson HL, Abdullah MM, et al. The Role of Animal Assisted Intervention on Improving Self-Esteem in Children With Attention Deficit/Hyperactivity Disorder. Front Pediatr. 2018;6:300. doi: 10.3389/fped.2018.00300. PMID: 30450352. [PMC free article: PMC6224337] [PubMed: 30450352] [CrossRef]

Schultz BK, Evans SW, Langberg JM, et al. Outcomes for adolescents who comply with long-term psychosocial treatment for ADHD. J Consult Clin Psychol. 2017 Mar;85(3):250–61. doi: 10.1037/ccp0000172. PMID: 28221060. [PMC free article: PMC5321617] [PubMed: 28221060] [CrossRef]

Sciberras E, Efron D, Gerner B, et al. Study protocol: the sleeping sound with attention-deficit/hyperactivity disorder project. BMC Pediatr. 2010 Dec 30;10:101. doi: 10.1186/1471-2431-10-101. PMID: 21192797. [PMC free article: PMC3022790] [PubMed: 21192797] [CrossRef]

Sciberras E, Mulraney M, Hayes N, et al. A brief clinician training program to manage sleep problems in ADHD: what works and what do clinicians and parents think? Sleep Med. 2021 Apr 20;89:185–92. doi: 10.1016/j.sleep.2021.04.007. PMID: 34001454. [PubMed: 34001454] [CrossRef]

Seattle Children’s Hospital, Washington Uo. Children’s Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study. 2009.

Sen B, Borle NC, Greiner R, et al. A general prediction model for the detection of ADHD and Autism using structural and functional MRI. PLoS One. 2018;13(4):e0194856. doi: 10.1371/journal.pone.0194856. PMID: 29664902. [PMC free article: PMC5903601] [PubMed: 29664902] [CrossRef]

Seoul National University Childrens Hospital. Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers. 2012.

Setyawan J, Yang H, Cheng D, et al. Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit/Hyperactivity Disorder. Value Health. 2015 Sep;18(6):824–31. doi: 10.1016/j.jval.2015.06.005. PMID: 26409610. [PubMed: 26409610] [CrossRef]

Shah MN, Nguyen RD, Pao LP, et al. Role of resting state MRI temporal latency in refractory pediatric extratemporal epilepsy lateralization. J Magn Reson Imaging. 2019 May;49(5):1347–55. doi: 10.1002/jmri.26320. PMID: 30350326. [PubMed: 30350326] [CrossRef]

Shahid Sadoughi University of Medical Sciences Y, Iran,. Clinical trial of efficacy evaluation of omega-3 capsule with risperidone and risperidone alone on improvement of hyperactivity and inattention symptoms and decrease of monthly frequency of seizure of children with attention-deficit/hyperactivity disorder (ADHD) and refractory epilepsy. 2016. https://en​.irct.ir/trial/2450. Accessed on October 6 2022.

Shang CY, Pan YL, Lin HY, et al. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2015 Sep;25(7):566–73. doi: 10.1089/cap.2015.0035. PMID: 26222447. [PubMed: 26222447] [CrossRef]

Shanghai Children’s Hospital. Intervention study of group executive function training combined with online parent training on children with attention deficit hyperactivity disorder 2021. https://www​.chictr.org​.cn/com/25/hvshowproject​.aspx?id=106593. Accessed on October 12 2022.

Shelton TL BR, Crosswait C, et al. Multimethod psychoeducational intervention for preschool children with disruptive behavior: two-year post-treatment follow-up. J Abnorm Child Psychol. 2000 Jun;28(3):253–66. doi: 10.1023/a:1005144304071. PMID: 10885683. [PubMed: 10885683] [CrossRef]

Shemmassian SK, Lee SS. Comparing four methods of integrating parent and teacher symptom ratings of attention-deficit/hyperactivity disorder (ADHD). Journal of Psychopathology and Behavioral Assessment. 2012;34:1–10. doi: 10.1007/s10862-011-9262-5. [CrossRef]

Shih HH, Shang CY, Gau SS. Comparative Efficacy of Methylphenidate and Atomoxetine on Emotional and Behavioral Problems in Youths with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2019 Feb;29(1):9–19. doi: 10.1089/cap.2018.0076. PMID: 30457349. [PubMed: 30457349] [CrossRef]

Shire. Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD). 2011.

Shire. Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder. 2012.

Shire, Takeda. Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD). 2003.

Shire, Takeda. SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms. 2006.

Shire, Takeda. Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD). 2008.

Shire, Takeda. Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17. 2008.

Shire, Takeda. Efficacy and Safety of SPD503 in Combination With Psychostimulants. 2008.

Shire, Takeda. Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17. 2009.

Shire, Takeda. Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate. 2010.

Shire, Takeda. Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD). 2015.

Shire, Takeda. Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD). 2017.

Shire T. Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17. 2003.

Shire T. Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17. 2004.

Shire T. Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17. 2005.

Shire T. Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study). 2009.

Shire T. Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD). 2010.

Shire T. Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl. 2011.

Shire T. Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years. 2017.

Sho’ouri N. Detection of ADHD From EOG Signals Using Approximate Entropy and Petrosain’s Fractal Dimension. J Med Signals Sens. 2022 Jul–Sep;12(3):254–62. doi: 10.4103/jmss.jmss_119_21. PMID: 36120401. [PMC free article: PMC9480511] [PubMed: 36120401] [CrossRef]

Sibley MH, Arnold LE, Swanson JM, et al. Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD. Am J Psychiatry. 2021 Aug 13;179(2):appiajp202121010032. doi: 10.1176/appi.ajp.2021.21010032. PMID: 34384227. [PMC free article: PMC8810708] [PubMed: 34384227] [CrossRef]

Sibley MH, Bickman L, Coxe SJ, et al. Community Implementation of MI-Enhanced Behavior Therapy for Adolescent ADHD: Linking Fidelity to Effectiveness. Behav Ther. 2021 Jul;52(4):847–60. doi: 10.1016/j.beth.2020.10.007. PMID: 34134825. [PMC free article: PMC8217725] [PubMed: 34134825] [CrossRef]

Sibley MH, Campez M, Raiker JS. Reexamining ADHD-related self-reporting problems using polynomial regression. Assessment. 2019 Mar 2019;26(2):305–14. doi: 10.1177/1073191117693349. PMID: 28201923. [PubMed: 28201923] [CrossRef]

Sibley MH, Coxe SJ. The ADHD teen integrative data analysis longitudinal (TIDAL) dataset: Background, methodology, and aims. BMC Psychiatry. 2020 Jul 8, 2020;20(1):359. doi: 10.1186/s12888-020-02734-6. PMID: 32641087. [PMC free article: PMC7346648] [PubMed: 32641087] [CrossRef]

Sibley MH, Coxe SJ, Page TF, et al. Four-Year Follow-Up of High versus Low Intensity Summer Treatment for Adolescents with ADHD. J Clin Child Adolesc Psychol. 2020 Nov 19:1–14. doi: 10.1080/15374416.2020.1833734. PMID: 33210938. [PubMed: 33210938] [CrossRef]

Sibley MH, Graziano PA, Coxe SJ, et al. A Randomized Community-Based Trial of Behavior Therapy vs. Usual Care for Adolescent ADHD: Secondary Outcomes and Effects on Comorbidity. Behavior Therapy. 2023. doi: 10.1016/j.beth.2023.03.001. [CrossRef]

Sibley MH, Kuriyan AB. DSM-5 changes enhance parent identification of symptoms in adolescents with ADHD. Psychiatry Research. 2016 Aug 30, 2016;242:180–5. doi: 10.1016/j.psychres.2016.05.036. PMID: 27288736. [PubMed: 27288736] [CrossRef]

Sibley MH, Morley C, Rodriguez L, et al. A peer-delivered intervention for high school students with impairing ADHD symptoms. School Psychology Review. 2020 2020;49(3):275–90.

Sibley MH, Olson S, Morley C, et al. A school consultation intervention for adolescents with ADHD: Barriers and implementation strategies. Child and Adolescent Mental Health. 2016 Nov 2016;21(4):183–91. doi: 10.1111/camh.12159. PMID: 32680339. [PubMed: 32680339] [CrossRef]

Sibley MH, Swanson JM, Arnold LE, et al. Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity. J Child Psychol Psychiatry. 2017 Jun;58(6):655–62. doi: 10.1111/jcpp.12620. PMID: 27642116. [PMC free article: PMC5809153] [PubMed: 27642116] [CrossRef]

Siebelink NM, Bögels SM, Boerboom LM, et al. Mindfulness for children with ADHD and Mindful Parenting (MindChamp): Protocol of a randomised controlled trial comparing a family Mindfulness-Based Intervention as an add-on to care-as-usual with care-as-usual only. BMC Psychiatry. 2018 Jul 25;18(1):237. doi: 10.1186/s12888-018-1811-y. PMID: 30045714. [PMC free article: PMC6060473] [PubMed: 30045714] [CrossRef]

Sierawska A, Prehn-Kristensen A, Brauer H, et al. Transcranial direct-current stimulation and pediatric attention deficit hyperactivity disorder (ADHD)-Findings from an interview ethics study with children, adolescents, and their parents. Prog Brain Res. 2021;264:363–86. doi: 10.1016/bs.pbr.2021.04.002. PMID: 34167663. [PubMed: 34167663] [CrossRef]

Silk TJ, Genc S, Anderson V, et al. Developmental brain trajectories in children with ADHD and controls: a longitudinal neuroimaging study. BMC Psychiatry. 2016 Mar 11;16:59. doi: 10.1186/s12888-016-0770-4. PMID: 26969310. [PMC free article: PMC4787204] [PubMed: 26969310] [CrossRef]

Silva R, Muniz R, Pestreich LK, et al. Efficacy of two long-acting methylphenidate formulations in children with attention- deficit/hyperactivity disorder in a laboratory classroom setting. J Child Adolesc Psychopharmacol. 2005 Aug;15(4):637–54. doi: 10.1089/cap.2005.15.637. PMID: 16190795. [PubMed: 16190795] [CrossRef]

Singh LJ, Gaye F, Cole AM, et al. Central executive training for ADHD: Effects on academic achievement, productivity, and success in the classroom. Neuropsychology. 2022 May;36(4):330–45. doi: 10.1037/neu0000798. PMID: 35343732. [PMC free article: PMC9035079] [PubMed: 35343732] [CrossRef]

Smith SD, Crowley MJ, Ferrey A, et al. Effects of Integrated Brain, Body, and Social (IBBS) intervention on ERP measures of attentional control in children with ADHD. Psychiatry Res. 2019 Aug;278:248–57. doi: 10.1016/j.psychres.2019.06.021. PMID: 31233935. [PMC free article: PMC6637759] [PubMed: 31233935] [CrossRef]

Smith T, Aman MG, Arnold LE, et al. Atomoxetine and Parent Training for Children With Autism and Attention-Deficit/Hyperactivity Disorder: A 24-Week Extension Study. J Am Acad Child Adolesc Psychiatry. 2016 Oct;55(10):868–76.e2. doi: 10.1016/j.jaac.2016.06.015. PMID: 27663942. [PMC free article: PMC5108566] [PubMed: 27663942] [CrossRef]

Smith ZR, Langberg JM. Do sluggish cognitive tempo symptoms improve with school-based ADHD interventions? Outcomes and predictors of change. J Child Psychol Psychiatry. 2020 May;61(5):575–83. doi: 10.1111/jcpp.13149. PMID: 31667859. [PubMed: 31667859] [CrossRef]

Sokolova E, Groot P, Claassen T, et al. Statistical Evidence Suggests that Inattention Drives Hyperactivity/Impulsivity in Attention Deficit-Hyperactivity Disorder. PLoS One. 2016;11(10):e0165120. doi: 10.1371/journal.pone.0165120. PMID: 27768717. [PMC free article: PMC5074570] [PubMed: 27768717] [CrossRef]

Solanto MV, Abikoff H, Sonuga-Barke E, et al. The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: a supplement to the NIMH multimodal treatment study of AD/HD. J Abnorm Child Psychol. 2001 Jun;29(3):215–28. doi: 10.1023/a:1010329714819. PMID: 11411784. [PubMed: 11411784] [CrossRef]

Solleveld MM, Schrantee A, Baek HK, et al. Effects of 16 Weeks of Methylphenidate Treatment on Actigraph-Assessed Sleep Measures in Medication-Naive Children With ADHD. Front Psychiatry. 2020;11:82. doi: 10.3389/fpsyt.2020.00082. PMID: 32184743. [PMC free article: PMC7058799] [PubMed: 32184743] [CrossRef]

Song S, Qiu J, Lu W. Predicting disease severity in children with combined attention deficit hyperactivity disorder using quantitative features from structural MRI of amygdaloid and hippocampal subfields. J Neural Eng. 2021 Mar 25;18(4). doi: 10.1088/1741-2552/abeddf. PMID: 33706290. [PubMed: 33706290] [CrossRef]

Sonuga-Barke E, Daley D, Thompson M. Does maternal ADHD reduce the effectiveness of parent training for preschool children’s ADHD? J Am Acad Child Adolesc Psychiatry. 2002;41(6):696–702. [PubMed: 12049444]

Soutullo C, Banaschewski T, Lecendreux M, et al. A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents. CNS Drugs. 2013 Sep;27(9):743–51. doi: 10.1007/s40263-013-0086-6. PMID: 23801529. [PMC free article: PMC3751426] [PubMed: 23801529] [CrossRef]

Spencer TJ, Faraone SV, Biederman J, et al. Does prolonged therapy with a long-acting stimulant suppress growth in children with ADHD? J Am Acad Child Adolesc Psychiatry. 2006 May;45(5):527–37. doi: 10.1097/01.chi.0000205710.01690.d4. PMID: 16670649. [PubMed: 16670649] [CrossRef]

Sprafkin J, Gadow KD, Nolan EE. The Utility of a DSM-IV-Referenced Screening Instrument for Attention-Deficit/Hyperactivity Disorder. Journal of Emotional and Behavioral Disorders. 2001 2001/07/01;9(3):182–91. doi: 10.1177/106342660100900304. [CrossRef]

Stein MA, Sikirica V, Weiss MD, et al. Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled Trial. CNS Drugs. 2015 Nov;29(11):953–62. doi: 10.1007/s40263-015-0291-6. PMID: 26547425. [PMC free article: PMC4653245] [PubMed: 26547425] [CrossRef]

Steiner N, Frenette EC, Rene KM, et al. Neurofeedback and cognitive attention training for children with attention-deficit hyperactivity disorder in schools. J Dev Behav Pediatr. 2014 Jan;35(1):18–27. doi: 10.1097/dbp.0000000000000009. PMID: 24399101. [PubMed: 24399101] [CrossRef]

Storebo OJ, Pedersen J, Skoog M, et al. Randomised social-skills training and parental training plus standard treatment versus standard treatment of children with attention deficit hyperactivity disorder - the SOSTRA trial protocol. Trials. 2011 Jan 21;12:18. doi: 10.1186/1745-6215-12-18. PMID: 21255399. [PMC free article: PMC3038941] [PubMed: 21255399] [CrossRef]

Sun Y, Zhao L, Lan Z, et al. Differentiating boys with ADHD from those with typical development based on whole-brain functional connections using a machine learning approach. Neuropsychiatric Disease and Treatment. 2020;16:691–702. doi: 10.2147/NDT.S239013. [PMC free article: PMC7071874] [PubMed: 32210565] [CrossRef]

Sunovion. Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia. 2009.

Sunovion. Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia. 2009.

Sunovion. Dasotraline Pediatric ADHD Study. 2015.

Sunovion. Dasotraline Pediatric Extension Study. 2015.

Supernus Pharmaceuticals I. Efficacy and Safety of SPN-812 (Viloxazine Extended-release Capsule) in Children With ADHD. 2016.

Supernus Pharmaceuticals I. Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Children With ADHD. 2017.

Supernus Pharmaceuticals I. Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD. 2017.

Supernus Pharmaceuticals Inc. A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD). 2011.

Supernus Pharmaceuticals Inc. Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 Extended Release (ER). 2016.

Supernus Pharmaceuticals Inc. Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Adolescents With ADHD. 2017.

Supernus Pharmaceuticals Inc. Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Children With ADHD. 2017.

Svanborg P, Thernlund G, Gustafsson PA, et al. Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in Swedish children and adolescents. Eur Child Adolesc Psychiatry. 2009 Dec;18(12):725–35. doi: 10.1007/s00787-009-0031-x. PMID: 19466476. [PMC free article: PMC2770135] [PubMed: 19466476] [CrossRef]

Swanson J, Arnold LE, Kraemer H, et al. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary. J Atten Disord. 2008 Jul;12(1):4–14. doi: 10.1177/1087054708319345. PMID: 18573923. [PubMed: 18573923] [CrossRef]

Swanson J, Arnold LE, Kraemer H, et al. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details. J Atten Disord. 2008 Jul;12(1):15–43. doi: 10.1177/1087054708319525. PMID: 18573924. [PubMed: 18573924] [CrossRef]

Swanson J GL, Wigal T, et al. Stimulant-related reductions of growth rates in the PATS. J Am Acad Child Adolesc Psychiatry. 2006;45(11):1304–13. [PubMed: 17023868]

Swanson JM, Arnold LE, Molina BSG, et al. Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression. J Child Psychol Psychiatry. 2017 Jun;58(6):663–78. doi: 10.1111/jcpp.12684. PMID: 28295312. [PMC free article: PMC6168061] [PubMed: 28295312] [CrossRef]

Swanson JM, Elliott GR, Greenhill LL, et al. Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):1015–27. doi: 10.1097/chi.0b013e3180686d7e. PMID: 17667480. [PubMed: 17667480] [CrossRef]

Swanson JM, Hinshaw SP, Arnold LE, et al. Secondary Evaluations of MTA 36-Month Outcomes: Propensity Score and Growth Mixture Model Analyses. Journal of the American Academy of Child & Adolescent Psychiatry. 2007 08/01/;46(8):1003–14. doi: 10.1097/CHI.0b013e3180686d63. PMID: EJ944777. [PubMed: 17667479] [CrossRef]

Swanson JM, Kraemer HC, Hinshaw SP, et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry. 2001 Feb;40(2):168–79. doi: 10.1097/00004583-200102000-00011. PMID: 11211365. [PubMed: 11211365] [CrossRef]

Swanson JM, Wigal T, Jensen PS, et al. The Qualitative Interview Study of Persistent and Nonpersistent Substance Use in the MTA: Sample Characteristics, Frequent Use, and Reasons for Use. J Atten Disord. 2018 Jul;22(9_suppl):21s–37s. doi: 10.1177/1087054717714058. PMID: 29090967. [PMC free article: PMC6746244] [PubMed: 29090967] [CrossRef]

Taisho Pharmaceutical Co. L. A Phase II, Placebo-Controlled, Double-Blind Trial of TS-141 in Children with Attention-Deficit Hyperactivity Disorder (ADHD). 2016. https://www​.clinicaltrials​.jp/cti-user/trial/Show.jsp. Accessed on October 11 2022.

Talebi N, Motie Nasrabadi A. Investigating the discrimination of linear and nonlinear effective connectivity patterns of EEG signals in children with Attention-Deficit/Hyperactivity Disorder and Typically Developing children. Comput Biol Med. 2022 Sep;148:105791. doi: 10.1016/j.compbiomed.2022.105791. PMID: 35863245. [PubMed: 35863245] [CrossRef]

Tehran University of Medical Sciences. Amantadine Versus Ritalin in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD). 2010.

Tehran University of Medical Sciences. Saffron versus Methylphenidate in the treatment of Attention Deficit/ Hyperactivity Disorder: a double-blind and randomized trial. 2017. https://en​.irct.ir/trial/943. Accessed on October 6 2022.

The National Center on Addiction Substance Abuse at Columbia University, Institute P-COR. Integrated Treatment for Adolescents With ADHD. 2015.

The Neurofeedback Collaborative Group. Neurofeedback for Attention-Deficit/Hyperactivity Disorder: 25-Month Follow-up of Double-Blind Randomized Controlled Trial. Journal of the American Academy of Child and Adolescent Psychiatry. 2023;62(4):435–46. doi: 10.1016/j.jaac.2022.07.862. [PMC free article: PMC10065891] [PubMed: 36521694] [CrossRef]

The University of Texas Health Science Center Houston. Interventions for Children With Attention and Reading Disorders. 2010.

Therapeutics N. Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD. 2007.

Tor HT, Ooi CP, Lim-Ashworth NS, et al. Automated detection of conduct disorder and attention deficit hyperactivity disorder using decomposition and nonlinear techniques with EEG signals. Comput Methods Programs Biomed. 2021 Mar;200:105941. doi: 10.1016/j.cmpb.2021.105941. PMID: 33486340. [PubMed: 33486340] [CrossRef]

Tran JLA, Sheng R, Beaulieu A, et al. Cost-Effectiveness of a Behavioral Psychosocial Treatment Integrated Across Home and School for Pediatric ADHD-Inattentive Type. Adm Policy Ment Health. 2018 Sep;45(5):741–50. doi: 10.1007/s10488-018-0857-y. PMID: 29480503. [PubMed: 29480503] [CrossRef]

Tremols V, Bielsa A, Soliva JC, et al. Differential abnormalities of the head and body of the caudate nucleus in attention deficit-hyperactivity disorder. Psychiatry Res. 2008 Aug 30;163(3):270–8. doi: 10.1016/j.pscychresns.2007.04.017. PMID: 18656331. [PubMed: 18656331] [CrossRef]

Trzepacz PT, Spencer TJ, Zhang S, et al. Effect of atomoxetine on Tanner stage sexual development in children and adolescents with attention deficit/hyperactivity disorder: 18-month results from a double-blind, placebo-controlled trial. Curr Med Res Opin. 2011;27 Suppl 2:45–52. doi: 10.1185/03007995.2011.599372. PMID: 21973230. [PubMed: 21973230] [CrossRef]

Tsang TW, Kohn MR, Hermens DF, et al. A randomized controlled trial investigation of a non-stimulant in attention deficit hyperactivity disorder (ACTION): rationale and design. Trials. 2011 Mar 13;12:77. doi: 10.1186/1745-6215-12-77. PMID: 21396130. [PMC free article: PMC3068100] [PubMed: 21396130] [CrossRef]

Tufts Medical Center. Study of Computer Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder. 2009.

Universität BernInstitut für Sportwissenschaft. The effects of an exergame intervention on the executive functions of children with ADHD. 2016. https://www​.drks.de/drks_web/navigate​.do?navigationId=trial​.HTML&TRIAL​_ID=DRKS00010171. Accessed on October 11 2022.

Université du Québec a Montréal, Montréal Ud, Sherbrooke Ud, et al. the Cogmed Program for Youths With ADHD. 2014.

University of Aarhus, Glostrup University Hospital C, TrygFonden D, et al. A Controlled Study of Parent Training in the Treatment of ADHD in Young Children. 2012.

University of California Los Angeles, Health NIoM. Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder. 2007.

University of Cincinnati, Abuse NIoD, University of Colorado D. Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance Use Disorders (SUD). 2006.

University of Cincinnati, Disorders NIoN, Stroke. Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children. 1999.

University of Cologne, Shire. Enhancement of Methylphenidate Treatment by Psychosocial Intervention and Support. 2012.

University of Genova. Taekwondo Practice in Adolescents With Attention Deficit Hyperactivity Disorder. 2015.

University of Nebraska. Study of the Effect of Calorie Supplementation on Growth in Young Children on ADHD Medication. 2006.

University of Pittsburgh. Effectiveness of Collaborative Services in Primary Care for Treating Children With Behavior Disorders. 2000.

University of Zurich, Foundation SNS. Neurofeedback and Computerized Cognitive Training in Different Settings for Children and Adolescents With ADHD. 2013.

Uppsala County Council CaAP. Structured skill training for adolescents with attention deficit hyperactivity disorder - a randomized controlled study. 2016. https://www​.isrctn.com​/ISRCTN17366720?q=ISRCTN17366720&filters​=&sort​=&offset​=1&totalResults​=1&page=1&pageSize=10. Accessed on October 11 2022.

van der Donk ML, Hiemstra-Beernink AC, Tjeenk-Kalff AC, et al. Interventions to improve executive functioning and working memory in school-aged children with AD(H)D: a randomised controlled trial and stepped-care approach. BMC Psychiatry. 2013 Jan 11;13:23. doi: 10.1186/1471-244x-13-23. PMID: 23311304. [PMC free article: PMC3548701] [PubMed: 23311304] [CrossRef]

van der Donk MLA, Hiemstra-Beernink AC, Tjeenk-Kalff AC, et al. Predictors and Moderators of Treatment Outcome in Cognitive Training for Children With ADHD. J Atten Disord. 2020 Nov;24(13):1914–27. doi: 10.1177/1087054716632876. PMID: 26951059. [PubMed: 26951059] [CrossRef]

van der Oord S, Prins PJ, Oosterlaan J, et al. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study. Clin Psychol Psychother. 2012 May–Jun;19(3):270–8. doi: 10.1002/cpp.750. PMID: 21404369. [PubMed: 21404369] [CrossRef]

van Mourik R, Research ZTNOfH, Development, et al. Train Your Brain and Exercise Your Heart? Advancing the Treatment for Attention Deficit Hyperactivity Disorder (ADHD). 2010.

Vander Stoep A, McCarty CA, Zhou C, et al. The Children’s Attention-Deficit Hyperactivity Disorder Telemental Health Treatment Study: Caregiver Outcomes. J Abnorm Child Psychol. 2017 Jan;45(1):27–43. doi: 10.1007/s10802-016-0155-7. PMID: 27117555. [PMC free article: PMC5083233] [PubMed: 27117555] [CrossRef]

Vice Chancellor for research of Tehran university of Medical Sciences. Effectiveness of Sweet almond syrup, Iranian Traditional Medicine product, compared with methylphenidate for Attention-Deficit/Hyperactivity Disorder in children: triple-blind randomized Clinical trial. 2015. https://en​.irct.ir/trial/19183. Accessed on October 6 2022.

Vimalajeewa D, McDonald E, Bruce SA, et al. Wavelet-based approach for diagnosing attention deficit hyperactivity disorder (ADHD). Sci Rep. 2022 Dec 19;12(1):21928. doi: 10.1038/s41598-022-26077-2. PMID: 36535997. [PMC free article: PMC9763347] [PubMed: 36535997] [CrossRef]

Vitiello B, Elliott GR, Swanson JM, et al. Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD. Am J Psychiatry. 2012 Feb;169(2):167–77. doi: 10.1176/appi.ajp.2011.10111705. PMID: 21890793. [PMC free article: PMC4132884] [PubMed: 21890793] [CrossRef]

Vitiello B, Severe JB, Greenhill LL, et al. Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA. J Am Acad Child Adolesc Psychiatry. 2001 Feb;40(2):188–96. doi: 10.1097/00004583-200102000-00013. PMID: 11211367. [PubMed: 11211367] [CrossRef]

von Wirth E, Breuer D, Mandler J, et al. Prediction of Educational Attainment and Occupational Functioning in Young Adults With a Childhood Diagnosis of ADHD: Results from the Cologne Adaptive Multimodal Treatment (CAMT) Study. J Atten Disord. 2021 Oct 26;26(7):10870547211045740. doi: 10.1177/10870547211045740. PMID: 34697953. [PubMed: 34697953] [CrossRef]

Wageningen University (The Netherlands). The INCA study: a study into the Impact of Nutrition on Children with Attention-Deficit Hyperactivity Disorder (ADHD). 2008. https://www​.isrctn.com​/ISRCTN76063113?q=ISRCTN76063113&filters​=&sort​=&offset​=1&totalResults​=1&page=1&pageSize=10. Accessed on October 11 2022.

Wainstein G, Rojas-Líbano D, Crossley NA, et al. Pupil Size Tracks Attentional Performance In Attention-Deficit/Hyperactivity Disorder. Sci Rep. 2017 Aug 15;7(1):8228. doi: 10.1038/s41598-017-08246-w. PMID: 28811624. [PMC free article: PMC5557799] [PubMed: 28811624] [CrossRef]

Wang C, Wang X, Jing X, et al. Towards high-accuracy classifying attention-deficit/hyperactivity disorders using CNN-LSTM model. J Neural Eng. 2022 Jul 20;19(4). doi: 10.1088/1741-2552/ac7f5d. PMID: 35797967. [PubMed: 35797967] [CrossRef]

Wang D, Hong D, Wu Q. Attention Deficit Hyperactivity Disorder Classification Based on Deep Learning. IEEE/ACM Trans Comput Biol Bioinform. 2022 Apr 26;Pp. doi: 10.1109/tcbb.2022.3170527. PMID: 35471884. [PubMed: 35471884] [CrossRef]

Wang D, Hu R, Wang Q, et al. Spatiotemporal consistency analysis of attention-deficit/hyperactivity disorder children. Neurosci Lett. 2020 Aug 24;734:135099. doi: 10.1016/j.neulet.2020.135099. PMID: 32470553. [PubMed: 32470553] [CrossRef]

Wang JB, Zheng LJ, Cao QJ, et al. Inconsistency in abnormal brain activity across cohorts of adhd-200 in children with attention deficit hyperactivity disorder. Frontiers in Neuroscience. 2017;11(JUN). doi: 10.3389/fnins.2017.00320. [CrossRef]

Wang P, Zhao X, Zhong J, et al. Localization and Diagnosis of Attention-Deficit/Hyperactivity Disorder. Healthcare (Basel). 2021 Mar 27;9(4). doi: 10.3390/healthcare9040372. PMID: 33801750. [PMC free article: PMC8066369] [PubMed: 33801750] [CrossRef]

Wang XH, Jiao Y, Li L. Predicting clinical symptoms of attention deficit hyperactivity disorder based on temporal patterns between and within intrinsic connectivity networks. Neuroscience. 2017 Oct 24;362:60–9. doi: 10.1016/j.neuroscience.2017.08.038. PMID: 28843999. [PubMed: 28843999] [CrossRef]

Wang XH, Jiao Y, Li L. Identifying individuals with attention deficit hyperactivity disorder based on temporal variability of dynamic functional connectivity. Sci Rep. 2018 Aug 7;8(1):11789. doi: 10.1038/s41598-018-30308-w. PMID: 30087369. [PMC free article: PMC6081414] [PubMed: 30087369] [CrossRef]

Wang XH, Jiao Y, Li L. Diagnostic model for attention-deficit hyperactivity disorder based on interregional morphological connectivity. Neurosci Lett. 2018 Oct 15;685:30–4. doi: 10.1016/j.neulet.2018.07.029. PMID: 30031733. [PubMed: 30031733] [CrossRef]

Wang XH, Xu J, Li L. Estimating individual scores of inattention and impulsivity based on dynamic features of intrinsic connectivity network. Neurosci Lett. 2020 Apr 17;724:134874. doi: 10.1016/j.neulet.2020.134874. PMID: 32114120. [PubMed: 32114120] [CrossRef]

Wang Y. 18.4 IMAGING THE TREATMENT OF ADHD. Journal of the American Academy of Child and Adolescent Psychiatry. 2021;60(10):S286. doi: 10.1016/j.jaac.2021.07.658. [CrossRef]

Wang Z, Zhou X, Gui Y, et al. Multiple measurement analysis of resting-state fMRI for ADHD classification in adolescent brain from the ABCD study. Transl Psychiatry. 2023 Feb 6;13(1):45. doi: 10.1038/s41398-023-02309-5. PMID: 36746929. [PMC free article: PMC9902465] [PubMed: 36746929] [CrossRef]

Wanga V, Danielson ML, Bitsko RH, et al. Stability of mental disorder prevalence estimates among school-aged children and adolescents: findings from the community-based project to learn about youth-mental health (PLAY-MH) and replication-PLAY-MH (Re-PLAY-MH), 2014-2017. Ann Epidemiol. 2022 Aug;72:82–90. doi: 10.1016/j.annepidem.2022.05.007. PMID: 35661706. [PMC free article: PMC10936225] [PubMed: 35661706] [CrossRef]

Wangler S, Gevensleben H, Albrecht B, et al. Neurofeedback in children with ADHD: specific event-related potential findings of a randomized controlled trial. Clin Neurophysiol. 2011 May;122(5):942–50. doi: 10.1016/j.clinph.2010.06.036. [PubMed: 20843737] [CrossRef]

Waxmonsky JG, Pelham WE, 3rd, Baweja R, et al. Predictors of Changes in Height, Weight, and Body Mass Index After Initiation of Central Nervous System Stimulants in Children with Attention Deficit Hyperactivity Disorder. J Pediatr. 2021 Sep 25. doi: 10.1016/j.jpeds.2021.09.030. PMID: 34571023. [PMC free article: PMC8792191] [PubMed: 34571023] [CrossRef]

Waxmonsky JG, Pelham WE, 3rd, Campa A, et al. A Randomized Controlled Trial of Interventions for Growth Suppression in Children With Attention-Deficit/Hyperactivity Disorder Treated With Central Nervous System Stimulants. J Am Acad Child Adolesc Psychiatry. 2020 Dec;59(12):1330–41. doi: 10.1016/j.jaac.2019.08.472. PMID: 31473291. [PMC free article: PMC7048642] [PubMed: 31473291] [CrossRef]

Wehmeier PM, Dittmann RW, Banaschewski T, et al. Does stimulant pretreatment modify atomoxetine effects on core symptoms of ADHD in children assessed by quantitative measurement technology? J Atten Disord. 2014 Feb;18(2):105–16. doi: 10.1177/1087054712445184. PMID: 22617861. [PubMed: 22617861] [CrossRef]

Wehmeier PM, Kipp L, Banaschewski T, et al. Does Comorbid Disruptive Behavior Modify the Effects of Atomoxetine on ADHD Symptoms as Measured by a Continuous Performance Test and a Motion Tracking Device? J Atten Disord. 2015 Jul;19(7):591–602. doi: 10.1177/1087054712456739. PMID: 22930789. [PubMed: 22930789] [CrossRef]

Wehmeier PM, Schacht A, Dittmann RW, et al. Effect of atomoxetine on quality of life and family burden: results from a randomized, placebo-controlled, double-blind study in children and adolescents with ADHD and comorbid oppositional defiant or conduct disorder. Qual Life Res. 2011 Jun;20(5):691–702. doi: 10.1007/s11136-010-9803-5. PMID: 21136299. [PubMed: 21136299] [CrossRef]

Wehmeier PM, Schacht A, Wolff C, et al. Neuropsychological outcomes across the day in children with attention-deficit/hyperactivity disorder treated with atomoxetine: results from a placebo-controlled study using a computer-based continuous performance test combined with an infra-red motion-tracking device. J Child Adolesc Psychopharmacol. 2011 Oct;21(5):433–44. doi: 10.1089/cap.2010.0142. PMID: 22040189. [PubMed: 22040189] [CrossRef]

Weisner TS, Murray DW, Jensen PS, et al. Follow-Up of Young Adults With ADHD in the MTA: Design and Methods for Qualitative Interviews. J Atten Disord. 2018 Jul;22(9_suppl):10s–20s. doi: 10.1177/1087054717713639. PMID: 28617075. [PMC free article: PMC5711631] [PubMed: 28617075] [CrossRef]

Weiss M, Childress A, Mattingly G, et al. Relationship Between Symptomatic and Functional Improvement and Remission in a Treatment Response to Stimulant Trial. J Child Adolesc Psychopharmacol. 2018 Oct;28(8):521–9. doi: 10.1089/cap.2017.0166. PMID: 30036076. [PMC free article: PMC6201781] [PubMed: 30036076] [CrossRef]

Weiss M, Childress A, Nordbrock E, et al. Characteristics of ADHD symptom response/remission in a clinical trial of methylphenidate extended release. Journal of Clinical Medicine. 2019;8(4). doi: 10.3390/jcm8040461. [CrossRef]

Weiss MD, Surman C, Khullar A, et al. Effect of a Multilayer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial Followed by a 6-Month Open-Label Follow-Up. J Child Adolesc Psychopharmacol. 2021 Nov;31(9):623–30. doi: 10.1089/cap.2021.0087. PMID: 34714112. [PubMed: 34714112] [CrossRef]

Wells KC, Epstein JN, Hinshaw SP, et al. Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study. J Abnorm Child Psychol. 2000 Dec;28(6):543–53. doi: 10.1023/a:1005131131159. PMID: 11104316. [PubMed: 11104316] [CrossRef]

Wells KC CT, Hinshaw SP, et al. Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder. J Consult Clin Psychol. 2006 Aug;74(4):649–57. doi: 10.1037/0022-006X.74.4.649. PMID: 16881772. [PubMed: 16881772] [CrossRef]

Wietecha LW, D.; Shaywitz, S.; Shaywitz, B.; Hooper, SR.; Wigal, SB.; Dunn, D.; McBurnett, K. Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial. J Child Adolesc Psychopharmacol. 2013 Nov;23(9):605–13. doi: 10.1089/cap.2013.0054. PMID: 24206099. [PMC free article: PMC3842866] [PubMed: 24206099] [CrossRef]

Wigal T GL, Chuang S, et al. Safety and tolerability of methylphenidate in preschool children with ADHD. J Am Acad Child Adolesc Psychiatry. 2006;45(11):1294–303. [PubMed: 17028508]

Wilens TE, McBurnett K, Turnbow J, et al. Morning and Evening Effects of Guanfacine Extended Release Adjunctive to Psychostimulants in Pediatric ADHD. J Atten Disord. 2017 Jan;21(2):110–9. doi: 10.1177/1087054713500144. PMID: 24071772. [PubMed: 24071772] [CrossRef]

Williamson D, Murray DW, Damaraju CV, et al. Methylphenidate in children with ADHD with or without learning disability. J Atten Disord. 2014 Feb;18(2):95–104. doi: 10.1177/1087054712443411. PMID: 22628142. [PubMed: 22628142] [CrossRef]

Winhusen TM, Lewis DF, Riggs PD, et al. Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011 Oct;21(5):455–63. doi: 10.1089/cap.2011.0014. PMID: 22040190. [PMC free article: PMC3243465] [PubMed: 22040190] [CrossRef]

Wolraich ML, Bard DE, Neas B, et al. The psychometric properties of the Vanderbilt attention-deficit hyperactivity disorder diagnostic teacher rating scale in a community population. J Dev Behav Pediatr. 2013 Feb;34(2):83–93. doi: 10.1097/DBP.0b013e31827d55c3. PMID: 23363973. [PubMed: 23363973] [CrossRef]

Wu CS, Shang CY, Lin HY, et al. Differential Treatment Effects of Methylphenidate and Atomoxetine on Executive Functions in Children with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2021 Apr;31(3):187–96. doi: 10.1089/cap.2020.0146. PMID: 33890819. [PubMed: 33890819] [CrossRef]

Xinhua Hospital Shanghai Jiao Tong University School of Medicine. A Randomized Controlled Study of MEFP for Preschool Children With ADHD. 2017.

Yale University, Health EKSNIoC, Development H, et al. Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD). 2012.

Yang L, Cao Q, Shuai L, et al. Comparative study of OROS-MPH and atomoxetine on executive function improvement in ADHD: a randomized controlled trial. Int J Neuropsychopharmacol. 2012 Feb;15(1):15–26. doi: 10.1017/S1461145711001490. PMID: 22017969. [PubMed: 22017969] [CrossRef]

Yasumura A, Kokubo N, Yamamoto H, et al. Neurobehavioral and hemodynamic evaluation of Stroop and reverse Stroop interference in children with attention-deficit/hyperactivity disorder. Brain Dev. 2014 Feb;36(2):97–106. doi: 10.1016/j.braindev.2013.01.005. PMID: 23414618. [PubMed: 23414618] [CrossRef]

Yin W, Li T, Mucha PJ, et al. Altered neural flexibility in children with attention-deficit/hyperactivity disorder. Mol Psychiatry. 2022 Nov;27(11):4673–9. doi: 10.1038/s41380-022-01706-4. PMID: 35869272. [PMC free article: PMC9734048] [PubMed: 35869272] [CrossRef]

Zeinab Mostajeran. Effect of Ma-Al -Jabin on expression symptoms in hyperactivity disorder: a randomized clinical trial. 2018. https://en​.irct.ir/trial/30538. Accessed on October 6 2022.

Zhan Y, Wei J, Liang J, et al. Diagnostic Classification for Human Autism and Obsessive-Compulsive Disorder Based on Machine Learning From a Primate Genetic Model. Am J Psychiatry. 2021 Jan 1;178(1):65–76. doi: 10.1176/appi.ajp.2020.19101091. PMID: 32539526. [PubMed: 32539526] [CrossRef]

Zhou X, Lin Q, Gui Y, et al. Multimodal MR Images-Based Diagnosis of Early Adolescent Attention-Deficit/Hyperactivity Disorder Using Multiple Kernel Learning. Front Neurosci. 2021;15:710133. doi: 10.3389/fnins.2021.710133. PMID: 34594183. [PMC free article: PMC8477011] [PubMed: 34594183] [CrossRef]

Zhou ZW, Fang YT, Lan XQ, et al. Inconsistency in abnormal functional connectivity across datasets of ADHD-200 in children with attention deficit hyperactivity disorder. Frontiers in Psychiatry. 2019;10(SEP). doi: 10.3389/fpsyt.2019.00692. [CrossRef]

Zhu L, Chang W. Application of deep convolutional neural networks in attention-deficit/hyperactivity disorder classification: Data augmentation and convolutional neural network transfer learning. Journal of Medical Imaging and Health Informatics. 2019;9(8):1717–24. doi: 10.1166/jmihi.2019.2843. [CrossRef]

ZIli Fan, University P. Intensive Executive Function Training. 2016.

Zimovetz EA, Beard SM, Hodgkins P, et al. A cost-utility analysis of lisdexamfetamine versus atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and inadequate response to methylphenidate. CNS Drugs. 2016 Oct 2016;30(10):985–96. doi: 10.1007/s40263-016-0354-3. PMID: 27530525. [PMC free article: PMC5035654] [PubMed: 27530525] [CrossRef]

Zou L, Zheng J, Miao C, et al. 3D CNN Based Automatic Diagnosis of Attention Deficit Hyperactivity Disorder Using Functional and Structural MRI. IEEE Access. 2017;5:23626–36. doi: 10.1109/ACCESS.2017.2762703. [CrossRef]

Zuberer A, Minder F, Brandeis D, et al. Mixed-Effects Modeling of Neurofeedback Self-Regulation Performance: Moderators for Learning in Children with ADHD. Neural Plast. 2018;2018:2464310. doi: 10.1155/2018/2464310. PMID: 29765401. [PMC free article: PMC5885491] [PubMed: 29765401] [CrossRef]

Daley D, Van Der Oord S, Ferrin M, et al. Practitioner Review: Current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder. J Child Psychol Psychiatry. 2018 Sep;59(9):932–47. doi: 10.1111/jcpp.12825. PMID: 29083042. [PubMed: 29083042] [CrossRef]

Sonuga-Barke EJ, Brandeis D, Cortese S, et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry. 2013 Mar;170(3):275–89. doi: 10.1176/appi.ajp.2012.12070991. PMID: 23360949. [PubMed: 23360949] [CrossRef]

Coghill D, Banaschewski T, Cortese S, et al. The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG). Eur Child Adolesc Psychiatry. 2021 Oct 22:1–25. doi: 10.1007/s00787-021-01871-x. PMID: 34677682. [PMC free article: PMC8532460] [PubMed: 34677682] [CrossRef]

Sibley MH, Bruton AM, Zhao X, et al. Non-pharmacological interventions for attention-deficit hyperactivity disorder in children and adolescents. Lancet Child Adolesc Health. 2023 Jun;7(6):415–28. doi: 10.1016/S2352-4642(22)00381-9. PMID: 36907194. [PMC free article: PMC10370370] [PubMed: 36907194] [CrossRef]

Wolraich ML, Hagan JF, Jr., Allan C, et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2019 Oct 2019;144(4).

Centers for Disease Control and Prevention. Attention-Deficit/Hyperactivity Disorder (ADHD). https://www​.cdc.gov/ncbddd/adhd/index​.html. Accessed on May 5, 2023.

Pliszka S, Issues AWGoQ. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007 Jul;46(7):894–921. doi: 10.1097/chi.0b013e318054e724. PMID: 17581453. [PubMed: 17581453] [CrossRef]

Barbaresi WJ, Campbell L, Diekroger EA, et al. Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder. J Dev Behav Pediatr. 2020 Feb/Mar;41 Suppl 2S:S35–S57. doi: 10.1097/DBP.0000000000000770. PMID: 31996577. [PubMed: 31996577] [CrossRef]

Hall CL, Valentine AZ, Groom MJ, et al. The clinical utility of the continuous performance test and objective measures of activity for diagnosing and monitoring ADHD in children: a systematic review. Eur Child Adolesc Psychiatry. 2016 Jul;25(7):677–99. doi: 10.1007/s00787-015-0798-x. PMID: 26620873. [PubMed: 26620873] [CrossRef]